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1. Summary 
 
The contamination of surface waters with organic micropollutants is a well known 
problem and increased over the last decades. One reason for their release and 
consequently their detection in surface waters is their incomplete degradation and 
therefore insufficient removal during conventional waste water treatment processes. 
To overcome this problem advanced oxidation processes have been proposed as an 
additional treatment step, since the formation of highly reactive hydroxyl radicals 
helps to degrade those substances. 
This study was therefore designed to investigate the toxicological properties 
(cytotoxic, genotoxic, mutagenic and estrogenic) of several substances before and 
after ozonation or UV/H2O2 treatment in either waste water treatment plant effluents 
or HPLC-water using toxicological in vitro methods. These methods are able to 
identify biological effects of the whole water sample thus the entire complexity of 
chemicals. In addition cellular based methods will give an overview on possible 
induction mechanisms which will lead to a manifestation of effects on the organ or 
even organism level.  
In the case of Terbutryn its genotoxicity before treatment was first increased at low 
ozone dosages (36, 100, and 195 µg/L) but was removed at the highest ozone 
dosage (800 µg). Similar results have been shown for TPP. Genotoxic effects were 
only seen before ozonation, but after 60 minutes of ozonation these effects were 
removed. 
The ozonation of Triclosan resulted in the formation of the by-product 2,4-
Dichlorophenol. Both substances did not exhibit cytotoxic effects up to a maximum 
tested concentration of 100 µg/L. Genotoxic effects were only seen for Triclosan 
starting at a concentration of 10 µg/L. Thus a less genotoxic by-product has been 
formed during ozonation. 
The estrogenicity tests showed that HPLC-water containing Bisphenol A did no 
longer have estrogenic effects after UV/H2O2 treatment whereas neither the 
ozonation nor the UV/H2O2 treatment of Ethinylestradiol for 60 minutes resulted in a 
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complete loss of estrogenic activity. The musk fragrance HHCB in contrast did not 
show estrogenic effects, neither before nor after ozonation. 
For the two beta blockers (Atenolol and Metoprolol), the antibiotics Sulfamethoxazole 
and Ofloxacin as well as the musk fragrance AHTN neither before nor after 
ozonation or UV/H2O2 oxidation cytotoxic effects were detected. The ozonation of 
Irgaol 1051 did also not lead to cyto- or genotoxic effects. The results of the 
oxidation experiments with Bisphenol A, Ciprofloxacin and HHCB demonstrated that 
formed oxidation by-products differ in regard to toxicity depending on treatment 
method and water matrix. Cytotoxic effects for all three substances were only 
detected in HPLC-water after 60 minutes of UV/H2O2 but not in waste water 
treatment plant effluent. In addition no toxicity was detected after the same time of 
oxidation using ozone. The tested concentrations of TCPP as well as TCEP were not 
toxic before oxidative treatment. However cytotoxic effects were detected after 
UV/H2O2 treatment whereas the ozonation did not induce cytotoxicity. 
 
In general it can be concluded that ozonation as well as UV/H2O2 oxidation are two 
useful methods for the removal of the here tested substances from the effluents of 
waste water treatment plants in regard to their degradation and to prevent the 
formation of toxic oxidation by-products considering the used test methods (MTT 
Test, PAN I, Alkaline Comet Assay, Ames Test, and ER Calux). However a 
generalized statement about micropollutants their removal and toxicity is not 
possible, and needs to be established on a case by case basis since operating 
conditions as well as the matrix composition vary over time. The successful use of 
toxicological in vitro methods for the detection of biological effects of waste water 
treatment plant effluents in combination with advanced oxidation processes is 
confirmed by other studies, e.g. a study performed by the Eawag at the waste water 
treatment plant in Regensdorf or the PILLS project.  
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2. Introduction 
Water is essential for life and therefore one of the most precious goods on earth. 
Since the amount of fresh water is limited its quality is the most important factor. The 
distribution of safe water, the removal of contaminants as well as the protection of 
the ecosystem and the human health have been a concern for many generations 
and even more to come.  
The occurrence of pharmaceuticals, personal care products and various other 
anthropogenic substances, so called micropollutants, in fresh water and waste water 
treatment plant (WWTP) influents is a well known problem [1-5]. Waste waters 
contain a high diversity of components varying over time and place. These 
components are microorganisms, metals, inorganic substances, organic substances, 
and biodegradable organic substances as well as nutrients [6]. For many of these 
components e.g. nutrients the removal efficiency is high but others like organic 
substances are released into the environment posing a threat to the environment.  
Most of these organic substances are biologically active and thus might have effects 
on the ecosystems and in the end on the human health. Due to an improvement in 
analytical methods the detection limits of micropollutants are becoming lower. It has 
been shown that these substances are not eliminated during waste water treatment 
and reach surface waters resulting in ng/L to even µg/L concentrations [3, 4, 7-14]. 
Because of this discovery waste water treatment plants have to face new problems, 
including new treatment methods as well as new methods to control the quality of 
WWTP effluents. Hereby the contaminated WWTP effluent might pose a threat to 
human health and lead to problems in drinking water treatment since e.g. 
pharmaceuticals are designed to work at low concentrations. Therefore appropriate 
methods need to be developed. These methods need to take into account the 
complete degradation of water contaminants to harmless molecules. Due to the 
variety of those contaminants there is no common treatment until now. The use of 
advanced oxidation processes (AOP) has been widely studied and AOP have been 
shown to be a promising method although in some cases a downstream filtration 
(e.g. through activated carbon or sand) is needed [8, 11, 14-23]. It has also been 
shown that an incomplete degradation promotes the formation of oxidation by-
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products that differ in structure and function from their parent compound and might 
therefore also have different toxicological effects on the environment [24, 25]. 
Therefore methods which are able to detect biological effects of organic 
micropollutants are required. Toxicological in vitro methods are helpful in the 
detection of these effects since there is a great variety of tests available with different 
endpoints which allow the identification of a complex mixture of substances in waste 
water treatment plant effeluents as a precursor for the manifestation of effects on the 
level of organs or organisms [26, 27]. 
 
 
 Micropollutants in waste water treatment plant effluents and 2.1.
surface water 
2.1.1. Guidelines for water quality control 
Although a variety of regulations for the safety and cleanliness of water systems 
have already been established in regard to the water quality on a national basis, the 
implementation of the Water framework directive (WFD) by the European Union is a 
step toward a more sincere water quality management internationally. This directive 
requires the monitoring of biological, chemical, and quantitative parameters for an 
environmental risk assessment. As part of the WFD 33 substances have been 
chosen as priority substances [28], and environmental quality standards have been 
regulated in an EU directive (2008/105/EG) to prevent short term as well as long 
term effects of priority substances on the environment with maximum concentrations 
between 0.004 and 50 µg/L depending on the substance [29]. In addition to the 
European regulations other substances which are not regulated in these directives 
can be regulated by each member state. The German “Oberflächen- 
gewässerverordnung” (Regulation for the protection of surface waters) regulates a 
variety of parameters in accordance with the two above mentioned directives. Priority 
as well as other substances need to be measured 4 – 13 times each year depending 
on their classification [30]. 
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2.1.2. Emission of micropollutants 
The routes by which micropollutants reach the water system are adverse (Figure 1). 
Pharmaceuticals are mainly introduced via the fecal-oral-cycle or by the disposal 
through the plumbing system finally reaching the waste water treatment plant. But 
not only the drug itself reaches the water systems, its metabolites are also 
introduced. After the ingestion of drugs only a part of them gets completely 
metabolized resulting in an input of residues as well as the original substance into 
the water system via excretion. This is true for both, human and veterinary 
pharmaceuticals. The same route can also be applied for personal care products 
which are used in the everyday life. Shampoos, soaps, perfumes etc. containing e.g. 
musk fragrances, are used on a daily basis and are also flushed down the drain 
reaching the water system. Biocides like herbicides, algicides, and insecticides are 
mainly introduced into the water by runoff from areas where they have been applied. 
Other sources of introduction are industrial and hospital waste waters which usually 
contain a high amount of organic substances. In addition to these common routes 
accidental spills or the intentional illegal disposal of chemicals etc. also contribute to 
the presence of anthropogenic substances in the water system. Thus it is either a 
direct input into the surface water or an input through waste water treatment plant 
effluents after an incomplete removal. 
 
Figure 1: Routes of micropollutant contamination of surface waters 
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2.1.3. Substances detected in waste water treatment plant effluents 
The group of organic micropollutants detected in waste water treatment plant 
effluents is composed of a variety of substances including pharmaceuticals, 
pesticides, personal care products, and other chemicals. Thus substances with 
different fields of application and a huge variety of properties are detected in WWTP 
effluents and receiving surface waters [31, 32]. The presence of pharmaceuticals is 
due to their ubiquitous use with 8280 drugs allowed in human medicine in Germany 
[33], as well as their high persistence. In 2010 the volume of defined daily doses 
(DDD) of the 30 most prescribed pharmaceuticals increased of 3.5 % to an amount 
of 35384 million DDD which reflects the trend of the last years [34] although the 
amount of DDD for some pharmaceuticals is decreasing. However this number only 
gives the amount of pharmaceuticals with the need of a prescription (6288 drugs) not 
taking into account over-the-counter drugs (1992 drugs), which have to be added to 
this number. Most of the pharmaceuticals commonly detected are also part of the 
WHO Model List of Essential Medicines, thus a bigger decline in its uses is 
improbable [35]. A literature and database review by Bergmann et al. (2011) 
demonstrates the large amount of pharmaceuticals present in water systems as well 
as the lack of information on their behavior in the environment [12]. In addition to 
human pharmaceuticals veterinary drugs need to be considered since they also 
reach waste water treatment plants and surface waters. Musk fragrances are 
another group of substances frequently detected in surface waters. They are 
constituents of personal care products and are thus also used on a daily basis. Like 
pharmaceuticals they are not easily biodegradable which leads to their detection in 
WWTP effluents and subsequently in surface waters and sediments [36-38].  
 
 
2.1.4. Waste water quality control 
Due to the presence of a variety of substances in the influents of waste water 
treatment plants the treatment efficiency of the plants needs to be surveyed to 
prevent the contamination of receiving surface waters. The quality control of waste 
water treatment plant effluents in Germany is usually determined by physical and 
chemical parameters. Sum parameters like the COD (chemical oxygen demand), 
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BOD (biological oxygen demand), TOC (total organic carbon), DOC (dissolved 
organic carbon), and the conductivity are determined. Group parameters describing 
substances with similar chemical properties, e.g. total nitrogen, are also determined. 
In addition characteristics like the color, turbidity and smell are recorded [39]. All 
these parameters are regulated in the “Abwasserverordnung” (Waste Water 
Ordinance) which defines the limit values allowed to release the waste water 
treatment plant effluent into surface waters (Table 1) taking into account different 
industrial waste waters. A variety of anions (e.g. fluoride, nitrogen compounds, 
phosphate, sulfate) and cations (e.g. aluminium, arsenic, copper, mercury) as well as 
adsorbable organic halogen compounds (AOX) and lipophilic compounds need to be 
determined. Besides these many other parameters need to be monitored. In regard 
to biologically active substances two in vitro methods, the umu-test for the 
determination of mutagenic effects and the luminescent bacteria inhibition test for the 
detection of cytotoxic effects are recommended in the German Abwasserverordnung. 
However these methods are based on bacterial responses and effects might differ 
when tested with eukaryotic cells. The in vivo methods listed in the 
Abwasserverordnung include the fish-egg test and the testing for toxicity in daphnia 
and algae, performed according to the corresponding DIN rules [40].  
 
Table 1: Requirements of the waste water treatment plant effluent at the discharge point at 
12 °C according to the German “Abwasserverordnung” (concentrations in mg/L) [40]. 
 Chemical 
oxygen 
demand 
(COD) 
Biological 
oxygen 
demand 
(BOD) 
Ammoniac 
nitrogen 
(NH4-N) 
Total 
nitrogen 
(Ntot) 
Total 
phosphate 
(Ptot) 
Class 1 150 40 - - - 
Class 2 110 25 - - - 
Class 3 90 20 10 - - 
Class 4 90 20 10 18 2 
Class 5 75 15 10 13 1 
Class 1: < 60 kg/d BOD5; Class 2: 60 – 300 kg/d BOD5; Class 3: 300 – 600 kg/d 
BOD5; Class 4: 600 – 6,000 kg/d BOD5; Class 5: > 6,000 kg/d BOD5 
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Depending on their classification, waste water treatment plants need to meet certain 
criteria. The waste water treatment plants are classified according to the BOD5 value. 
This value describes the amount of oxygen needed for the aerobic degradation of 
organic materials by microorganisms. Thus it gives a measure for the degree of 
pollution. It is an approximate measure for the amount of oxidized organic 
substances after five days because at that time most of the organic matter is 
supposed to be degraded by microorganisms [6]. The BOD5 therefore is a value of 
the population equivalent describing the pollution load. 
 
 
2.1.5. Common waste water treatment 
The first ideas of waste water treatment reach back to ancient times. However the 
development of techniques used during waste water treatment nowadays has been 
started in the late 19th century followed by a steady development of new techniques 
and ways of treatment [41]. 
 
A common waste water treatment plant consists of a pre-treatment and three 
subsequent treatment steps (Figure 2). Before the primary treatment is applied the 
waste water is commonly subjected to the pre-treatment (mechanical treatment) 
where materials like branches, leaves or litter are mechanically removed by a rack. 
During primary treatment, the incoming pre-treated waste water reaches a tank 
where it remains for some time to allow the settlement of bigger solid particles (e.g. 
sand). Dissolved as well as suspended organic matter which was not removed 
during primary treatment is removed during secondary treatment (aerobic-biological 
treatment). This step includes a basin where microorganisms degrade the remaining 
organic matter by the addition of oxygen for an aerobic environment. The best 
possible outcome of this treatment step is a complete degradation of the organic 
matter as well as an oxidation of the inorganic matter. The last step before the water 
is finally released into the environment is the tertiary treatment where the activated 
sludge originating from secondary treatment is removed by deposition. Part of the 
activated sludge is transported back into the secondary treatment basin whereas the 
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other part is transferred to a final sludge treatment which can be done by digestion or 
incineration before it gets deposited. In addition to this a further treatment (e.g. 
disinfection, sand filtration) can be applied according to the further use of the waste 
water treatment plant effluent but is not mandatory. An important part of the waste 
water treatment process is the removal of nutrient salts. The removal of nitrogen 
compounds (nitrification/denitrification) is linked to the biological treatment of the 
secondary treatment. Phosphorous compounds can be removed by flocculation with 
a subsequent filtration [39]. 
 
 
Figure 2: Schematic of a waste water treatment plant. AOP = Advanced Oxidation Processes 
 
However as described before, not all organic substances (e.g. pharmaceuticals, 
personal care products) are removed during the whole treatment process and a 
fourth treatment step is therefore needed to ensure a good water quality according to 
the WFD and national regulations before the effluent is released into receiving 
waters. A variety of possible methods to be applied as a fourth treatment step are 
discussed below. 
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2.1.6. Advanced waste water treatment 
2.1.6.1. Filtration 
The use of membranes for water purification processes has been established in the 
early 20th century with a steady improvement using ceramic or polymeric materials 
with defined pore sizes (0.05 – 5 µm). The principle of a membrane is the filtration 
based on the properties of some substances to pass the membrane without being 
altered. If a substance will pass the membrane is determined by the size of the 
membrane pores thus the pore size is selective. According to the pore size four 
membrane processes can be distinguished (Figure 3). These are reverse osmosis 
(RO; pore size < NF), nanofiltration (NF; pore size < 2 nm), ultrafiltration (UF; pore 
size 2 – 50 nm), and microfiltration (MF; pore size > 50 nm) listed according to the 
pore sizes from small to large [42].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Membrane separation processes overview [42]. 
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Reverse osmosis is a technique commonly used for the desalination of seawater by 
separating the water molecules and the ions through a membrane under pressure 
(20 – 100 bar) [31]. This method is also thought of as an additional treatment step to 
remove remaining micropollutants after waste water treatment. However there are 
some limitations. Organic substances might be dissolved in the membrane remaining 
there for a certain time before they are released. Thus also the water is thought to be 
clean, at some point it might be polluted again. Another limitation is the property of 
organic substances to penetrate the membrane more easily than the water 
molecules resulting in no removal at all [31, 43]. Nanofiltration is used for the 
separation of dissolved organic matter (> 200 g/mol), divalent cations and anions. It 
is therefore often used for the softening of water. During ultrafiltration viruses and 
colloids are rejected by the membrane whereas the microfiltration technique having 
the biggest pore size is only able to separate suspended solids, e.g. bacteria and 
bigger materials from the water [42]. This defined pore size is at the same time the 
limitation of the filtration process because the pores might easily clog or biofilms are 
formed which leads to a high energy consumption [39, 43]. Other facts like biofouling 
also limit the time of usage of the membranes. These facts in addition with high costs 
and the operating expenses limit the use of especially reverse osmosis but also the 
other three filtration techniques as a fourth treatment step. 
 
Although oxidative treatment methods have been proven successfully in the 
complete removal of micropollutants a further treatment using filtration techniques 
might be useful especially for the removal of oxidation by-products. One of these 
filtration methods is the sand filtration. Sand filters are commonly used for the 
purification of water, both during drinking and waste water treatment. While sand 
filters are mainly used for disinfection purposes of drinking water and the removal of 
odor and taste they are used as an additional step during waste water treatment as a 
filter for the adsorption of remaining organic matter. The final report of the Eawag 
(Swiss Federal Institute of Aquatic Science and Technology) regarding the ozonation 
of treated waste water showed that the ozonation of the WWTP effluent already 
resulted in a high removal efficiency, however after sand filtration the removal rate 
was even higher especially with regard to formed by-products [14, 44].  
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2.1.6.2. Sorption: Activated Carbon 
Activated carbon describes a class of carbon materials produced synthetically from 
materials like wood, nut shells or coal. One advantage of activated carbon is its 
highly porous surface and therefore big area which allows reactions with substances 
[43, 45]. The porous surface is produced by drying and heating the carbon material 
using air, steam or carbon dioxide. A subsequent heating step using oxidation gases 
or CO2 at temperatures above 800 °C is applied for activating the surface area by 
increasing it [46]. Although activated carbon is used in many fields (e.g. product 
purification) its main application is during environmental processes for a pollution 
control. Two types of activated carbon are available: Granular Activated Carbon 
(GAC) and Powdered Activated Carbon (PAC). GAC is composed of crushed 
granules originating from coal or shell and the particles are between 0.2 and 5 mm. 
PAC in contrast is made from wood with a particle size of 15 to 25 µm. While PAC 
can either be added to the activated sludge or in a separate tank, GAC is always 
used as a separate treatment step. 
Besides the use in drinking water treatment activated carbon is also used during 
waste water treatment. The first application of activated carbon for waste water 
treatment was in California in 1965 in a municipal plant. Nowadays activated carbon 
is mainly used for the treatment of industrial waste waters [45].  
During waste water treatment activated carbon is used as a material to adsorb 
dissolved organic matter because of the high adsorbance capacity [47-50]. It has 
also been proven to remove the toxic activity after ozonation [24]. Due to its high 
costs e.g. through the processing for reuse, it is usually only applied when no other 
treatment is successful or as a last treatment step when most of the micropollutants 
have already been removed and only substances which are not biodegradable are 
present [45]. 
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2.1.6.3. Advanced Oxidation Processes (AOP) 
Since organic micropollutants are not removed during the different steps of common 
waste water treatment and some of them are highly persistent another fourth 
treatment step is needed. Currently it is being discussed which technique would be 
the best to eliminate these substances and thus there are a variety of requirements. 
From an economic point of view the fourth step needs to be easy to apply and most 
efficient with low costs. Another fact that needs to be considered is the minimization 
of an environmental risk through the use of an additional treatment step. In this 
context advanced oxidation processes (AOP’s) are believed to be the best possible 
method and thus different methods have been developed and successfully applied 
[51-55]. However, the oxidation of micropollutants has some disadvantages. It has 
been shown for drinking water treatment that the presence of e.g. bromide results in 
the formation bromate, a suspected carcinogen, through disinfection processes [56, 
57]. To avoid this disadvantage of oxidation processes, the chosen AOP is of great 
importance and might vary depending on the composition of the waste water. 
Advanced oxidation processes are defined as processes which initiate the formation 
of hydroxyl radicals (OH°) in such amounts that they are able to support the water 
purification [58] by degrading water contaminants. Due to their highly reactive 
(second order rate constants 106 – 109 M-1 s-1) and mostly unselective properties as 
well as their high oxidation potential (2.8 V) they react with the organic matter 
resulting in an oxidation of the pollutants [59, 60]. Another similarity of all possible 
AOP’s is the need of a pre-treated wastewater with a low chemical oxygen demand 
(COD; ≤ 5 g/L) since the AOP alone is not sufficient in removing the organic matter 
(Figure 4). A high organic load would increase the amount of oxidant needed and 
would not only raise the treatment costs but would also lower the efficiency of 
treatment. The best possible outcome after an oxidative treatment is the complete 
mineralization of the micropollutants to CO2, H2O or an inorganic product. An 
incomplete mineralization only promotes the formation of by-products [51]. The 
degradation process itself is mainly unknown for many substances and is specific for 
each applied method. 
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Figure 4: Suitability of water treatment technologies according to the chemical oxygen 
demand (COD in g/L) [51]. 
 
2.1.6.3.1. Ozone 
Apart from chlorine, ozone is nowadays one of the most used disinfectants during 
water treatment processes. Besides its beneficial effects during drinking water 
treatment, e.g. removing taste, color, and odor, as well as the elimination of 
microorganisms and humic substances, the use of ozone still has some 
disadvantages. Although ozone is known to be unstable in water it easily undergoes 
reactions with water compounds resulting in the formation of by-products. The 
mechanisms already described for drinking water treatment can also be applied for 
the use of ozone as an additional step in waste water treatment. In contrast to 
drinking water treatment the focus of the ozone usage during waste water treatment 
is the removal of organic micropollutants and not on disinfection. In addition the 
resulting by-products might differ from those known for drinking water depending on 
the much more complex water matrix. 
The ozonation itself can take place in two ways with different reactions. The 
reactions can either occur through a direct reaction by the ozone molecule itself or 
an indirect reaction through the formation of OH° (Figure 5), thus leading to different 
oxidation by-products and different reaction rate constants (direct = 1.0 – 106 M-1 s-1, 
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indirect = 108 – 1010 M-1 s-1). Another difference of the two reaction pathways is the 
way of the oxidative attack. A direct ozonation by O3 is selective and compounds 
with unsaturated bonds (e.g. aromatic compounds) are mainly attacked. The higher 
the electron density the faster the reaction takes place. Indirect reactions are initiated 
through the presence of OH- ions. At the end of the reactions hydroxyl radicals are 
formed which then subsequently react with the micropollutants thus oxidizing them.  
 
 
Figure 5: Reaction pathways of the OH° (encircled) formation by ozone [48] 
 
Both reactions can take place simultaneously but depending on the properties of the 
water (pH, temperature) one of the reactions is favored. A high pH for example 
results in an oxidation through OH° whereas a low pH favors the direct ozonation. 
This also indicates that depending on the water matrix (DOC content) one of the 
reactions dominates. In addition ozone is not specific for organic miropollutants thus 
inorganic compounds e.g. iron or nitrogen compounds might also be oxidized [61] 
therefore a complete elimination of these inorganic compounds before the use of 
ozone is advantageous. 
 
2.1.6.3.2. UV treatment with and without H2O2 
UV light is a radiation with a wavelength of 4 – 400 nm and invisible to the human 
eye. In order to be oxidized by UV light, substances present in the water need to be 
able to absorb this radiation. They mainly absorb UV light at wavelengths between 
200 and 280 nm [60] thus the range of the UV-C radiation which is 100 – 280 nm 
[62]. During the treatment of wastewater, low pressure mercury lamps (LP - Hg) are 
mainly used with a wavelength of 253.7 nm. However the sole use of UV light in 
regard to the oxidative potential is limited since the substances have to absorb the 
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UV light to become oxidized. The addition of H2O2 resolves this limitation by the 
formation of highly active OH radicals (OH°) which then react with the 
micropollutants in an unselective way. 
Therefore UV treatment processes can either include the direct photolysis with the 
sole use of UV radiation (Figure 6a) or the use of a combination with OH° driven 
reactions through the additional use of H2O2 resulting in an indirect oxidation reaction 
(Figure 6b). The OH° formation during UV/H2O2 treatment is based on the photolysis 
of H2O2 [60]. Due to the two varying reaction pathways different oxidation by-
products might be formed.  
 
 
Figure 6: Oxidation and reaction pathways of the UV treatment without (a) and with (b) H2O2 
 
However this method is also limited by the turbidity of the WWTP effluent due to 
effects of the water matrix. This can result in an incomplete degradation because big 
molecules are only partially oxidized and the treatment duration would therefore 
increase in order to result in a complete degradation of the micropollutants to CO2 
and H2O. 
 
2.1.6.3.3. Fenton and Fenton like reactions 
The Fenton reaction was first described in the 1890’s by Henry John Horstman 
Fenton. Fenton detected the oxidation of tartaric acid in the presence of H2O2 and 
iron ions. The use of a mixture composed of H2O2 and ferrous iron thus enables the 
oxidation of organic molecules and the use during waste water treatment [63].  
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During the Fenton reaction, iron-compounds acting as the catalyst are reduced 
resulting in a free iron ion (Fe(II)) which will react with H2O2 thus leading to the 
formation of OH° radicals (Figure 7) [21, 64].  
 
 
Figure 7: Fenton reaction 
 
Although this reaction already results in the formation of OH° the additional use of 
irradiation increases the degradation rate due to the photoreduction of the Fe3+ to 
Fe2+ ions. Subsequently the Fenton reaction can take place where the formed Fe2+ 
ions are then able to produce more OH° in the presence of H2O2 (Figure 8) [65]. This 
reaction mechanism is then called Photo-Fenton reaction. 
 
 
Figure 8: Photo-Fenton reaction 
 
These processes have already been shown to be sufficient in the removal of organic 
micropollutants from waste water treatment plant effluents [21, 65-69]. However the 
applicability due to the complex reaction needs as well as the need for a low pH 
limits its use for the treatment of waste water treatment plant effluents. 
 
2.1.6.3.4. Photocatalysis  
Another possible treatment method includes the use of TiO2 nanoparticles acting as 
a semiconductor. These particles are irradiated in the presence of oxygen finally 
leading to the formation of OH° (Figure 9) including redox reactions of adsorbed 
water, oxygen and other molecules. The use of the UV radiation results in the 
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formation of an electron-hole pair subsequently followed by a transfer of the electron 
leading to the formation of OH° radicals [21, 64, 70]. 
 
Figure 9: Reaction pathway of the TiO2 photocatalysis 
 
However, despite all these possible methods only few of them are feasible. 
Photocatalysis, as well as membrane and Fenton processes are limited due to their 
quite complicated requirements as well as the high costs when applying these 
methods. In contrast processes like ozonation and UV/H2O2 treatment are more 
efficient in regard to costs, applicability and the removal of micropollutants through 
OH° formation. All methods also might result in the formation of oxidation by-
products due to an incomplete degradation which should be prevented by finding the 
most applicable treatment setting.  
 
 
 Toxicological testing for the determination of biological 2.2.
effects of micropollutants 
The use of toxicological methods helps to identify substances as well as the 
conditions (e.g. concentration, time of exposure) which lead to biological effects in a 
dose dependent manner. In fact not one single test is sufficient in predicting the 
possible risk, thus many tests need to be performed in order to perform a risk 
assessment. For example Kase et al. (2009) proposed a multistep process for the 
investigation of endocrine or reproductive effects suggesting the combination of 
different in vivo and in vitro methods which allow the detection of toxicological effects 
at the molecular, cellular as well as organism level. These tests should be able to 
identify effects selectively and mode of action based and an extrapolation of these 
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effects to organisms or population effects should be possible [71]. Looking at the 
process of placing a pharmaceutical on the market it can be seen that it is a 
multistep process including a variety of chemical, physical and toxicological test. 
However this multistep process is only applicable for the testing of chemicals etc. but 
not for water samples. As can be seen in the German “Abwasserverordnung” the 
quality of waste water is mainly determined by chemical parameters [40]. In fact with 
a steady improvement in analytical methods the concentrations of substances 
detected in water systems are becoming lower. However the sole detection, 
respectively the quantification, of a substance does not give any information on its 
biological effects. In addition, the detection of a single substance does not give any 
information about accumulative effects occurring in a water sample. These effects in 
contrast can be detected and determined using biological test systems. Therefore 
the establishment of toxicological methods for the use in water testing is important 
[72]. This becomes even more important in regard to the definition of limit values 
especially with the focus on the human health and an exposure as low as possible. 
As a matter of fact, in 2003 the German Umweltbundesamt recommended the use of 
“Gesundheitliche Orientierungswerte” (GOW, health assessment value) for the 
evaluation of substances present in drinking water when only little or no information 
regarding their toxicity is available (Table 2). This GOW sets a limit of the highest 
concentration of a substance allowed in drinking water and is based on the available 
data on its genotoxic and neurotoxic effects [73]. 
Table 2: Definition of the Gesundheitliche Orientierungswerte (health assessment values) 
adapted from the German Umweltbundesamt [73] 
Available information about substance GOW [µg/L] 
Predominantly no in vitro genotoxicity and carcinogenicity of 
the substance, but otherwise no significant ecotoxicological 
data is available 
≤ 0.3 
No verifiable genotoxicity (see above). In addition significant 
in vitro and in vivo data on oral neurotoxicity and on its germ 
cell damaging effects are available. These data do not lead 
to values below 0.3 µg/L. 
≤ 1 
The substance is neither genotoxic, nor germ cell damaging 
or neurotoxic (see above). In addition significant in vivo data 
of at least one study on the subchronic-oral toxicity is 
available. These data do not lead to values below 1 µg/L. 
≤ 3 
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Pharmaceuticals have been designed to be biologically active in order to induce a 
beneficial effect on humans. However at the same time they might lead to adverse 
effects when exposed at higher doses or a mixture of those bioactive substances as 
present in water systems. It has already been shown that certain contaminants are 
linked to the development of diseases e.g. cancer as a result of a heavy metal 
exposure. But besides cancer other health aspects e.g. effects on the nervous or 
immune system as well as the endocrine or reproductive system are of concern. 
Because these systems are important for the basic functions of an organism it is 
important to identify environmental contaminants and their possible threat to the 
whole environment. This includes the evaluation of a human risk potential and 
subsequently the definition of limit values (e.g. GOW) based on results gained from 
toxicological studies. Advances in toxicological testing approaches are therefore 
needed in order to establish a reliable human risk assessment concerning 
environmental contaminants. This includes a chemical characterization of those 
contaminants in combination with toxicological tests based on human or in general 
eukaryotic cell lines (Figure 10) [74].  
 
Figure 10: Testing strategy proposed by the Committee on Toxicity Testing and Assessment of 
Environmental Agents [74] 
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Toxicological in vitro methods using cell culture based systems are thereby important 
first step approaches to identify possible risks at the molecular level to gain 
information on outcomes at the organisms or population level (Figure 11) [26]. 
 
Figure 11: Bioanalytical tools for the assessment of human health risks adapted from Escher 
et al. 2011 [26] 
 
The field of toxicology in general deals with the detection and identification of 
substance properties in regard to their potential to cause harm. The use of 
toxicological in vitro methods for the testing of chemicals is widespread because they 
can be used to gain data on the mechanisms of cell damage which in fact can be 
transferred to humans. Especially with the focus on the REACH regulation 
(Registration, Evaluation, Authorization and Restriction of Chemicals) by the EU 
council the minimization of animal testing through the use of in vitro methods is 
supposed [75].  
On the basis of various of initiatives to reduce the number of animals in toxicity 
testing [76-79] in regard to the “3R” principle (Replacement, Reduction, Refinement) 
in vitro methods should be established and performed. A variety of studies have 
been published proving a good correlation between in vivo and in vitro data but a 
combination of both would be most favorable [80, 81]. In vivo studies require a large 
amount of testing animals and range from short term acute studies to long term 
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chronic studies sometimes including several generations. Limitations of these 
studies are the high efforts and costs. However the advantage is their ability to e.g. 
detect systemic influences and healing processes. In addition, the kinetics (intake, 
distribution, metabolization, excretion) of a substance including a metabolization 
after exposure can only be measured in vivo. In vitro methods in contrast, are fast, 
non-complex screening methods with a high throughput, a lesser variation of the 
results, and thus a higher potential for standardization (Figure 12). They allow the 
testing of different substances and concentrations at the same time and the 
identification of the mode of action, thus lowering efforts and costs. With the addition 
of liver enzyme mixtures (e.g. S9) they are also able to show effects after 
metabolization [82-84]. Another advantage of cellular based systems is that their 
results can be used for an effect description for different organisms. Although both, 
in vivo and in vitro, methods can be applied for the testing of water samples it has to 
be decided which tests would be most applicable for the desired outcome of the 
specific studies.  
 
Figure 12: Level of toxicological effect and time until manifestation of effects in regard to the 
method, adapted from Kase et al. 2009 [71]. 
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Since the variety of micropollutants as well as their biologic effects are adverse a 
battery of different toxicological methods need to be applied to gain an 
understanding on their mode of action. In combination with chemical techniques an 
effect-directed analysis is then possible. With respect to existing guidelines and 
toxicological endpoints effects like general cell damages (cytotoxicity), DNA 
damages (genotoxicity), heritable DNA damages (mutagenicity), and effects on the 
endocrine system (e.g. estrogenicity) should be observed when applying in vitro 
methods. The methods used for determining biological effects therefore need to be 
selective and sensitive to detect effects resulting from low concentrations of 
substances usually found in water bodies.  
 
Comparing the different regulations which are applied for water treatment in 
Germany in regard to the methods required to determine the water quality only the 
Abwasserverordnung (waste water guideline) requires different toxicological tests. In 
addition only biota studies need to performed according the the german surface 
water guideline as well as the Water Framework Directive whereas all other 
guidelines for water quality control solely include chemical analyses (Table 3) [28, 
30, 40, 85, 86].  
Table 3: Summary of toxicological test systems required according to corresponding 
guidelines 
Test Method Surface 
water 
Drinking 
water 
Groundwater Waste water Water frame-
work directive 
Fish egg test - - - yes - 
Daphnia test - - - yes - 
Algal growth 
inhibition test 
- - - yes - 
Luminescent 
bacteria test 
- - - yes - 
Umu test - - - yes - 
Biota studies  yes - - yes yes 
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A battery of four different biological in vitro tests was therefore used in this study to 
determine the behavior of micropollutants in waste water treatment plant effluents 
based on their cytotoxic, genotoxic, mutagenic, and estrogenic effects. Displayed in 
Table 4 are the used test methods according to the mode of action.  
 
Table 4: Used test systems 
Cytotoxicity MTT Test Mitochondrial activity 
PAN I:  
 LDHe 
 XTT Test 
 Neutral Red 
 Sulforhodamine B 
 
Membrane integrity 
Mitochondrial activity 
Lysosomal activity 
Total protein content 
Genotoxicity Alkaline Comet Assay Single strand and double 
strand DNA breaks, alkali 
labile sites 
Mutagenicity Ames Test Frameshift (TA98) and 
base pair substitution 
mutations (TA100) 
Estrogenicity ER Calux Human estrogen receptor 
activation 
 
 
These in vitro tests were chosen since the focus was laid on the effects of 
micropollutants and their oxidation by-products on the human health and considering 
the requirements of the GOW concept which also includes the use of in vitro data for 
the establishment of limit values. The tests were also chosen with regard to their 
possible application for screening purposes due to their ease of applicability, low 
costs and high throughput. 
 
This battery of tests was then applied to the non-oxidized as well as to the oxidized 
samples after ozonation or UV ± H2O2 treatment and first tested for cytotoxic 
effects. In case of no cytotoxic effects the samples were then subsequently tested for 
genotoxicity. The occurrence of mutagenic or estrogenic effects was further on only 
investigated when the substances were known or supposed to induce such effects 
(Figure 13). Chemical analyses (grey box) of the same samples were also performed 
by collaborating groups but not as a part of this thesis. 
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Figure 13: Schematic of toxicological and chemical (grey box) testing as part of this project. 
Chemical analyses have been performed by the working groups of the IUTA e.V. or the 
University of Duisburg-Essen. 
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2.2.1. Cytotoxicity 
A substance is defined as cytotoxic when cellular functions are disturbed or if it 
induces cell death. Tests to determine the cytotoxic effects of a single substance or a 
mixture are used for the investigation of damages to basic cellular functions e.g. 
membrane integrity or mitochondrial activity. These results can then be further used 
for the investigation of other toxic effects (e.g. genotoxicity, mutagenicity and 
estrogenicity) using sub-cytotoxic concentrations [84]. Due to the complexity of a 
cell, the mode of action of chemicals differs depending on their affinity for certain 
structures (e.g. membrane, mitochondria, lysosomes). So far no in vitro method 
using mammalian cells for the detection of cytotoxic effects of water samples is 
recommended in a guideline. However these in vitro methods are regulated in the 
DIN EN ISO 10993-5:2009-10 guideline for the biological evaluation of medical 
devices which includes the standard procedure for four different cytotoxicity methods 
(Table 5) [87]. 
Table 5: Cytotoxicity tests required according to DIN EN ISO 10993-5:2009-10 
Test method Toxicological endpoint 
Neutral Red Test Lysosomal activity 
Colony formation Test Ability to form colonies 
MTT Test Mitochondrial activity 
XTT Test Mitochondrial activity 
 
However, despite these four tests, many others are available (e.g. trypanblue assay, 
LDH) to investigate the variety of possible cytotoxic effects. 
 
 
2.2.2. Genotoxicity 
The field of genotoxicity deals with the identification of DNA damages previous to 
mutations. These tests therefore give information on the level of structural DNA 
damages but do not necessarily provide evidence for mutations. A variety of test 
systems have been developed in order to detect changes at the DNA level. However 
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these methods are subjected to steady changes due to new demands. Therefore 
guidelines have been established to set basic conditions to perform genotoxicity 
tests. However, as can be seen in Table 6 not every genotoxicity test is regulated by 
a guideline. In regard to the toxicological evaluation of waste waters the OSPAR 
convention (The Convention for the Protection of the Marine Environment of the 
North-East Atlantic) established an expert group on whole effluent assessment. In 
2002 this group published a report summarizing and providing guidelines for the 
methods used to detect genotoxic effects in water bodies [88].  
 
Table 6: Selection of in vitro tests for the detection of genotoxic effects 
Test name Mode of 
action/ 
endpoint 
Organism/cell 
line 
Guideline Reference 
Chromosomal 
aberration test 
Structural 
chromosomal 
abberations 
Mammalian cells 
OECD TG 473 
EPA-HQ-OPPT-
2009-0156-0029 
[89-91] 
Sister Chromatid 
Exchange 
Reciprocal 
DNA 
exchanges 
Mammalian Cells OECD TG 479 [92, 93] 
Unscheduled DNA 
Synthesis  
DNA repair 
and synthesis 
Mammalian cells OECD TG 482 [94] 
Micronucleus Assay 
Micronuleus 
formation 
Mammalian cells  OECD TG 487 [95, 96] 
Alkaline DNA-
Elution assay 
DNA strand 
breaks 
Mammalian cells  [97-99] 
p53 Calux test 
Reporter 
gene Assay 
HepG2/U2OS  [100] 
Comet Assay 
(Single cell gel 
electrophoresis 
assay) 
Single/double 
strand DNA 
breaks, alkali 
labile sites 
Mammalian cells 
Guidelines for in vitro 
and in vivo genetic 
toxicology testing 
OECD Guideline in 
progress 
[101-103] 
GreenScreen HC 
assay 
DNA damage 
response/ 
stress path-
way 
p53-competent TK6 
lymphoblastoid cell 
line 
 [104] 
Toxicogenomics 
Gene 
expression 
Mammalian cells  [105-107] 
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2.2.3. Mutagenicity 
A mutation describes a DNA damage which can be transferred to the offspring, thus 
being hereditary. This is in contrast to general genotoxic effects, which are 
characterized as structural damages. Therefore mutagenic effects can be described 
as a subgroup of genotoxic effects [82]. Different kinds of mutations are known 
depending on their effect (negative, positive or no effect) or their range (gene, 
chromosme or genome) [82, 83]. Table 7 displays a selection of available in vitro test 
systems for the detection of mutagenic effects. 
 
Table 7: Selection of in vitro tests for the detection of mutagenic effects 
Test name 
Mode of 
action/ 
endpoint 
Organism/         
cell line 
Guideline Reference 
In vitro Mammalian Cell 
Gene Mutation Test 
(TK, HPRT, XPRT) 
Gene mutations Mammalian cells 
OECD TG 476 
EPA-HQ-OPPT-
2009-0156 
[82, 108, 109] 
Mouse lymphoma test Gene mutations L5178Y OECD 476 [108, 110] 
Gene Mutation Assay 
Base substitution, 
Frameshift 
Saccharomyces 
cerevisiae 
OECD TG 480 [111] 
Mitotic Recombination 
Assay 
Gene conversion, 
crossing over 
Saccharomyces 
cerevisiae, 
OECD TG 481 [112] 
Ames Test  
Base substitution, 
deletion, addition 
Salmonella 
typhimurium 
OECD TG 471 [113-115] 
Umu Test 
Base substitution, 
deletion, addition 
Escherichia coli OECD TG 471 [113] 
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2.2.4. Estrogenicity 
The endocrine system enables the communication between different organs and 
parts of a body using hormones to regulate vegetative functions [116]. A great 
number of studies have been published showing the effects of substances with 
estrogenic activity on the ecosystem. Effects include influences on the reproduction, 
immune system, damages to sexual organs or the brain or influences on the 
embryonal development [71, 117-120]. In order to detect disturbances to this system 
through endocrine disruptors, tests with a low sensitivity are needed since hormones 
are able to induce effects at very small concentrations. For the testing of the 
estrogenic activity of a substance a variety of in vitro methods are available (Table 
8). 
 
Table 8: Selection of in vitro tests for the determination of estrogenic effects 
Test name 
Mode of 
action/endpoint 
Organism/ 
cell line 
Guideline Reference 
Yeast estrogen 
screen 
Receptor binding assay 
(human ER) 
Saccharomyces 
cerevisiae 
 [121] 
E-screen 
Estrogen dependent 
proliferation 
MCF-7  [122, 123] 
rt-YES 
Receptor binding assay 
(fish ER) 
Saccharomyces 
cerevisiae 
 [124, 125] 
A-Yes 
Receptor binding assay 
(human ER) 
Arxula 
adeninivorans 
 [126, 127] 
ER CALUX Reporter gene assay T47D/U2-OS  [128] 
Ceri-hER-alpha Transcriptional Activation HeLa-9903 OECD TG 455 [129] 
MVLN Reporter gene assay MVLN  [130, 131] 
RTG-2 Assay Reporter gene assay RTG-2  [132] 
H295R  Steroidogenesis Assay NCI-H295R OECD TG 456 [133, 134] 
ELRA 
Enzyme-Linked-Receptor-
Assay 
Purified estrogen 
receptor 
 [135] 
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Due to the variety of methods available, in vitro and in vivo, the OECD initiated a 
task force on Endocrine Disruptor Testing and Assessment (EDTA) in the late 1990s 
[136]. In 2002 the Conceptual Framework for the Testing and Assessment of 
Endocrine Disrupting Chemicals was then released [137]. This framework includes 
five levels of testing starting with a classification/sorting based on available 
information (level 1) followed by in vitro assays (level 2) and in vivo testing (levels 3 
to 5) suggesting test systems to be used. Kase et al. (2009) also supposed the use 
of a combination of in vitro and in vivo test systems to evaluate endocrine effects as 
well as others [71, 138]. This is in accordance to the OECD Conceptual Framework 
which supposes a simultaneous measurement of cytotoxic and estrogenic effects 
[137].  
Although the number of available test systems for the evaluation of estrogenic 
effects is high, only a few of them are regulated through guidelines. Therefore in 
2011 a DIN working group has been formed in Germany to establish a guideline for 
the estrogenicity testing in water systems (DIN-Arbeitskreis NA 119-01-03-05-09 AK 
"Hormonelle Wirkungen (Xenohormone)). 
Despite the variety of available toxicological test systems only few of them are 
applied in water testing on a regular basis. Just a few of these methods are 
regulated through guidelines and are not part of any guideline for the evaluation of 
water quality. 
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3. Aims of the study 
Micropollutants are commonly detected in the aqueous environment because they 
are not sufficiently removed durig conventional waste water treatment. These 
micropollutants include biocides, pharmaceuticals, personal care products as well as 
other chemicals. Since many of them are designed to be biologically active they 
might pose a risk to the environment. In addition for most of these substances 
knowledge about their environmental fate and toxicity is scarce. Thus additional 
waste water treatment steps are needed. Therefore the aims of this study were  
 the adaptation and optimization of toxicological in vitro test methods for the 
testing of water samples 
 the application of toxicological methods for the comparison of ozonation and 
UV oxidation with H2O2 in regard to the removal of organic micropollutants  
 the comparison of ozonation and UV oxidation with H2O2 in regard to the 
formation of toxic oxidation by-products 
 the toxicological evaluation of micropollutants and their oxidation by-products 
before and after oxidative treatment 
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4. Material and Methods 
The chemicals and materials as well as the equipment used during this study are 
listed in the annex (chapter 8). The solutions used for the specific tests are listed 
below. 
 
 Solutions 4.1.
4.1.1. Cell Culture 
4.1.1.1. CHO cells 
Table 9: Cell culture solutions for CHO cells 
Solution Composition 
Growth Medium HAM’s F12 with 10 % FCS, 3 mL Gentamycin and 3 mL L-
Glutamine 
Freezing medium HAM’s F12 with 15 % FCS and 7.5 % DMSO 
Trypsine (0.05 %) Trypsine and EDTA (0.2 g/L) 
 
 
4.1.1.2. T47D cells 
Table 10: Cell culture solution for T47D cells 
Solution Composition 
Growth Medium DMEM F12 with 7.5 % FCS, 3 mL Gentamycin and 5 mL 
NEAA 
Freezing medium 7 mL DMEM F12, 1 mL DMSO and 2 mL FCS 
Trypsine (0.05 %) Trypsine and EDTA (0.2 g/L) 
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4.1.2. PAN I Multitox Test 
Table 11: Solutions for the PAN I Multitox test 
Solution Composition 
Solvent control 4.5 mL HAM’s F12 and 0.5 mL Millipore water 
Positive control 0.7 mL HAM’s F12 and 1 % Triton® X-100 
LDH II / LDH III mix (1 plate) 16 mL LDH II and 3.4 mL LDH III 
XTT I / XTT II mix (1 plate) 4 mL XTT I and 40 µL XTT II 
 
 
 
4.1.3. MTT Test 
Table 12: Solutions for the MTT test 
Solution Composition 
Solvent control 4.5 mL HAM’s F12 and 0.5 mL Millipore water 
Positive control 0.7 mL HAM’s F12 and 1 % Triton® X-100 
MTT solution 0.125 g 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromid dissolved in 25 mL DPBS 
and filter sterilized 
Lysis solution 99.4 mL DMSO, 0.6 mL 100 % acetic acid and 10 g 
SDS 
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4.1.4. Alkaline Comet Assay 
Table 13: Solutions for the Alkaline Comet Assay 
Solution Composition 
ENU stock solution 
(10 mg/L) 
10 mg ENU dissolved in 1 L Ampuwa 
Tris-Solution (1 M) 157.6 g Trizma dissolved in 1 L Ampuwa  
NaOH Solution (2 M) 80 g NaOH dissolved in 1 L Ampuwa  
EDTA (0.5 M) 
186.1 g EDTA dissolved in 1 L Ampuwa and adjusted to 
pH 8 with NaOH (2M) 
Lysis solution I 
10 mL Tris-solution (1 M), 146.1 g NaCl, 100 mL EDTA 
(1 M) und 10 g N-Laurylsarcosine Sodium Salt were 
filled up to 1 L with Ampuwa and heated to 100 °C 
Lysis solution II 100 mL DMSO and 10 mL Triton-X were mixed and 
stored protected from light 
Neutralization solution 200 mL Tris-solution (1 M) were filled up to ~500 mL 
with Ampuwa and adjusted to pH 7.5 with NaOH (2M). 
50X TAE Buffer 242 g Trizma, 57.1  mL glacial acetic acid and 100 mL 
EDTA (0.5 M) filled up to 1 L with Ampuwa 
1X TAE Buffer 10 mL 50X TAE Puffer diluted with 490 mL Ampuwa 
L.M.P. Agarose (0.75%) 
0.75 g Low Melting Point Agarose dissolved in 100 mL 
PBS 
Electrophoresis solution 
75 mL NaOH (2 M), 1 mL EDTA (0.5 M) and 0.79 g 
Trizma filled up to 500 mL with Ampuwa and adjusted to 
pH 12.7 using HCl 
SYBR®-Green stock 
solution 
1 mg/mL SYBR®-Green in DMSO 
SYBR-Green® staining 
solution  
5 µL SYBR-Green® stock solution added to 50 mL 1X 
TAE Buffer 
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4.1.5. Ames Test 
Table 14: Solutions for the Ames Test 
Solution Composition 
S9 Mix 1.438 mL S9 buffer salts, 0.063 mL S9 G-6-P, 0.250 mL 
S9 NADP, 0.750 mL S9 Fraction 
 
 
 
4.1.6. ER Calux 
Table 15: Solutions for the ER Calux 
Solution Composition 
Assay Medium I 
DMEM F12 (without phenol red) with 5 % stripped FCS 
and 5 mL NEAA  
Assay Medium II 9 mL Assay Medium I and 1 mL Ampuwa 
Assay Medium III 11 mL Assay Medium I and 11 µL DMSO 
Lysis reagent (400 mL; 
pH 7.8) [purchased 
from BDS] 
33.03 g Glycylglycine, 36.97 g MgSO4, 15.22 g EGTA, 
4 mL Triton® X-100; 0.2 M NaOH to adjust pH 
GlowMix (1 L; pH 7.8) 
[purchased from BDS] 
3.58 g Tricine, 0.52 g C4H2Mg5O14, 0.60 g MgSO4, 0.037 g 
EDTA, 5.14 g DTT, 0.21 g Co-enzyme A, 0.15 g Luciferine, 
0.29 g ATP 
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 Cell Culture methods 4.2.
4.2.1. CHO cells 
CHO cells (Figure 14) are a permanent epithelian cell line derived from the ovaries of 
the Chinese Hamster Cricetulus griseus by Puck et al. in 1957 [139]. These are 
adherent cells cultivated in HAM’s F12 medium supplemented with 10 % FCS, 0.5 % 
L-Glutamine and 0.5 % Gentamycin and grown at 37 °C with 5 % CO2 and 95 % 
humidity. 
 
Figure 14: CHO cells; passage 30 
 
4.2.1.1. Thawing 
Before the cells are thawed a cell culture flask (25 cm2) is filled with 10 mL preheated 
HAM’s F12 medium (37 °C). The cryovial is then taken out of the liquid nitrogen and 
quickly thawed using a waterbath (37 °C) until only a small frozen part is left. 
Subsequently the cell suspension is transferred to the prepared culture flask and 
stored in the incubator (37 °C, 5 % CO2, 95 % humidity). The next day the medium is 
changed and the cells are again incubated until further use. 
 
4.2.1.2. Subculturing 
For passaging the medium is removed and the cells are washed once with PBS. 
Culture flasks with a confluent cell growth are then trypsinated for 10 to 15 seconds 
using a 0.05 % trypsin solution with EDTA. After discarding the trypsin the cells are 
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incubated for 3 minutes at 37 °C. The trypsinated cells are then resuspended in 
HAM’s F12 medium and counted with a Neubauer Chamber to determine the total 
cell number. Depending on the further use, new culture flasks or well plates are then 
seeded with the appropriate cell number. 
 
4.2.1.3. Freezing 
For the cryoconservation the CHO cells are trypsinated as described above and 
resuspended in 15 mL HAM’s F12 medium. The cell suspension is then transferred 
to a 15 mL vial and centrifuged at room temperature and 1200 rpm for 5 min. After 
centrifugation the supernatant is removed and the cells are resuspended in cooled 
(4 °C) freezing medium (HAM’s F12 with 15 % FCS and 7.5 % DMSO) and aliquots 
of 1.8 mL are transferred to cryovials. The vials containing the cell suspension are 
then frozen in a three step process. First the vials are kept at -20 °C for 1 hour and 
then stored at -80 °C over night before they are kept in liquid nitrogen until further 
use. 
 
 
4.2.2. T47D cells 
T47D cells (Figure 15) are cultivated in DMEM F12 (Dulbecco’s Modified Eagles 
Medium: Nutrient Mixture F12) medium with phenolred in a CO2 incubator at 37 °C 
with 5 % CO2 and 95 % humidity. These cells are a human breast adenocarcinoma 
cell line which is stably transfected with an estrogen-responsive luciferase reporter 
gene (pEREtata-Luc). This pEREtata-Luc reporter gene regulates the response of a 
luciferase reporter gene construct containing three human estrogen-responsive 
elements [128]. 
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Figure 15: T47D cells; passage 22 
 
4.2.2.1. Thawing 
Three new culture flasks are filled with 10 mL of growth medium and kept in the 
incubator for 4 h. The cells in the cryovial are thawed until just a little ice is visible 
before 0.5 mL of growth medium from the culture flask is added to the cryovial. Then 
the cell suspension is transferred into the three previously prepared culture flasks as 
described below, before the flasks are stored in the incubator until further use: 
Culture flask 1: 150 μL cell suspension 
Culture flask 2: 450 μL cell suspension 
Culture flask 3: 900 μL cell suspension 
 
4.2.2.2. Subculturing 
When a confluent growth of 85 – 95 % is reached the cells are subcultured into new 
culture flasks. For this the medium is removed, the cells are washed with 5 mL PBS 
and trypsinated with 2 mL trypsin for 10 seconds. The trypsin is then removed and 
the flask is stored in the incubator for 5 minutes. After this step, the cells are 
resuspended in 10 mL growth medium and the appropriate volume of suspension is 
added to a new culture flask. 
 
4.2.2.3. Freezing 
The freezing medium is prepared fresh and stored on ice until use. The cells are 
trypsinated as described above and resuspended in 10 mL growth medium. The 
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suspension is transferred into a sterile tube and centrifuged at 1100 rpm for 
5 minutes. Then the supernatant is removed and the cell pellet is resuspended in 
4 mL of ice-cold freezing medium. 1 mL of this suspension is then pipetted into the 
cryovials which have been stored on ice. After storing the cryovials at -80 °C for one 
day they are transferred to liquid nitrogen for long-term storage. 
 
 
 Toxicological methods 4.3.
4.3.1. Cytotoxicity 
4.3.1.1. PAN I: LDHe – XTT – NR – SRB  
For the determination of cytotoxicity the PAN I: LDHe-XTT-NR-SRB test was used. 
This test allows the combined colorimetric detection of plasma membrane integrity, 
mitochondrial activity, lysosomal integrity and the rate of protein synthesis of cells 
exposed to various substances, i.e. chemicals, pharmaceuticals or other 
anthropogenic compounds. The advantage of this approach is the sequential 
measurement of four parameters using just one cell culture. 
 
LDHe 
This test allows the detection of the extracellular lactate dehydrogenase by 
measuring the oxidation rate of NADH to NAD+ as well as the reduction of pyruvate 
to lactate: 
 
 
The lactate dehydrogenase (LDH) is a stable enzyme present in the cytoplasm of all 
cells. Damages to the cell membrane result in a release of LDH into the cell culture 
medium. However since LDH has a molecular weight of 140 kDa it does not easily 
penetrate the cell membrane and a high amount of damage is needed in order to 
Pyruvate + NADH + H
+
   →   Lactate + NAD
+
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detect LDH outside the cytoplasm [140]. This release can then be determined 
kinetically by measuring the consumption of NADH. 
 
 
XTT 
The mitochondrial activity is determined using the XTT test. XTT (2.3-bis(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxyanilide inner salt) is a yellow 
tetrazolium salt which gets cleaved to an orange formazan by the enzyme succinate 
dehydrogenase (Figure 16) [140]. For their survival viable cells need an intact 
mitochondrial respiratory chain. In the case of an exposure to a cytotoxic substance 
which affects the mitochondria, XTT will not be cleaved and a change in enzyme 
activity can then be measured photometrically. The reduction rate of XTT therefore 
directly correlates with the mitochondrial activity/integrity. 
 
Figure 16: Chemical equation of the XTT cleavage to XTT formazan by succinate 
dehydrogenases 
 
 
Neutral Red (NR) 
Neutral Red (Figure 17) is a cationic dye used to determine the viability of cells since 
it penetrates the cell membrane by nonionic passive diffusion and binds to anionic 
and phosphate groups within the lysosomes. This is possible due to the pH gradient 
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between the cytoplasm and the lysosomes (lysosomal pH (4.5 - 5) < cytoplasmic pH 
(~7)) which results in a charging of the dye once it reaches the lysosomes. Thus the 
dye is kept inside the lysosomes [141]. Lysosomes are cellular structures which 
contain enzymes to break down waste and cellular debris [142]. Effects on the cell 
surface or the lysosomal membrane result in a decreased incorporation and binding 
of neutral red. The amount of dye taken up by the cells can then be measured 
photometrically and is proportional to the number of viable cells and allows a 
differentiation between viable, damaged and dead cells. 
 
Figure 17: Structural formula of neutral red 
 
 
Sulforhodamine B (SRB) 
Sulforhodamine B (Figure 18) is an aminoxanthene-dye used for the detection of 
cytotoxic effects. The anionic dye binds electrostatically to cellular proteins thus 
being a toxicological marker for cell proliferation or cell death [143]. The number of 
viable cells can therefore be directly correlated with the total protein synthesis. 
 
Figure 18: Structural formula of Sulforhodamine B 
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4.3.1.1.1. Procedure 
Exposure 
CHO cells are trypsinated and resuspended as described above. The cell number is 
adjusted to 10,000 cells/200 μL medium. 200 μL of sterile PBS are added to the 
outer wells of a 96-well microtiter plate. Then 200 μL of the adjusted cell suspension 
is transferred to the 60 inner wells of the plate. The plate is then stored in the 
incubator for 24 h. Exposure of the cells to 200 μL of the controls is then done as 
illustrated below (Figure 19). The cells are exposed to the samples by adding 180 μL 
of HAM’s F12 and 20 μL of the sample. After this exposure step the plates are then 
stored in the incubator for 24 h before further analysis. 
 
 
Figure 19: Layout of the 96 well plate seeded with CHO cells (20000 cells/0.2 mL). B = 200 μL 
blank control: culture medium + solvent without cells; GC = 200 μL cell growth control: culture 
medium + cells; SC = 200 μL solvent control: culture medium + cells + solvent; TL = 200 μL 
positive control: culture medium + cells + 1 % Triton® X-100 
 
 
Cell handling 
After 24 h of exposure 20 μL of the supernatant from each exposed well is 
transferred to a new 96 well plate and the plate containing the cells is again 
incubated until further use. 20 μL of LDH II/LDH III mix is subsequently added to 
each well containing the supernatant and the kinetic reading is started immediately. 
After this the original plate containing the cells is taken from the incubator and the 
cells are washed once with 200 μL PBS before 200 μL of fresh culture medium is 
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added into each well. 50 μL/well of freshly prepared XTT I/XTT II mix is added and 
the plate is then further incubated for 2 h at 37 °C and 5 % CO2. After incubation the 
contents of each well are carefully mixed and the OD480 is measured.  
For measuring the Neutral Red (NR) uptake the XTT staining solution is removed 
and each well is washed with 300 μL of NR I solution. Then 200 μL of NR II labeling 
solution are pipetted into each well and the plate is again incubated for 3 h. The 
NR II solution is then removed and 200 μL of NR III fixing solution are added and 
discarded after 1 min. Finally 200 μL NR IV solubilization solution are added to each 
well, the plate is incubated at room temperature for 15 min, gently mixed and the 
OD540 is finally determined. The last step of the cytotoxicity detection is the SRB test. 
Therefore the NR IV solution is removed and the cells are washed with 300 μL SRB I 
washing solution followed by the addition of 250 μL SRB II fixing solution and 1 h of 
incubation. Then the cells are washed three times with 200 μL deionized water and 
50 μL SRB III labeling solution are added. The plate is then again incubated for 
15 min at room temperature and washed two times with 400 μL SRB IV rinsing 
solution. After this washing step the plates are air dried overnight. Then 200 μL of 
SRB V solubilization solution are added to each well and the plate is further 
incubated for 30 min at room temperature. The OD540 is then measured after gently 
mixing. 
 
 
4.3.1.1.2. Measurement 
The OD was measured with the TECAN GENios platereader (TECAN; Crailsheim, 
Germany) 
LDHe: absorbance at 340 nm for 25 minutes measuring kinetically every 5 minutes 
XTT: OD at 480 nm 
NR: OD at 540 nm 
SRB: OD at 540 nm 
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4.3.1.1.3. Data analysis 
LDHe: First the OD340 values from the kinetic reading are plotted vs. time to visualize 
the activity of the tested samples. From this graph a time interval is chosen where 
the curves are almost linear and the ∆OD/min for each well is calculated and the 
extracellular amount of NADH is presented as “nm consumed NADH/min/mL” 
(Figure 20).  
 
 
Figure 20: Equation used to calculate the extracellular NADH amount 
 
With: 
0.260 = reaction volume [mL] 
1000 = gives the result in mL 
6.2 = NADH extinction coefficient at 340 nm [mM] 
20 = volume used in the assay [μL] 
 
 
Based on the calculation of the amount of extracellular LDHe the viability of the cells 
is finally calculated (Figure 21). 
 
Figure 21: Equation used to calculate the percent of viable cells 
 
An overview of the steps needed to finally calculate the number of viable cells using 
the LDHe test is presented in Table 16. 
NADH consumed =  
∆OD/min x 0.260 x 1000
6.2 x 20
Viability [%] =  100 * 
mean OD treated cells
mean OD growth control
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Table 16: Steps of calculating the viability of the LDHe test 
Step Calculation 
1. tstart linearity – tend linearity 
2. (tstart linearity – tend linearity)/min 
3. (tstart linearity – tend linearity)/min - blank 
4. Units NADH consumed 
5. Viability 
 
 
The % viability in the XTT, the NR and SRB test is calculated the same way. First the 
mean OD values for each sample and control are calculated. Then the mean OD 
values of the samples and the controls are corrected by subtracting the mean OD of 
the blank. Finally the viability is determined using the following equation: 
 
 
 
4.3.1.2. MTT Test 
The MTT test is a colorimetric assay used to detect cytotoxic effects based on the 
cleavage of the MTT tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide). The principle of the MTT test is the same as for the XTT test 
with the difference in the solubility of the tetrazolium salts. Mitochondrial 
dehydrogenases cleave the MTT resulting in an unsoluble formazan (Figure 22) thus 
measuring the mitochondrial activity. Cells which are exposed to a cytotoxic sample 
might have a compromised mitochondrial respiratory chain resulting in a lesser 
content of the formazan which allows a direct correlation of transformed MTT and the 
number of viable cells [144, 145]. 
Viability [%] =  
100 * corrected mean OD sample
corrected mean OD solvent control
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Figure 22: Chemical equation of the MTT cleavage to MTT formazan 
 
 
4.3.1.2.1. Procedure 
Exposure 
CHO or T47D cells were trypsinated and seeded into a 96 well plate with 20,000 
cells/200 µL into each of the inner 60 wells. The outer wells were filled with 200 µL 
PBS and the plate was stored in the incubator (37 °C, 5 % CO2, 95 % humidity) for 
24 h. Before exposure the medium was removed and 180 µL fresh medium as well 
as 20 µL of the sample were added to the appropriate well. 50 µM MMA III were 
used as a positive control. The cells were then further incubated for another 24 h. 
Each sample and control was tested in three individual experiments per test.  
 
Cell handling 
After 24 h of incubation the exposure medium was removed, 100 µL fresh medium 
and 10 µL MTT solution were added, the plate was gently shaken for 5 min at room 
temperature and then again incubated for 2 h before the supernatant was removed 
and 100 µL lysis solution were added. After 5 min the plate was shaken for five more 
minutes before the OD was measured. 
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4.3.1.2.2. Measurement 
After lysing and incubating the cells the OD was measured at 595 nm and a 
reference wavelength of 620 nm using the TECAN GENios (TECAN; Crailsheim, 
Germany) microplate reader. 
 
4.3.1.2.3. Data analysis 
For each single experiment the viability of the cells was determined by calculating 
the mean percent of viable cells compared to the negative control using the following 
equation: 
 
The mean and the standard deviation of three individual experiments are then 
displayed graphically. 
 
 
4.3.2. Degree of Cytotoxicity 
The calculated viability resulting both from the MTT test and the PAN I test was then 
classified according to the DIN EN ISO 10993-5 guideline [146] as displayed in Table 
17. 
Table 17: Degree of cytotoxicity 
Degree of 
damage 
Viability [%] Cytotoxicity 
0 81 – 100 % no cytotoxicity 
1 71 – 80 % weak cytotoxicity 
2 61 – 70 % moderate cytotoxicity 
3 0 – 60 % strong cytotoxicity 
Viability [%] =  100 * 
mean OD treated cells
mean OD negative control
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4.3.3. Genotoxicity 
4.3.3.1. Alkaline Comet Assay 
The Comet Assay is a technique used to measure DNA damage. These damages 
can result from two different types of effects. Either endogenous e.g. through 
reactive oxygen species (ROS) formed during metabolic activity, or exogenous 
caused by different types of radiation or chemicals, thus substances from outside the 
cell. DNA damaging agents can then induce a variety of effects on the DNA. One 
type of damage is the DNA strand break. These breaks can occur either directly by 
ROS attacking the sugar-phosphate backbone of the DNA or through the activity of 
endonucleases during DNA repair processes. Another type of DNA damage are 
alkali-labile sites. These are then transformed into DNA single-strand breaks under 
alkaline conditions and can therefore also be detected using the alkaline comet 
assay [82]. 
The Comet Assay is a sensitive microgel electrophoresis technique to detect DNA 
damage in single cells and was first described by Ostling et al. in 1984 [102]. They 
embedded the cells in agarose, lysed them in a neutral detergent solution and 
applied a weak electric field. During electrophoresis the positively charged DNA 
migrates towards the anode. In case of a damage DNA fragments of different sizes 
will migrate in a certain pattern which looks like a comet, while undamaged DNA 
appears as a solid circle (Figure 23). Various fluorescent stains which bind DNA can 
then be used to visualize the DNA and to analyze its degree of damage by means of 
the migration pattern. However, the limitation of this approach is the neutral lysing 
condition since this only allows the detection of double strand breaks. Therefore 
Singh et al. (1988) further optimized this method. They used alkaline conditions 
during lysis and electrophoresis which resulted in a more sensitive assay detecting 
both single strand and double strand DNA breaks as well as alkali labile sites [103]. 
In the present study I further modified the method described above for the use of 
CHO cells and the testing of water samples according to the procedures described 
by Singh et al. and to the guidelines for in vitro testing published by Tice et al. (2000) 
[101]. 
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Figure 23: Comet Assay analysis of undamaged (a) and damaged (b) CHO cells stained with 
SYBR Green® and analyzed using the Comet Assay 4 Software. 
 
 
4.3.3.1.1. Procedure 
Exposure: 
CHO cells were cultured in HAM’s F12 medium. 24 h prior to exposure the cells were 
seeded in 24 well plates with 100,000 cells per well in 2 mL medium. Before 
exposure the medium was removed and fresh medium was added. The cells were 
then exposed to the samples for 24 h at a 1:10 ratio (1.8 mL medium and 0.2 ml 
sample). 0.1 mg/mL N-ethyl-N-nitrosourea (ENU) were used as a positive control 
and the cells were exposed for 30 min.  
 
Microgel preparation: 
Microgels were prepared by sticking a chamber slide with eight chambers to a 
GelBond® film. Each chamber was sealed by adding 50 μL low melting point 
(L.M.P.) agarose which was then allowed to solidify on ice. 
 
Cell handling: 
After exposure the medium was discarded and the cells were washed with 1 mL 
PBS. Then the cells were trypsinated for 10 sec followed by 3 min of incubation at 
37 °C without trypsin. Depending on their confluency they were then resuspended in 
PBS, counted, and the cell number was adjusted to 8000 cells/20 μL. These 20 µL of 
each cell suspension were then mixed with 45 μL L.M.P. agarose and added to the 
prepared chambers. After all gels were solidified, the chamber slides were removed 
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and the film was placed in a 4 °C tempered lysis solution and stored at 4 °C over 
night.  
 
Electrophoresis: 
For electrophoresis the freshly prepared solution was cooled down to 4 °C before 
use. Prior to applying the electric field the films were incubated in electrophoresis 
solution for 20 min and the electrophoresis was then run for 20 min at 300 mA. Then 
the films were transferred to neutralization solution for 30 min and further transferred 
to ethanol absolute for 2 h before the gels were left to dry over night. 
 
Staining: 
The dried gels were stained with the SYBR-Green® working solution for 18 min and 
gently washed with water. To avoid air bubbles a few water drops were added onto 
the film before a cover glass was applied.  
 
4.3.3.1.2. Analysis 
For analysis the Comet Assay 4 software from Perceptive Instruments was used. 
Each gelbond film contains eight microgels including a positive and a negative 
control (Figure 24a). The gels were analyzed in an s-shaped pattern (Figure 24b) 
always starting at the top left corner until 50 nuclei had been scored. As a measure 
of DNA damage the Olive Tail Moment [147] is displayed graphically  
 
 
Figure 24: a) Gelbond film containing eight microgels. b) Scoring pattern of a single microgel. 
pos = positive control; neg = negative control; 1 – 6 = gels containing cells exposed to the 
samples. 
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4.3.3.1.3. Statistics 
Statistical analysis was done using GraphPad Prism column analysis. The data of 
three individual experiments were summarized and plotted using their mean value 
and the standard error of mean. The significance of DNA damage compared to the 
negative control was analyzed using the Mann-Whitney Test and classified 
according to the p-value (Table 18). 
 
Table 18: Significance of DNA damage according to the Mann Whitney Test 
P-value > 0.05 0.01 – 0.05 0.001 – 0.01 < 0.001 
P-value 
summary 
n.s. * ** *** 
Significance not significant significant very significant 
highly 
significant 
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4.3.4. Mutagenicity 
4.3.4.1. Ames Test 
Mutagenic activity of water samples containing chemicals and other substances was 
detected using the Ames MPFTM 98/100 Aqua. The two used histidin-dependent 
Salmonella typhimurium strains TA98 and TA100 either carry a frameshift mutation 
(TA98) or a base substitution mutation (TA100) in their histidin operon [148]. Thus 
they are not able to synthesize histidin themselves and need histidin-containing 
medium to grow. Once the Salmonella are exposed to samples with mutagenic 
activity and a frameshift or base substitution mutation takes place the bacteria are 
able to grow in histidin-free medium, since they regained their ability to synthesize 
histidin [149]. 
The test is then performed in two different ways. Due to the fact that some 
substances are only activated through metabolization and bacteria lack the 
appropriate eukaryotic metabolic enzymes the exposure is done with and without the 
addition of a liver enzyme mix (S9 Mix). This addition results in an in vitro 
metabolization of the tested substances thus the mutagenic activity of metabolites 
can also be detected [148, 149]. 
 
4.3.4.1.1. Procedure 
The Ames test was performed using the AMES MPFTM 98/100 Aqua version 
provided by Xenomtrix (CH). This test includes the Salmonella typhimurium strains 
TA98 and TA100. Two Erlenmeyer flasks were filled with 10 mL growth medium and 
10 µL ampicillin (50 mg/mL). In addition a third Erlenmeyer flask was filled with 
10 mL medium only as a negative control. The vials containing the bacterial 
suspension were thawed and 50 µL of the suspension were transferred to the 
prepared Erlenmeyer flasks which were then incubated for 16 h in a shaking water 
bath at 37 °C. After incubation the OD was measured at 600 nm. For that purpose 
900 µL of growth medium and 100 µL of the bacterial suspension as well as the 
negative control were filled into cuvettes and measured. The samples were then 
tested in triplicate with and without metabolic activation by S9 using a 24-Well plate. 
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For exposure the medium, samples, bacteria, water and S9 were mixed as shown in 
Table 19 and incubated at 37 °C for 90 min. 
Table 19: Scheme of pipetting for exposure 
 TA98 TA100 
 -S9 +S9 -S9 +S9 
10x Exposure 
medium 
25 µL 25 µL 25 µL 25 µL 
Sample 185 µL 185 µL 185 µL 185 µL 
Water 15 µL -- 15 µL -- 
Bacteria 25 µL 25 µL 25 µL 25 µL 
S9 Mix -- 15 µL -- 15 µL 
Total volume 250 µL 250 µL 250 µL 250 µL 
 
After incubation 2.8 mL of indicator medium were added to each well and mixed 
properly. Then the contents of each well were transferred to 48 wells of a 384-well 
plate by pipetting 50 µL into each of the 48 wells. After this the plates were placed 
into a plastic bag and then further incubated for 48 h at 37 °C. 
 
4.3.4.1.2. Analysis 
After incubation the plates were removed from the incubator and the number of 
positive wells containing revertant bacteria (wells where the medium has turned 
yellow) for each sample was counted (Figure 25). The results were then analyzed 
using an Excel data sheet provided by Xenometrix (Allschwil, CH). 
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Figure 25: 384-Well plate after 48 h of exposure. The medium of the positive wells containing 
bacteria with reversed mutations has changed to yellow and the medium of the wells without 
mutated bacteria is purple. 
 
4.3.4.1.3. Statistics 
The statistical analysis was done using the provided Excel data sheets (Xenometrix; 
Allschwil, CH). A sample was classified mutagenic when the amount of positive wells 
was two-times higher than the negative control (fold increase over baseline ≥ 2). 
Statistical analysis was done using the 1-sided t-test based on unpaired data. 
The results are declared reliable when the quality standards listed in Table 20 are 
met. The number of positive wells thereby describes the wells which have turned 
yellow or contain a colony, thus wells containing bacteria with reversed mutations. 
Table 20: Ames MPF® 98/100 quality standards  
Controls  Mean number of positive wells 
  TA98 TA100 
Negative control Solvent ≤ 8 ≤ 12 
Positive controls 4-NQO ≥ 25 ≥ 25 
 2-NF ≥ 25 ≥ 25 
 2-AA (only +S9) ≥ 25 ≥ 25 
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4.3.5. Estrogenicity 
4.3.5.1. ER Calux 
The ER Calux (Estrogen Receptor - Chemical Activated Luciferase gene 
eXpression) is a test developed to detect estrogenic effects of chemicals and other 
substances. Estrogens, e.g. estradiol, might affect the thyroid function, the 
reproductivity, the nervous system as well as the cardiac system [150]. Thus 
increased amounts of these substances might pose a risk to human health. The test 
uses a modified T47D cell line which is a human breast adenocarcinoma cell line. 
These cells have been genetically modified to emit light with an intensity correlated 
to the amount of endocrine substances present in the sample. Therefore an estrogen 
responsive element (ERE) was coupled to a luciferase gene. Once the chemical 
reporter binds to the ERE it induces the expression of the luciferase gene associated 
with the ERE. The activity of the luciferase can then be detected and correlated to 
the amount of estrogenic substances in the sample [128]. 
 
4.3.5.1.1. Procedure 
Exposure 
48 h prior to incubation the 60 inner wells of a 96 well plate were filled with 100 μL 
cell suspension whereas the outer wells were filled with 200 μL PBS. For this culture 
flasks with 85 – 95 % confluent growth were used. The growth medium was removed 
and the cells were washed with 5 mL PBS before trypsination with 2 mL trypsin for 
10 seconds. The flasks were then stored in the incubator for 5 minutes. Then the 
cells were resuspended in 10 mL assay medium I, counted and diluted with assay 
medium I to achieve a concentration of 100,000 cells/mL. After incubating the plates 
for 24 h at 37 °C and 5 % CO2 the medium was removed and new assay medium I 
added, before the plates were again stored in the incubator for 24 h. To expose the 
cells to the 17ß-ethinylestradiol standards 1 µL of each standard was mixed with 
1 mL of assay medium II. 100 µL of each solution were then added to the 
appropriate wells. The DMSO control was also prepared by mixing 1 µL DMSO with 
1 mL assay medium II and the same was done for the water control. The samples 
were then added to the wells using a 1:10 dilution into assay medium III with a final 
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volume of 100 µL/well and the plates (Figure 26) were incubated for 24 h before the 
analysis was performed. 
 
 
Figure 26: ER Calux exposure plate (BDS). E2 = 17ß-ethinylestradiol; E2-0 to E2-30 = 17ß-
ethinylestradiol concentration [pM/well]; DMSO = wells containing 1 % DMSO; medium = wells 
containing medium only; 1 – 10 = wells containing the cells exposed to different samples. 
 
Cell handling 
After an exposure time of 24 h the medium was removed and 50 μL of lysis reagent 
was added to the exposed wells before the plates were stored at room temperature 
for 15 minutes. 30 µL of each well were then transferred to a new white 96-well plate. 
 
4.3.5.1.2. Analysis 
30 μL of GlowMix solution are then added to the 30 µL of supernatant and the 
luminescence was immediately measured using the TECAN GENios microplate 
reader resulting in an excel sheet displaying the measured values as relative light 
units. These values were then copied into an excel sheet provided by BDS allowing 
the automated analysis and determination of estradiol equivalents (EEQ) displayed 
as the mean pM EEQ/well. EEQ values were considered right when the following 
quality standards (Table 21) were met. 
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Table 21: ER Calux quality standards 
Automatic verification 
Cell on excel 
sheet 
General parameter  
EC50 should be between 2 and 8 pM/well D4 
Induction should be ≥ 6 D5 
R2 should be ≥ 0.98 D8 
Sample parameters  
Reaction of cells should be < EC50 H30 – H40 
Reaction of cells should be > LOQ (1.5 pM) I30 – I40 
Standard deviation should not be > 15 % J30 – J40 
No remarks were made K30 – K40 
Overall verification  
All above mentioned parameters should be answered with 
„true“ D15 – D25 
Non-automatic verification 
The negative control (E2-0) should not be higher than the LOQ  
Verification of the reference materials  
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 Oxidation of water samples 4.4.
The water samples were prepared, oxidized and chemically analyzed either by the 
working group of Dr. Jochen Türk at the Institut für Energie und Umwelttechnik e.V. 
in Duisburg (IUTA e.V.) or by the working group of Dr. Kai Bester at the Department 
of Environmental Chemistry at the University Duisburg-Essen (UDE). Experimental 
conditions as well as the operating procedures were adapted from the final report of 
the IGF project No. 15862 N “Oxidationsnebenprodukte” [151]. The investigated 
substances and chemicals used for the oxidation experiments and chemical 
analyses are listed in Table 22. 
Table 22: Chemicals and investigated substances used for oxidation experiments 
Chemical Company 
2,4-Dichlorophenol Sigma-Aldrich; Steinheim, D 
Acetone Merck; Darmstadt, D 
Acetonitrile LGC Promochem; Wesel, D 
AHTN Dr. Ehrensdorfer; Augsburg, D 
Atenolol Sigma-Aldrich; Steinheim, D 
Bisphenol A Dr. Ehrensdorfer; Augsburg, D 
Catalase (Aspergillus niger) Sigma-Aldrich; Steinheim, D 
Ciprofloxacin Sigma-Aldrich; Steinheim, D 
Ethinylestradiol Riedel-de Häen; Seelze, D 
HHCB Dr. Ehrensdorfer; Augsburg, D 
HHCB-Lacton Dr. Ehrensdorfer; Augsburg, D 
HPLC-water J.T.Baker; Deventer, NL 
Hydrogen peroxide (H2O2) Sigma-Aldrich; Steinheim, D 
Irgarol 1051 Hempel; Pinnberg, D 
Methanol Merck; Darmstadt, D 
Methyl tert-butyl ether (MTBE) Merck; Darmstadt, D 
Metoprolol Sigma-Aldrich; Steinheim, D 
N-Butyl Methyl Ether J.T.Baker; Deventer, NL 
Ofloxacin Sigma-Aldrich; Steinheim, D 
Sulfamethoxazole Sigma-Aldrich; Steinheim, D 
Terbutryn Dr. Ehrensdorfer; Augsburg, D 
Toluol Merck; Darmstadt, D 
Triclosan Dr. Ehrensdorfer; Augsburg, D 
Triphenylphosphate (TPP) Sigma-Aldrich; Steinheim, D 
Tris-(2-butoxyethyl)-phosphate (TBEP) Sigma-Aldrich; Steinheim, D 
Tris-(1-chloro-2-propyl)-phosphate (TCPP) Akzo Nobel; Amersfoort, NL 
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Stock solutions: 
The substances were dissolved in HPLC-water containing 50 % acetonitrile with a 
concentration of 1 g/L. Substance concentrations during the oxidation experiments 
were between 0.1 and 18 mg/L. Table 23 displays the systems used for the oxidation 
of the individual samples. 
 
Table 23: Systems used for oxidation experiments of the tested samples, and their final 
concentration during toxicological testing. IUTA = Institut für Energie- und Umwelttechnik e.V.; 
UDE = Institute of Environmental Chemistry, University Duisburg-Essen 
Substance System 
(Place) 
Final concentration after exposure for 
toxicological tests 
AHTN (UDE) 0.1 mg/L 
Atenolol (UDE) 0.2 mg/L 
Bisphenol A (IUTA ) 1.4 mg/L (Ozonation); 0.1 mg/L (UV/H2O2) 
Ciprofloxacin (IUTA) 1.4 mg/L (Ozonation); 0.1 mg/L (UV/H2O2) 
Ethinylestradiol (IUTA) 1.5 mg/L 
HHCB (UDE) 0 – 50 µg/L; 0.1 mg/L (UV/H2O2) 
HHCB-Lacton (UDE) 0 – 50 µg/L 
Irgarol 1051 (UDE) 0.75 mg/L 
Metoprolol (IUTA) 1.4 mg/L (Ozonation); 0.1 mg/L (UV/H2O2) 
Ofloxacin (IUTA) 18 mg/L 
Sulfamethoxazole (IUTA) 1.4 mg/L (Ozonation); 0.1 mg/L (UV/H2O2) 
TCEP (UDE) 0.1 mg/L 
TCPP (UDE) 0.1 mg/L 
TPP (UDE) 0.1 mg/L 
Terbutryn (UDE) 0.49 mg/L 
Triclosan (UDE) 0 – 100 µg/L 
2.4-Dichlorophenol (UDE) 0 – 100 µg/L 
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4.4.1. Ozonation 
4.4.1.1. Laboratory scale ozonation 
Institut für Energie und Umwelttechnik e.V. (IUTA e.V.): 
During laboratory scale ozonation experiments (up to 1 L of sample), the ozone gas 
was produced using technical oxygen and an ozone generator (COM AD-01; 
Anseros, Tübingen, D). To produce ozone water, the gas was directed through 
distilled, cooled water immediately after generation. A platinum catalyzer was used 
to destroy the remaining excessive ozone. The ozone concentration was determined 
photometrically at 260 nm (SPECORD® PC 200 UV VIS Spectrophotometer; 
Analytik Jena AG, Jena, D) in regard to the Lambert-Beer law using a molar 
absorption coefficient of 3300 mol-1 cm-1. 
Pure water as well as WWTP effluents were then spiked with the single substances 
before the previously prepared ozone water was then added to the samples. After 
the reactions of the ozone with the water contaminants the samples were filter 
sterilized (Chromafil RC, 0.45 µm; Macherey-Nagel, Düren, D) and either directly 
stored in HPLC-MS-vials or after a subsequent solid phase extraction (SPE; see 
chapter 4.5.1). In addition WWTP effluent was also oxidized and analyzed without 
the addition of substances.  
 
Department of Environmental Chemistry: 
All tested substances were dissolved either in HPLC-water or WWTP effluent with 
concentrations between 0.1 and 44 mg/L. These solutions were then used for 
ozonation experiments. Residue-free methanol, toluol, acetone or MTBE were used 
to terminate the OH° formation. Mixing the solutions with O3 at different ratios, 
samples with different mole-ratios were gained (1:1 up to 1:10). Ozone was 
produced using an ozone generator (Enaly 1000BT-12, Enaly M&E Ltd, Shanghai, 
China) and technical oxygen (0.5 L/min) resulting in an ozone input of 2-5 mg/L into 
the system. The amount of ozone was detected using UV-VIS spectrometry 
(Shimadzu, Duisburg, Germany) and samples were taken time-dependent.  
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4.4.1.2. Pilot scale ozonation (IUTA e.V.) 
To perform experiments with a sample volume of 200 to 500 L a pilot plant (OCS 
H2O2-UV; Wedeco, Herford, D) with an attached ozone generator (OCS-GSO 20; 
Wedeco, Herford, D) and an ozone surveillance device (DH 5; BMT Messtechnik. 
Berlin, D) was used. The ozone generator was adjusted to discharge 80 – 90 g/m3 
gaseous ozone into the pilot plant with a flow rate of 0.5 m3/h. All experiments were 
performed at 20 °C and before starting an experiment the plant was rinsed with the 
used water. Samples were then taken in a time-dependent manner. 
 
4.4.2. UV/H2O2 oxidation 
4.4.2.1. Laboratory scale UV oxidation with and without H2O2 
(IUTA e.V.) 
Oxidation experiments using UV light were performed at a laboratory scale system 
with a volume of 1 L. The construction was coupled to a low pressure UV lamp 
(TNN15/32 Hg lamp, 254 nm; Heraeus, Hanau. D). Before the oxidation, spiked and 
non-spiked pure water as well as WWTP effluents were evenly distributed in the 
system and the oxidation was started. At the beginning of the experiments performed 
with the addition of H2O2 the UV lamp was allowed to reach full power (5 min) before 
H2O2 (0.3 g/L) was added. To remove remaining peroxides after treatment catalase 
(0.25 mL; c = 0.4 kU/mL) was added to the system. All experiments were performed 
at 30 °C and sampling was done time-dependent.  
 
4.4.2.2. UV/H2O2 oxidation of TPP, TBEP and TCPP (UDE) 
Each of the three organophosphates was dissolved in 1 L HPLC-water with a final 
concentration of 1 mg/L and subjected to UV treatment. The samples were treated 
with UV light (Heraeus TNN15/32; 3 Watt, 254 nm; Hg-LP; Heraeus, Hanau, 
Deutschland) and 1 mg/L H2O2 for up to 120 min with a time-dependent sampling. 
After sampling, 100 µL catalase (0.4 kU/mL) were added to remove remaining 
peroxides. Subsequent a SPE (see chapter 4.5.2) was performed before GC-MS-
Screening. 
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4.4.2.3. Pilot scale UV oxidation with and without H2O2 (IUTA e.V.) 
The previously described pilot scale plant (Volume = 200 L) was also used for UV 
experiments. All samples were UV treated the same way as was done during 
ozonation. For oxidation a low pressure UV lamp (XLR 10, 33 W, 180 nm and 
254 nm; Wedeco, Herford, D) or a medium pressure lamp (uviblox® WTP; 2x4 Watt; 
IBL, Heidelberg, D) was used. During oxidation experiments with hydrogen peroxide 
the lamp was switched on 10 min prior to the addition of 0.3 g/L H2O2. Again the 
samples were taken time-dependently and catalase (0.25 mL; c = 0.4 kU/mL) was 
added to terminate the reaction. 
 
4.4.2.4. UV and UV/H2O2 oxidation using the flow through system 
(IUTA e.V.) 
The IBL uviblox® WTP 2x4 flow-through unit (IBL, Heidelberg, D) equipped with two 
4 kW medium pressure lamps was used for oxidation experiments. For this purpose 
the water sample was stored in a 1 m3-IBC-Container and directly pumped into the 
system passing the UV lamps and dispatched back into the container.  
 
4.4.2.5. UV and UV/H2O2 oxidation at the flow through system 
(Waste water treatment plant) 
The above described system was also placed at a waste water treatment plant 
taking the water directly from the effluent of the plant and releasing it into the 
discharge system. When H2O2 was added to the water an amount of 1 L/h (c = 35 %) 
was pumped into the system. The flow-through as well as the power of the UV lamps 
varied (3 – 12 m3, 1x0.8 – 2x4 kW). 
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 Extraction methods 4.5.
4.5.1. Solid Phase Extraction (SPE) 
Chemical analyses were performed either using the filtered undiluted non-enriched 
sample or samples after solid phase extraction. Prior to extraction the samples were 
filter sterilized using a 1 µm glass-fiber filter (Pall Life Science, Washington, NY, US). 
Extraction was done using an automated Gilson-System (Valvemate® II; Gilson 
International B.V., Limburg, D) with Strata X (Phenomenex, Aschaffenburg, D), 
Strata XL (Phenomenex, Aschaffenburg, D), and ENV+ (Biotage, Uppsala, SE) 
cartridges. Before extraction, the samples were adjusted to pH 3 and internal 
standards were added. After extraction the samples were concentrated under 
nitrogen gas. Pharmaceuticals were eluted with 1 mL water:ACN (50:50) containing 
1 % formic acid. Extracts containing Bisphenol A were concentrated under nitrogen 
gas, eluted using 1 mL methanol, again concentrated and eluted in 100 µL Bis-
(trimethylsilyl)-trifluoro-acetamide with 1 % trimethylchlorosilane, mixed and 
derivatized at 70 °C for 30 min. The extracts of the three organophosphates (TPP, 
TCEP, TCPP), HHCB and AHTN were stored at -20 °C for 2 h to remove remaining 
water and afterwards concentrated using a Büchi-Syncore system (Büchi, Flawil, 
CH) with 60 °C, 40 mbar and 180 rpm (organophosphates) or 50 °C, 60 mbar and 
180 rpm (HHCB, AHTN) resulting in a final volume of 1 mL. In addition to the 
concentration of the organophosphates, the solvent was changed to toluol by adding 
10 mL toluol to the sample and concentrating it to 1 mL twice. All samples were then 
transferred to a vial for measurement. Irgarol 1051 and Terbutryn were transferred to 
a vial directly after extraction without any further handling. 
 
4.5.2. Liquid-liquid-extraction (LLE) 
The three organophosphates as well as the biocides Irgarol 1051 and Terbutryn 
were extracted using a liquid-liquid-extraction method. Therefore 2 mL of each 
sample were mixed with 2 mL toluol and 100 µL internal standard was added. After 
mixing the sample and the toluol for 20 min at 500 rpm the sample was stored at -
20 °C for at least two hours. 1 mL of the toluol phase was then aspirated and 
transferred to a GC-vial for further testing. 
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 Analytical Chemistry 4.6.
Part of the analytical chemistry is the qualitative and quantitative determination of 
compounds as well as the identification of structures through separation processes. 
These processes include chromatographic as well as spectroscopic methods. A 
linkage of both results in a more sensitive analytical tool which allows an 
improvement in the detection and identification of substances. 
 
Chromatography 
During chromatographic separation processes the substance to be analyzed is 
dissolved in the mobile phase (liquid, gas) and moved over the stationary phase 
(column, flat-bed). The separation then takes place due to interactions of the 
compound with the stationary phase resulting in a chromatogram. As the name 
implies, the gas chromatography is based on a gas used as the mobile phase. After 
evaporation the sample is then moved across the stationary phase by this gas 
resulting in a time dependent detection of each compound (retention time). Another 
type of chromatography is the high performance liquid chromatography (HPLC). The 
HPLC is a chromatography method using a liquid mobile phase [152].  
Mass Spectroscopy 
During mass spectroscopy the compounds to be measured are transformed into fast 
moving, ionizing gases and then detected according to the mass to charge ratio 
(m/z). This ratio deflects the separation of the ions in an electric or magnetic field 
[152].  
 
 
4.6.1. HPLC-MS/MS 
A HPLC-MS/MS method was performed to quantify the analytes with the API 3000 
(CTC Analytics, Zwingen, CH) and a Q Trap 3200 (AB Sciex, Darmstadt, D) using a 
Multiple Reaction Monitoring (MRM) mode. Two characteristic mass changes were 
detected for each substance (Table 24). Chromatographic division was done using a 
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Synergi Polar RP 80 HPLC column (150 x 2 mm; 4 µm; Phenomenex, 
Aschaffenburg, D) on both systems. Three different eluents were used: (1) water 
with 0.1 % HCOOH and ACN with 0.1 % HCOOH, (2) water with 0.1 % HCOOH and 
methanol with 0.1 % HCOOH as well as (3) water with 4 mM ammonium acetate 
(pH 4) and acetonitrile with 0.1 % HCOOH.  
 
Table 24: Mass changes of the analytes during HPLC-MS/MS 
Compound HPLC-MS 
method 
Rentention 
time [min] 
Q1 Mass 
[Da] 
Q3 Quanti-
fication [Da] 
Q3 Verifi-
cation [Da] 
Ciprofloxacin Q Trap 3200 2.31 332 314 288 
Ethinylestradiol Q Trap 3200 4.80 297 107 77 
Irgarol 1051 API 3000 
Pharm. (pos) 
2.97 254 198 83 
Metoprolol API 3000 
Pharm. (pos) 
7.40 268 116 77 
Ofloxacin Q Trap 3200 2.17 362 318 261 
Sulfamethoxazole API 3000 
Pharm. (pos) 
8.70 254 156 92 
Sulfamethoxazole Q Trap 3200 2.27 254 156 92 
Terbutryn API 3000 
Pharm. (pos) 
2.71 242 186 68 
Pharm. = Pharmaceutical ; pos = positive mode 
 
API 3000: 
For the measurements using the API 3000 system the column temperature was set 
to 35 °C and the pharmaceuticals were quantified in positive and negative mode. 
Settings for either mode are presented in Table 25. 
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Table 25: Measurement settings for pharmaceutical quantification using the API 3000 system 
 Positive mode Negative mode 
Flow-through 0.35 mL/min 0.3 mL/min 
Nebulizer 12 V 12 V 
Curtain gas 10 V 10 V 
Ion source temperature 450 °C 450 °C 
Ionization voltage 5000 V -4500 V 
 
 
Q Trap 3200: 
The column temperature of the Q Trap system was set to 40 °C and the samples 
were transferred to the MS via electron spray ionization (ESI). The settings were as 
followed: Curtain gas = 15 V, Ion source temperature = 550 °C, Gas 1 = 40 psi, 
Gas 2 = 80 psi, Ionization voltage = 5500 V, Declustering potential = 50 V, Entrance 
potential = 6 V, Cell entrance potential = 18 V, Collision energy = 27 eV, Cell exit 
potential = 4 V. The flow-through was set to 0.4 mL/min for sulfamethoxazole and 
0.3 mL/min for the fluoroquinolones. 
The analyses were then done with the Analyst 1.5 (AB Sciex; Darmstadt, D) using an 
external calibration for direct measurements and an internal calibration for previously 
processed samples. The calibration was weighted 1/x with linear regression, the limit 
of detection was defined with a signal to noise ratio of 3:1 and the limit of 
quantification was defined with a signal to noise ratio of 10:1. 
In addition to the quantification of known micropollutants a method was developed to 
screen the samples for unknown micropollutants as well as oxidation by-products. A 
linear gradient was used for chromatographic division and the detection was carried 
out with an Information Dependent Acquisition (IDA) experiment. For this purpose, 
masses between m/z = 50 and 500 were scanned and the ion trap was set to 1000. 
The following system settings were chosen for the experiment: Collision 
energy = 10 V, Mass tolerance = 250 mmu. Isotopes with an area of 4.9 Da were 
excluded and the settings for the gases were the same as in the quantification 
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experiments. During each IDA experiment the two masses with the highest intensity 
were filtered and further fractioned to gain information on the molecular structure of 
the unknown substances.  
 
 
4.6.2. GC-MS 
Bisphenol A was analyzed with a GC-MS (Trace GC Ultra coupled to a DSQ Mass 
spectrometer; Thermo-Scientific, Dreieich, D) using a Restek Rxi – 5Sil-MS column 
(30 m x 0.25 mm, 0.25 µm; Restek, Bellefonte, PA, US). Helium 5.0 (Air Liquide, 
Düsseldorf, D) was used as carrier gas and the oven temperature was set to 100 °C. 
The heating rate was 40 °C/min until 260 °C were reached. Then the heating rate 
was adjusted to 5 °C/min until reaching 310 °C. A DB-5MS column (15 m x 0.25 mm, 
0.25 µm; J&W Scientific, Folsom, US) with a linear temperature setting (increasing 
from 70 °C to 280 °C in 30 min) was used for the analyses of the organophosphates, 
Triclosan, HHCB and AHTN. 
The samples were then vaporized using a Programmed Temperature Vaporizer- 
(PTV) cooled injection system and transferred to the MS device. The injection 
volume was set to 1 µL and Helium 5.0 was used as carrier gas (Flow-rate = 
1.3 mL/min). Between 100 °C and 320 °C the heating rate was 14.5 °C/min and the 
temperature of the ion source was 200 °C (Bisphenol A) or 230 °C 
(Organophosphates, Triclosan, HHCB and AHTN). The Selected Ion Monitoring 
(SIM) method was used for measurements. Mass transfers for the quantification are 
depicted in Table 26. The Xcalibur software from Thermo-Scientific (Dreieich, D) was 
used for the analysis, including a linear regression. The limit of detection was defined 
with a signal to noise ratio of 3:1 and the limit of quantification was defined with a 
signal to noise ratio of 10:1. 
 
 
Material and Methods 
94 
 
Table 26: Mass transfer of the analytes during GC-MS measurements 
Compound 1. Mass [Da] 3. Mass [Da] 
AHTN 243 258 
Bisphenol A 357 372 
HHCB 243 258 
TCPP 277 279 
TBEP 199 299 
TPP 325 326 
Triclosan 288 290 
 
 
 
 Peroxide testing 4.7.
The testing for remaining peroxides after UV/H2O2 treatment was done using 
peroxide tests strips (Quantofix®) which allow a semiquantitative analysis (Figure 27) 
based on a color scale. With these test strips peroxides were detected at 
concentrations between 0.5 and 25 mg/L. 
 
Figure 27: Peroxide Test-strips (Quantofix®). Left: negative for peroxides; right: peroxides 
detected 
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 Waste water treatment plant effluent used for testing 4.8.
The here used effluent was collected at a waste water treatment plant which is able 
to clean up to 8500 L/sec and which is designed for a capacity of 1.22 million 
population equivalents serving five cities with a population between ca. 75,000 and 
574,635 persons. It was build as a conventional treatment plant consisting of a 
mechanical treatment (rack, sand and grease removal through sedimentation), an 
activated sludge basin, and primary as well as secondary treatment steps. Up to 
now, advanced or oxidative treatment step are not applied before the water is 
released. 
The DOC of the here used WWTP effluent ranged from 6 to 8 mg/L over the course 
of the experiments and the pH was between pH 7 and pH 8.5. Chemical analyses 
revealed that the WWTP effluent still contained micropollutants, however at 
concentrations below 1 µg/L. 
 
 
 
 Sample preparation before toxicological testing 4.9.
The water samples had to be sterilized by filtration before they were added to the 
cells in order to prevent bacterial contamination. For this reason sterile filters with a 
pore size of 0.2 µm were used. 
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5. Results 
 Adaptation of toxicological methods 5.1.
5.1.1. MTT Test, PAN I and Alkaline Comet Assay 
The MTT test, the PAN I test and the alkaline comet assay are methods routinely 
used for the detection of toxic effects of chemicals and other substances, e.g. 
nanoparticles or pharmaceuticals. However they are not suitable for the testing of 
water samples since the addition of water to the cells might lead to an increase in the 
osmotic pressure and subsequent cell death. 
In order to apply the mentioned tests, the MTT test and the Alkaline Comet Assay 
had to be adapted to the matrix since they are not applicable for the testing of water 
samples and to prevent false positive and false negative results.  
The first step therefore was the determination of the highest water concentration that 
can be used for an exposure without causing toxic effects leading to false positive 
results. Positive controls were monomethylarsonous acid (MMA III; 50 µM) for the 
MTT test and 0.1 mg/mL N-ethyl-N-nitrosourea (ENU) for the Alkaline Comet Assay. 
The testing of a dilution series with different amounts of water added to the exposure 
medium showed that a final concentration of 10 % water does neither lead to 
cytotoxic nor genotoxic effects in CHO or T47D cells (Table 27) whereas the smaller 
dilution factor (1:2) results in strong toxic effects in the MTT test and highly 
significant DNA damages in the Alkaline Comet Assay. Based on these results a 
dilution of 1:10 of the water samples into the exposure medium was then further 
used during the course of all experiments. 
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Table 27: Toxic effects of different amounts of water in exposure medium  
Sample 
[dilution] 
MTT Test 
[degree of cytotoxicity] 
Alkaline Comet Assay 
[statistical significance of 
DNA damage] 
 CHO cells T47D cells CHO cells 
Neg. control 0 0 not significant 
Pos. control 3* 3* highly significant# 
1:2 3 3 n.t. 
1:10 0 0 not significant 
1:20 0 0 not significant 
n.t. = not tested; * = 50 µM MMA III; # 0.1 mg/mL ENU; not significant = p > 0.05; 
highly significant = p < 0.001 
 
 
5.1.2. ER Calux 
The ER Calux is a test which can be used for the testing of water samples however 
the directions provided by BDS include an extraction step followed by an elution in 
DMSO. To avoid this step in order to test the water sample non-enriched for a 
realistic statement the method was optimized. Therefore it was first determined 
whether a white or a black 96-well plate should be used for the luminescence 
measurement. A concentration series of a Luciferase standard was used after 
adding the GlowMix to the solution. The results show that the relative light units 
(RLU) of the Luciferase standard in the white plate resulted in a coefficient of 
determination (R2) of 0.94 whereas the measurement of the black plate resulted in a 
R2 of 0.71 (Figure 28). Based on this data the white plate was then used for the RLU 
measurements. 
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Figure 28: Luminescence measurement of a Luciferase standard using a white and a black 96-
well plate. 
 
 
5.1.3. Ames Test 
The Ames MPFTM 98/100 Aqua in contrast has been developed for the testing of 
water samples. Thus there was no need for adaptation or optimization and the test 
was performed according to the manual provided by Xenometrix (see section 2.6.5 
Ames Test). 
 
 
5.1.4. H2O2 
Due to the use of hydrogen peroxide (H2O2) during UV treatment a proportion of 
peroxides might still remain in the sample because of an incomplete reaction. When 
the cells are then exposed to water samples still containing these remaining 
peroxides the sample might be toxic leading to false positive results. To overcome 
these effects catalase was added to the oxidized samples to degrade remaining 
peroxides before exposure.  
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Catalase is an enzyme which reduces the toxic H2O2 to oxygen and water [153]: 
 
 
 
Preliminary tests showed that UV/H2O2 treated samples had both cytotoxic (Figure 
29a) and genotoxic (Figure 29b) effects. In addition the test for peroxides was 
positive.  
 
Figure 29: a) Cytotoxic effects of UV/H2O2 treated samples. b) DNA damaging effects of 
UV/H2O2 treated samples. The addition of catalase resulted in the elimination of toxic effects. 
2 H
2
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Samples treated with UV and H2O2 resulted in a loss of viability and were classified 
as moderately (10 min and 30 min) or weakly (60 min) cytotoxic. The statistical 
analysis of the Olive Tail Moments (OTM) showed highly significant increases in the 
OTM of the treated sample compared to the negative control. However the addition 
of 0.25 mL catalase (0.4 KU/mL) to the toxic samples resulted in a complete 
elimination of peroxides and thus toxic effects (Figure 29). Catalase itself did not 
result in cytotoxic or genotoxic effects and neither did the matrix control. Therefore 
catalase was then added to all H2O2 treated samples and they were then in addition 
checked for remaining peroxides to rule out false positive results. 
 
 
5.1.5. Contaminations 
In regard to the testing of waste water treatment plant effluents bacterial 
contamination has to be avoided. Filtration has been proven as a sufficient method. 
As shown in Figure 30 the samples were spread on blood agar plates before and 
after sterile filtration. The sample plated without filtration shows a heavy microbial 
contamination (Figure 30a) whereas the filtered sample does not result in microbial 
growth (Figure 30b). Further on all waste water samples were therefore filtered 
before exposure. 
 
Figure 30: Blood agar plates with bacterial growth after plating an unfiltered WWTP effluent 
sample (a) and a plate without colonies after plating a filtered sample (b) incubated for 24 h at 
37 °C. 
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 Matrix controls 5.2.
For all tests either HPLC-water or waste water treatment plant effluent was used to 
dissolve the substances for oxidative treatment and further chemical and 
toxicological analysis. Therefore these waters were first tested for cytotoxicity and 
genotoxicity before and after treatment to prevent matrix effects through the 
oxidation methods or in the case of the WWTP effluent through substances present 
in the water. 
 
5.2.1. HPLC-water 
The HPLC-water used to dissolve the substances was first tested for toxic effects to 
rule out possible false positive or negative effects due to the water matrix.  
 
Figure 31: No cytotoxicity (a) and genotoxicity (b) of HPLC-water before and after ozonation 
(2 mg O3/L) or UV/H2O2 treatment. 
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Therefore the HPLC-water was tested before and after ozonation (5 mg/L O3) or 
UV/H2O2 (Hg-LP, 15 W; 1 g/L H2O2) treatment. Neither test (PAN I Multitox test or 
Alkaline Comet Assay) revealed toxic effects when compared to the negative control 
(Figure 31). 
 
 
To rule out false positive effects through methodological errors during extraction, 
extracts of HPLC-water (C18 and Strata X) were also tested for toxic effects (Figure 
32). The results of the Alkaline Comet Assay show that neither the extracted nor the 
original HPLC-water samples had a statistically significant influence on the Olive Tail 
Moment compared to the negative control. There was also no difference of the 
extracted samples compared to the original HPLC-water sample. In addition the 
ozonation also did not have an influence on the genotoxicity of the samples. 
 
Figure 32: No genotoxicity of HPLC water extracts (C18 and Strata X) before and after 60 
mintes of ozonation 
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5.2.2. Waste water treatment plant effluent 
In addition to the above presented results for HPLC-water, waste water treatment 
plant effluent was also tested for cytotoxicity and genotoxicity before and after 
oxidative treatment without the addition of the substances. The results demonstrated 
that neither the untreated, nor the effluent after ozonation or UV/H2O2 treatment 
resulted in a loss in viability (Figure 33a) or an increase in DNA damage (Figure 
33b). 
 
 
Figure 33: Waste water treatment plant effluent before and after oxidative treatment. No 
cytotoxic (a) or genotoxic (b) effects. 
 
 
Extracts of waste water treatment plant effluent using C18 or Strata X columns were 
then also tested for their potential to induce DNA damaging effects before and after 
ozonation, to rule out false positive effects due to the extraction procedure. As can 
be seen in Figure 34 the Olive Tail Moments of both extracts (C18 and Strata X) are 
comparable to both, the original water sample without extraction as well as the 
negative control. There is also no statistically significant difference in the Olive Tail 
Moment between the untreated samples and the samples after 60 minutes of 
ozonation. 
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Figure 34: No genotoxicity of WWTP extracts (C18 and Strata X) of WWTP effluent before and 
after ozonation 
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 ß-Blocker 5.3.
Atenolol and Metoprolol both belong to the group of ß1-adrenoreceptor antagonists 
inhibiting the function of hormones like adrenaline and noradrenaline. Both 
hormones belong to the group of catecholamines, synthesized in cells of the adrenal 
cortex and are transported to the heart as a response to stress affecting heart cells 
by binding to the adrenergic receptors which subsequently will lead to an increase in 
the heart rate and blood pressure as well as other metabolic functions [116]. Thus ß-
blocker are used to treat a variety of diseases compromising the cardiac system 
[154]. Metoprolol is still the most frequently prescribed ß-blocker and Atenolol the 
third most one [34]. Their widespread use for many years (e.g. 204,088 kg in 2009 
[12]) and an increase of 6.4 % in the amount prescribed in 2010 compared to 2009 
[34] has led to their high abundance in the water system.  
 
 
5.3.1. Atenolol 
2 mg/L Atenolol were dissolved in HPLC-water were then tested for toxicity before 
and after oxidative treatment leading to a concentration of 0.2 mg/L Atenolol during 
exposure. The results show that neither before nor after ozonation with 2 mg O3/L 
cytotoxic (Figure 35a) or genotoxic (Figure 35b) effects occur since the viability of 
the CHO cells does not decrease below 80 % in the XTT, SRB and NR test. In 
addition the relative LDHe activity after an exposure to the water samples is 
comparable to the negative control. The same is true for the genotoxicity testing. The 
Olive Tail Moment of the exposed CHO cells is in the range of the negative control 
and no statistically significant changes were detected. Thus the results prove that 
Atenolol itself is not cyto- or genotoxic at the tested concentration. The degradation 
analyses of Atenolol after ozonation revealed no formation of oxidation by-products 
since it was degraded immediately after adding 2 mg/L of ozone to the water sample 
[151]. 
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Figure 35: No cytotoxicity (a) and genotoxicity (b) of 0.2 mg/L Atenolol in HPLC-water before 
and after ozonation (2 mg O3/L). 
 
 
5.3.2. Metoprolol 
For the ozonation experiments using HPLC-water, 14 mg/L of Metoprolol were 
added to HPLC-water and subjected to 5 mg/L of ozone for 60 minutes. No 
cytotoxicity (Figure 36a) or genotoxicity (Figure 36b) of 1.4 mg/L Metoprolol were 
detected and no differences were seen before (untreated) or after (O3) ozonation. 
The same results were detected for HPLC-water containing 0.1 mg/L Metoprolol 
before and after UV/H2O2 treatment, where also no toxic effects on the cell viability 
were detected in the MTT test (Figure 36a) or damages to the DNA using the 
Alkaline Comet Assay (Figure 36b).  
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Figure 36: a) No cytotoxicity or genotoxicity (b) of HPLC-water containing 1.4 mg/L Metoprolol 
before and after ozonation or 0.1 mg/L Metoprolol before and after UV/H2O2 treatment for 60 
minutes. 
 
The same concentrations of Metoprolol were then also tested for toxic effects when 
added to waste water treatment plant effluent and then oxidatively treated for 60 
minutes. No decrease in viability was detected before and after ozonation or 
UV/H2O2 treatment (Figure 37a). The Alkaline Comet Assay also did not show any 
influence of the tested samples on the Olive Tail Moment as the measure for DNA 
damage (Figure 37b). 
 
Figure 37: a) No cytotoxicity or genotoxicity (b) of WWTP effluent with 1.4 mg/L Metoprolol 
before and after ozonation or of 0.1 mg/L Metoprolol after UV/H2O2 treatment for 60 minutes. 
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 Estrogenic substances 5.4.
Estrogens like estradiol or estrone are hormones, promoting the development of the 
female secondary sex characteristics. Besides this they play a role e.g. during 
osteogenesis or the lipid metabolism [116]. Their mode of action is based on the 
diffusion through the cell membrane followed by binding to an estrogen receptor only 
present in specific tissues (e.g. breast, uterus, ovaries). The now activated 
estrogen:receptor complex migrates into the nucleus and binds to an estrogen 
responsive element of the DNA initiating DNA transcription and the production of 
proteins. Naturally, estrogens are synthesized in vertebrates and also some 
invertebrates through the transformation of male sexual hormones. Synthetic 
estrogens, also known as xenoestrogens, are present as chemicals, plasticizers (e.g. 
Bisphenol A), pharmaceuticals (e.g. 17α-ethinylestradiol) and cosmetics [155]. 
Although the use of estrogens and xenoestrogens in medicine is widespread the 
amount of prescribed pharmaceuticals containing estradiol slightly decreased 
(0.9 %) in 2010 compared to the amount prescribed in 2009 [34]. 
Synthetic estrogens are the most important compounds described as endocrine 
disrupting chemicals (EDC). The word endocrine defines the process of the 
formation of a hormone in an organ and its transport to the target location via the 
blood [116]. EDC is the term for exogenous substances which mimic the action of 
natural hormones thus affecting the hormonal system by interfering with natural 
signaling pathways resulting in a variety of possible health effects [156, 157]. 
The most prevalent effects of EDC in the water system have been detected in fish. In 
order to develop the female type estrogens are essential [116]. Thus if estrogens are 
present in the environment at high concentrations a feminization of this fish 
population might take place. Despite this, in vitro test sytems have also been able to 
show the presence of EDC in different water bodies [158]. 
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5.4.1. Ethinylestradiol 
Ethinylestradiol (EE2) is a synthetic derivative of the natural estrogen estradiol and is 
mainly used as a contraceptive [34]. Since it is one of the most used 
pharmaceuticals, the consumption of pharmaceuticals containing Ethinylestradiol 
was almost 633 kg in 2009 [12]. Compared to estradiol the bioavailability of 
ethinylestradiol is increased due to the substitution of an ethyl-group at the C17 
position resulting in a decreased first-pass-effect in the liver and therefore lower 
biodegradability and a higher excretion rate of the unmetabolized molecule [34]. 
 
First 15 mg/L Ethinylestradiol were dissolved in HPLC water and subjected to UV 
radiation with H2O2 and treated for up to 60 minutes. In addition the same 
concentration of EE2 was also treated with 1, 5 or 10 mg/L of ozone for 10 or 60 
minutes. Both sets of samples were then first tested for cytotoxic effects against 
T47D cells with a final concentration of 1.5 mg/L EE2 during exposure. As can be 
seen in Figure 38 neither the untreated EE2 sample nor the UV/H2O2 treatment (Hg-
LP, 15 W; c(H2O2) = 0.3 g/L) for 10 or 60 minutes did result in cytotoxic effects. In 
addition the ozonation using three different concentrations of ozone (1, 5, and 
10 mg/L) did also not lead to a decrease in the number of viable T47D cells below 
80 %, thus there were also no cytotoxic effects detected for ozonated samples. 
 
Figure 38: No cytotoxicity of 1.5 mg/L Ethinylestradiol before and after UV/H2O2 treatment or 
ozonation (1-10 mg/L O3). 
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Since Ethinylestradiol is a synthetic estrogen the samples were also tested for the 
induction of estrogenic effects before and after oxidative treatment using the ER 
Calux. Displayed in Table 28 are the results of the testing before and after ozonation 
or UV/H2O2 treatment of HPLC-water containing 1.5 mg/L Ethinylestradiol. The EEQ 
values clearly show that there is a decrease in estrogenicity after both treatment 
methods compared to the untreated sample. An increase in treatment duration 
(UV/H2O2) and ozone concentration leads to a decrease in estrogenic activity. In fact 
the UV/H2O2 treatment resulted in a lower estrogenic activity after 60 min than the 
highest ozone concentration (10 mg/L) after 60 minutes. However both methods did 
not result in a complete elimination of the estrogenic activity from the water sample 
and only slight differences in EEQ values were seen after treatment. 
Table 28: Estrogenicity of 1.5 mg/L Ethinylestradiol dissolved in HPLC-water before and after 
UV treatment and ozonation. 
Sample 
Estrogenicity          
(ER Calux EEQ 
[pM/Well]) 
Estrogenicity         
(ER Calux EEQ 
[ng/L]) 
untreated 1.8 4.90 
10 min UV* 1.4 3.81 
60 min UV* 0.9 2.45 
1 mg/L O3 
# 1.6 4.36 
5 mg/L O3 
# 1.3 3.54 
10 mg/L O3
 # 1.1 3.00 
* Hg-LP, 15 W; c(H2O2) = 0.3 g/L; 
# duration = 60 min 
 
5.4.2. Bisphenol A 
According to the European Food Safety Authority, Bisphenol A is a chemical 
substance mainly used as a basic material for the synthesis of polycarbonates and it 
is also used as an antioxidant in plasticizers. These polycarbonates are then used in 
everyday products e.g. storage boxes and plastic bottles. Due to its widespread use 
(global production = 3.8 million tonnes in 2006 [159]), it has been detected in surface 
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waters and waste water treatment plant effluents and thus might pose a threat to the 
environment because of its endocrine disrupting mode of action. 
The toxicity of Bisphenol A was tested before and after oxidative treatment of waste 
water treatment plant effluent or HPLC-water. The results of HPLC-water containing 
1.4 mg/L Bisphenol A show no cytotoxic effects after ozonation (O3 = 5 mg/L), 
whereas 0.1 mg/L Bisphenol A resulted in a decrease in viability indicating strong 
cytotoxic effects and the formation of toxic oxidation by-products (Figure 39a) after 
60 minutes of UV oxidation (Hg-LP lamp: 15 W) in combination with H2O2 (c = 1 g/L). 
In addition no increase in Olive Tail Moment was detected for the ozone treated 
sample, while the cytotoxic sample was not tested for genotoxic effects (Figure 39b). 
Thus no genotoxicity could be detected for the used concentrations. 
 
Figure 39: a) No cytotoxic effects of HPLC-water containing 1.4 mg/L Bisphenol A after 
ozonation, but cytotoxic effects after UV/H2O2 treatment. b) No genotoxic effects of tested 
samples. No cytotoxic (c) or genotoxic (d) effects of WWTP effluent containing Bisphenol A 
before and after ozonation or UV/H2O2 treatment.    cytotoxic effects ;# = not tested 
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In addition to the cytotoxicity and gentoxicity testing 0.1 mg/L Bisphenol A in HPLC-
water were also tested for the induction of estrogenic effects before and after 
UV/H2O2 treatment. EEQ values were only detected in the untreated sample, 
whereas 10 min or 60 min resulted in a complete loss in estrogenicity (Table 29).  
 
Table 29: EEQ values [pM/100 µL] of 0.1 mg/l Bisphenol A in HPLC-water  
UV/H2O2 treatment 
(Hg-LP, 15 W; 1 g/L H2O2) 
ER Calux EEQ 
[pM/100 µL] 
ER Calux 
EEQ [ng/L] 
Untreated 2.7 5.72 
10 min -* -* 
60 min -* -* 
* = no estrogenicity detected 
 
 
 
 Antibiotics 5.5.
Antibiotics are natural substances synthesized mostly by fungi as metabolites and 
are selectively effective against other microorganisms, e.g. bacteria [160, 161]. The 
first antibiotic (Penicillin) was isolated from a broth culture of the mold Penecillium 
notatum (now Penicillium chrysogenum) and described by Alexander Fleming in 
1929 [162]. Since that time many more antibiotic substances have been isolated and 
are commercially synthesized for the use in medicine. Antibiotics are effective by e.g. 
inhibiting the cell wall synthesis, interfering with the membrane permeability, 
inhibiting the protein synthesis, metabolic functions or the nucleic acid synthesis and 
replication of microorganisms. They can therefore either be bacteriostatic by 
inhibiting proliferation or bactericidal by killing these organisms. Due to their mode of 
action antibiotics are classified into different groups (ß-lactams, sulfonamids, 
quinolones, cephalosporines etc.) [160, 161]. For the years 2008 and 2009 a total 
amount of approximately 374 million DDD of antibiotics and 41 million prescriptions 
for ambulant therapies excluding hospital cases were listed. This numbers make 
antibiotics one of the top three pharmaceutical groups prescribed annually [163].  
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In this project the antibiotics Sulfamethoxazole, Ciprofloxacin, Ofloxacin, and 
Triclosan were investigated for their toxicological effects before and after oxidative 
treatment. 
 
 
5.5.1. Sulfamethoxazole 
Sulfamethoxazole belongs to the group of sulfonamide antibiotics and is used for the 
treatment of e.g. urinary tract infections and pneumonia [160]. It is always applied in 
combination with Trimethoprim, another bacteriostatic agent [164]. Sulfonamide 
antibiotics work by inhibiting the 4-Aminobenzoic acid, an intermediate during the 
synthesis of folate, which in the end leads to interruptions of DNA and RNA 
synthesis and thus a disturbed synthesis of amino acids, proteins and nucleotides. It 
can be used in human medicine since humans do not synthesize folic acid 
themselves and therefore will not be affected by this group of antibiotics [160]. The 
sum of Sulfamethoxazole containing antibiotics added up to 15.8 million DDD in 
2011 which is a decline of 3.5 % compared to 2009. In fact sulfonamide antibiotics 
are the group with the lowest number of prescriptions in 2011 compared to other 
groups of antibiotics, e.g. fluoroquinolones or makrolides [34]. 
As can be seen in Figure 40 the viability of CHO cells exposed to HPLC-water 
containing 0.1 mg/L Sulfamethoxazole before and after UV/H2O2 treatment (Hg-LP 
lamp, 15 W; 1 g/L H2O2) did not result in a decrease of the viability below 80 %, and 
therefore no cytotoxicity was detected. The Olive Tail Moment of the CHO cells 
exposed to the same samples did also not increase significantly in comparison to the 
negative control. Thus there are neither cytotoxic nor genotoxic effects of 
Sulfamethoxazole itself and its oxidation by-products in HPLC-water. 
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Figure 40: Sulfamethoxazole (0.1 mg/L) in HPLC-water before and after UV/H2O2 treatment. No 
cytotoxicity (a) or genotoxicity (b) detected. 
 
 
The ozonation (5 mg/L O3) of HPLC-water containing 14 mg/L Sulfamethoxazol did 
also not lead to the detection of cytotoxic (Figure 41a) or genotoxic (Figure 41b) 
effects in CHO cells after an exposure to 1.4 mg/L Sulfamethoxazole. There was no 
significant difference between the untreated (0 in) and treated (60 min) samples. 
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Figure 41: Sulfamethoxazole (1.4 mg/L) in HPLC-water before and after ozonation. No 
cytotoxicity (a) or genotoxicity (b) detected. 
 
Sulfamethoxazole was then dissolved in WWTP effluent (14 mg/L) and also tested 
for cytotoxic and genotoxic effects before and after ozonation using 5 mg/L O3. The 
results of the PAN I cytotoxicity test revealed no effects of 1.4 mg/L 
Sulfamethoxazole, neither before nor after ozonation (Figure 42a). The same 
samples did also not result in a significant increase in DNA damage (Figure 42b) 
thus no toxicity was detected with the used test systems. 
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Figure 42: No cytotoxicity (a) and genotoxicity (b) of 1.4 mg/L Sulfamethoxazole in WWTP 
effluent before (0 min) and after (60 min) ozonation (5 mg/L O3). 
 
Finally, 0.1 mg/L Sulfamethoxazole were tested for cytotoxicity and genotoxicity in 
WWTP effluent before and after UV/H2O2 treatment (Hg-LP, 15 W; 1 g/L H2O2). The 
results clearly show that there is no significant decrease in cell viability in all tested 
samples compared to the negative control (Figure 43a). In addition the same 
samples of Sulfamethoxazole were tested using the Alkaline Comet Assay and no 
genotoxicity was detected for 0.1 mg/L Sulfamethoxazole itself, (0 min) and the 
formed oxidation by-products (60 min). 
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Figure 43: No cytotoxicity (a) and genotoxicity (b) of 0.1 mg/L Sulfamethoxazole in WWTP 
effluent before and after UV/H2O2 treatment. 
 
 
5.5.2. Ciprofloxacin 
Ciprofloxacin is a second generation quinolone antibiotic. This group of antibiotics 
contains a fluorine atom thus called fluoroquinolone antibiotics. Fluoroquinolones 
inhibit the activity of the bacterial enzyme gyrase which is responsible for the 
supercoiling and packaging of bacterial DNA. Thus fluoroquinolone antibiotics are 
mostly bactericidal. The use of Ciprofloxacin is mainly during the treatment of urinary 
tract infections and influenza infections [160, 161]. Between the years 2002 and 
2009 the amount of consumed Ciprofloxacin was almost doubled (17183.1 kg in 
2002 and 32979.5 kg in 2009) [12] which is also displayed in 17.8 DDD in 2009 with 
a plus of 9.5 % compared to 2008 [34].  
17 mg/L Ciprofloxacin in HPLC-water were treated with UV-light (Hg-LP, 15 W) and 
H2O2 (1 g/L) for up to 60 min. While there was no cytotoxicity of the untreated 
sample (1.7 mg/L Ciprofloxacin), the UV/H2O2 treatment resulted in moderate 
cytotoxic effects reducing the viability to 69.35 % (Figure 44a). Except the one 
cytotoxic sample (60 min UV/H2O2 treatment) all others were also tested for 
genotoxicity with an additional sample after 30 min of oxidative treatment. However 
none of the samples resulted in genotoxic effects (Figure 44b). For a completion of 
the toxicity testing with Ciprofloxacin in HPLC-water, samples containing 14 mg/L 
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Ciprofloxacin were also treated with ozone (5 mg/L) and tested for their potential 
cytotoxicity and their DNA damaging potential.  
 
Figure 44: a) Cytotoxic effects of 1.7 mg/L Ciprofloxacin in HPLC-water after 60 min UV/H2O2 
treatment. b) No genotoxic effects before and after a maximum of 30 min UV/H2O2 oxidation. c) 
No cytotoxic or (d) genotoxic effects of 1.4 mg/L of Ciprofloxacin in HPLC-water before and 
after ozonation.   Cytotoxic; n.t. = not tested 
 
The results displayed in Figure 44c indicate that neither before nor after the 
ozonation cytotoxic effects of 1.4 mg/L Ciprofloxacin occur. The same samples did 
also not induce an increase in DNA damage (Figure 44d). 
WWTP effluent spiked with 14 mg/L Ciprofloxacin was subjected to ozonation 
(5 mg/L O3) and tested for toxicity after 60 min of treatment. No effects on the 
viability of the CHO cells was seen (Figure 45a) using the PAN I cytotoxicity test. 
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Figure 45: WWTP effluent containing 1.4 mg/L Ciprofloxacin show no cytotoxic (a) and 
genotoxic (b) effects after ozonation (5 mg/L).  
 
There were also no genotoxic effects of 1.4 mg/L Ciprofloxacin detectable before 
and after ozonation (Figure 45b). In addition a WWTP sample containing 1 mg/L 
Ciprofloxacin was also tested for cytotoxicity and genotoxicity (1 mg/L Ciprofloxacin) 
before and after UV/H2O2 oxidation but neither a decrease in cell viability (Figure 
46a) nor an increase in the OTM (Figure 46b) was detected, thus no toxic oxidation 
by-products have been formed.  
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Figure 46: a) No cytotoxic and b) genotoxic effects of untreated and UV/H2O2 (Hg-LP, 15 W; 
1 g/L H2O2) treated WWTP effluent with 0.1 mg/L Ciprofloxacin. 
 
 
Ciprofloxacin is also thought of as a mutagenic substance since a few studies have 
been published showing its mutagenic activity [165, 166]. However the results 
concerning the mutagenicity of Ciprofloxacin are differing since others showed no 
effects [167, 168]. Therefore the Ames test was also performed with the above 
presented samples. The results are displayed in Table 30. 1.4 mg/L Ciprofloxacin in 
HPLC-water did not result in a reversed mutation in the Ames test using the 
Salmonella typhimurium strains TA98 and TA100. No significant differences were 
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observed between the untreated (0 min) and the UV/H2O2 treated samples (10, 30 
and 120 min). There was also no difference in the number of positive wells 
detectable comparing the strains tested with and without the addition of the S9 liver 
homogenate. Thus the metabolism has no influence on the mutagenicity of 
Ciprofloxacin at the here tested concentrations. 
 
Table 30: Ames test results of 1.4 mg/L Ciprofloxacin in HPLC-water before and after UV/H2O2 
treatment showing the average number of positive wells. 
 TA98 –S9 TA98 +S9 TA100 –S9 TA100 +S9 
Negative control 1 1 2,33 1,83 
0 min 0 0 0 0 
10 min 0 0 0 0 
30 min 1,33 1 0 0,33 
120 min 0,67 0,67 2,67 0,67 
Positive control 29,33 48 29,67 18,67 
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5.5.3. Ofloxacin 
Like Ciprofloxacin, Ofloxacin belongs to the second generation of fluoroquinolone 
antibiotics and is used to treat infections of the pulmonary tract, the gastrointestinal 
tract, and the urinary tract system [169]. According to its safety data sheet only little 
information about toxic effects is available. A total amount of 2 Million DDD (defined 
daily doses) of Ofloxacin containing antibiotics were prescribed in 2010 [34]. 
 
 
Figure 47: Cytotoxicity (a) and genotoxicity (b) testing of HPLC-water containing 18 mg/L 
Ofloxacin before and after ozonation (10 mg/L O3). No cytotoxicity (c) or genotoxicity (d) of 
18 mg/L Ofloxacin in HPLC water before and after UV/H2O2 treatment. 
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In this study cytotoxicity and genotoxicity tests have been performed with Ofloxacin 
in WWTP effluent as well as in HPLC-water. The final Ofloxacin concentration during 
exposure was 18 mg/L. The exposure of CHO cells to HPLC-water with Ofloxacin 
before and after ozonation did not result in cytotoxic (Figure 47a) or genotoxic 
(Figure 47b) effects when treated for up to 60 min. There were also no cytotoxic 
(Figure 47c) or genotoxic (Figure 47d) effects detectable after UV/H2O2 treatment for 
up to 4 h.  
 
CHO cells were also exposed to WWTP effluent containing 18 mg/L Ofloxacin before 
and after ozonation and UV/H2O2 treatment (both for 60 min). The results displayed 
in Figure 48 show that there neither is a loss in viability (Figure 48a), nor is there a 
statistically significant increase in the amount of DNA damage (Figure 48b). Thus no 
toxic by-products have been formed. 
 
 
Figure 48: No cytotoxicity (a) or genotoxicity (b) of 18 mg/L Ofloxacin in WWTP effluent before 
(Matrix control) and after 60 min of ozonation (10 mg/L O3) or UV/H2O2 treatment. 
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5.5.4. Triclosan and 2,4-Dichlorophenol 
Triclosan (2,4,4’-trichloro-2’hydroxydiphenylether) is an antimicrobial agent used in a 
variety of everyday life products, e.g. toothpaste, kitchen supplies, sports clothing, 
cosmetics, childrens toys etc. [170, 171]. Although it is not used as a pharmaceutical 
agent, its ubiquitous use has led to detections in water systems, including WWTP 
effluents and surface waters, in concentrations up to several µg/L where it might 
pose a threat to the environment [171, 172].  
 
The ozonation of Triclosan using three different Triclosan:ozone ratios (1:1, 1:3 and 
1:5) resulted in the formation of a variety of oxidation by-products with 2,4-
Dichlorophenol being the most prevalent one as shown in Figure 49 [173].  
 
 
Figure 49: HPLC-MS/MS Q1-Scan chromatogram of a sample with different triclosan:ozone 
ratios of 1:1, 1:3 and 1:5 [173]. 
 
Therefore sterile concentration series of Triclosan and 2,4-Dichlorophenol (0 – 
100 µg/L) were prepared in Ampuwa and the cytotoxicity as well as the genotoxicity 
were determined. The MTT test showed that neither substance had cytotoxic effects 
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up to a concentration of 100 µg/L since the viability lies above 90 % for all tested 
concentrations (Figure 50a). In contrast the genotoxicity testing did reveal toxic 
effects. The higher concentrations of Triclosan result in a statistically significant 
increase in the Olive Tail Moment whereas the same concentrations of 2,4-
Dichlorophenol did not result in significant changes compared to the negative control 
(Figure 50b). These results clearly show that the ozonation is a useful method in the 
removal of the genotoxic Triclosan. 
 
Figure 50: a) No cytotoxicity of 0 – 100 µg/L Triclosan or 2,4-Dichlorophenol. b) Genotoxic 
effects of triclosan but not 2,4-Dichlorophenol at higher concentrations. 
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 Biocides 5.6.
According to the guideline 98/8/EG of the European parliament and the Council of 
the European Union, biocides are substances or compounds which are meant to 
destroy, render harmless or frighten off vermins as well as to prevent damages 
through them [174]. Since these substances are biological active they might pose a 
high environmental risk, including a risk to the human health. Due to their mode of 
action the use is widespread including agriculture, medicine and industry.  
 
5.6.1. Irgarol 1051 
Irgarol® 1051 also known as Cybutryn is used as an algicide e.g. on ship hulls or in 
antifouling paints e.g. on facades. According to its safety data sheet it is classified as 
being highly toxic to aquatic organisms [175].  
7.5 mg/L Irgarol® 1051 were dissolved in HPLC-water and subjected to 56 or 400 µg 
O3 for 60 minutes. The toxicity tests (MTT test and Alkaline Comet Assay) revealed 
no effects of 0.75 mg/L Irgarol® 1051. Neither cytotoxic (Figure 51a) nor genotoxic 
effects (Figure 51b) were detected since the viability as well as the Olive Tail 
Moment of the cells exposed to the samples are comparable to the values of the 
negative control. There is also no significant difference between the two tested O3 
concentrations in regard to the toxicity.  
 
Figure 51: No cytotoxicity (a) or genotoxicity (b) of 0.75 mg/L Irgarol 1051 after ozonation. 
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5.6.2. Terbutryn 
Terbutryn is an herbicide and a constituent of a variety of products [176]. As Irgarol® 
1051, Terbutryn works by inhibiting photosynthesis [177] and is thus used in 
agriculture as well as in the aquatic environment to prevent algal growth [176, 178]. 
 
The formation of possibly toxic oxidation by-products of Terbutryn has been studied 
using four different concentrations of ozone. Terbutryn was dissolved in HPLC-water 
and had a final concentration of 490 µg/L during the toxicity tests. The MTT test 
showed, that Terbutryn itself, as well as the samples after ozonation did not lead to 
effects on the mitochondria (Figure 52a), thus no cytotoxicity was detected. In 
contrast, the Alkaline Comet Assay revealed genotoxic effects. As can be seen in 
Figure 52b 490 µg/L Terbutryn already resulted in very significant (p = 0.001-0.01) 
DNA damages compared to the negative control. These effects were then increased 
after ozonation with 36, 100 and 195 µg ozone per liter resulting in highly significant 
(p < 0.001) DNA damages. In contrast, using an ozone concentration of 800 µg/L no 
genotoxic effects were observed.  
 
Figure 52: a) No cytotoxic effects of 490 µg/L Terbutryn in HPLC water before and after 
ozonation. b) Genotoxic effects of Terbutryn before and after ozonation (0 – 195 µg/L O3) but 
no genotoxicity using 800 µg/L O3. 
Results 
128 
 
 Musk fragrances 5.7.
Musk fragrances are aromatic substances used in personal care products (e.g. 
shampoo, perfume, soap, etc.) with AHTN and HHCB being two of the most used 
compounds [179]. Their ubiquitous use (both classified as high production volume 
chemicals) has led to their detection in surface waters [38] and WWTP effluents 
since they are not removed during conventional treatment processes. Their presence 
in the water system is of great concern since musk xylene has already been added 
to the candidate list of substances of very high concern for authorization by the 
European Chemicals Agency (ECHA) [180]. In addition polycyclic musks, like AHTN 
and HHCB have also been detected in water and fish samples as well as in human 
fat [181]. 
 
 
5.7.1. AHTN 
AHTN (8 1-(3,5,5,6,8,8-hexamethyl-6,7-dihydronaphthalen-2-yl)ethanone) also 
known as Tonalid is one of the most used polycyclic musks in cosmetics [179]. The 
exposure of AHTN on a daily basis was shown to be 409 µg/d after an application to 
the skin. Blood concentrations range up to a maximum of 0.29 µg/L [182] and 
environmental concentrations have been reported to be in the range of ng/L to µg/L 
concentrations [36, 37, 183, 184]. According to the SCHER risk assessment report, 
AHTN is not considered genotoxic or carcinogenic [185].  
Up to 5 min UV treatment (low pressure UV-Hg lamp; 254 nm) of 1 mg/L AHTN in 
HPLC-water had no influence on the cytotoxicity, whereas 20 min UV treatment 
resulted in cytotoxic effects (Figure 53a) after an exposure to 0.1 mg/L AHTN. The 
viability of the used CHO cells was decreased to 74.3 % (± 7.7 %) thus the sample 
was classified as weakly cytotoxic. In addition, the cytotoxic sample was tested for 
remaining peroxides but none were detected indicating the formation of cytotoxic 
oxidation by-products since there was also no initial cytotoxicity of AHTN before the 
application of UV treatment. The Alkaline Comet Assay in contrast did not show any 
effects for all three time points of UV treatment (Figure 53b). 
Results 
129 
 
 
Figure 53: UV/H2O2 oxidation of 0.1 mg/L AHTN in HPLC water. a) Weak cytotoxic effects after 
20 min UV treatment. B) No genotoxic effects before and after UV treatment.    cytotoxic effects 
 
The same concentration of AHTN (0.1 mg/L) was also tested for toxicity before and 
after ozonation (10 mg/L O3). Cytotoxic effects were neither detected before nor after 
10 min or 60 min of ozonation. Looking at the results of the genotoxicity testing it can 
be seen that the Olive Tail Moment of all samples was not significantly increased 
compared to the negative control. Thus no genotoxic effects were detected after 10 
and 60 minutes of ozonation.  
 
Figure 54: Ozonation (10 mg/L O3) of 0.1 mg/L AHTN in HPLC-water. No cytotoxic (a) and 
genotoxic effects (b). 
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5.7.2. HHCB 
HHCB (4,6,6,7,8,8-hexamethyl-1,3,4,7-tetrahydrocyclopenta[g]isochromene) also 
known as Galaxolid® is a musk fragrance used in personal care products, e.g. 
shampoo or soap on a daily basis, thus it is detected in water systems. The use of 
cosmetics containing HHCB might result in an exposure of 51.2 µg/d by an uptake 
through the skin. It has also been shown to be present in the blood with the highest 
concentration being 6.9 µg/L [182]. 
The ozonation of HHCB resulted in the formation of the oxidation by-product HHCB-
lactone [186]. Therefore concentration series (0.05 – 50 µg/L) of HHCB and HHCB-
lactone were tested for toxicity. The MTT test revealed no cytotoxic effects for both 
substances of the tested concentrations (Figure 55a). The viability of all 
concentrations was above 90 % thus HHCB and HHCB-lactone are both classified 
as not cytotoxic up to a concentration of 50 µg/L. In addition there was also no 
genotoxicity detected for the same concentrations (Figure 55b). 
 
Figure 55: No cytotoxicity (a) and genotoxicity (b) of HHCB and its oxidation by-products 
HHCB Lactone at concentrations between 0.05 and 50 µg/L. 
 
 
The UV/H2O2 oxidation of HHCB also resulted in the formation of oxidation by-
products, however the chromatogram showed the formation of more and different by-
products than the chromatogram of the ozone treated sample [186]. Toxicity tests of 
the untreated and the UV/H2O2 treated samples (15 W) of 0.1 mg/L HHCB in HPLC-
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water showed that only the sample after 60 min of UV treatment resulted in a 
decrease in viability to 54.2 % (± 0.7 %) viable CHO cells. In contrast, before 
treatment and after 30 min treatment no cytotoxic effects were detected (Figure 56a). 
The cytotoxic sample was also tested for remaining peroxides but none were 
detected, thus the effects can be related to formed oxidation by-products. Except the 
one cytotoxic sample (60 min), all others were tested for genotoxic effects using the 
Alkaline Comet Assay. Comparing the OTM of the untreated (0 min) and the treated 
sample (30 min) it can be seen, that the values were not significantly increased 
(Figure 56b), thus there was no genotoxic activity of 0.1 mg/L HHCB or the by-
products at this time points of treatment.  
 
Figure 56: Cytotoxicity (a) and genotoxicity (b) of 0.1 mg/L HHCB in HPLC-water before (0 min) 
and after 30 min or 60 min of UV/H2O2 treatment (15 W).     cytotoxic effects; n.t. = not tested 
 
Musk fragrances are also thought to exhibit estrogenic effects, however the ER 
Calux performed with the HHCB concentration series revealed no estrogenic activity 
(Figure 57). Comparing the RLU values of the HHCB samples and the 17ß-
Ethinylestradiol standard series it can be seen, that they are lower than the negative 
control, thus smaller than the LOD and therefore the tested concentrations were not 
estrogenic.  
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Figure 57: a) Relative light units (RLU) of the 17ß-Estradiol standard series. b) Relative light 
units of 0.5 – 50 µg/L HHCB. 
 
 
 
 Organophosphates 5.8.
Organophosphate is the general term for esters or amides of the phosphoric acid. 
They are used as pesticides or additives in hydraulic fluid, plastic materials or flame 
retardants [37, 155]. 
 
5.8.1. Tris(2-chloro-1-methylethyl) phosphate (TCPP) 
Like the other two organophosphates (TCEP and TPP) TCPP is used as a flame 
retardant in plastic materials.  
1 mg/L TCPP were dissolved in HPLC-water and treated with ozone or UV/H2O2 for 
up to 60 minutes. Displayed in Figure 58a are the results of the MTT test. It can be 
seen that the ozonation has no effects on the toxicity of 0.1 mg/L TCPP. The 
UV/H2O2 treatment however resulted in a decrease of the viability to 68 %. Since 
there was no cytotoxicity detectable before treatment and the test for peroxides was 
negative, the effects can be related to formed oxidation by-products. The results of 
the genotoxicity testing of the ozonated and the UV/H2O2 treated sample at 0 min 
show no statistically significant increase in the OTM compared to the negative 
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control (Figure 58b). The cytotoxic sample (60 min UV/H2O2) was then not tested for 
genotoxicity.  
 
Figure 58: a) Cytotoxicity and b) genotoxicity of 0.1 mg/L TCPP before (0 min) and after 
(60 min) ozonation or UV/H2O2 treatment.    cytotoxic effects; n.t. = not tested 
 
 
5.8.2. Tris(2-chloroethyl)phosphate (TCEP) 
TCEP is also used as a plasticizer, flame-retardant and viscosity regulator for 
materials used in airplanes, vehicles or toys. Since the 1990’s its use is declining 
due to the substitution with other substances e.g. TCPP [187].  
No cytotoxicity was detected for 0.1 mg/L TCEP before and after 60 min of 
ozonation. The UV/H2O2 treatment (60 min) in contrast resulted in a loss of viability 
which was not due to remaining peroxides (Figure 59a). Thus toxic oxidation by-
products have been formed. Except the one cytotoxic sample (UV/H2O2 60 min) the 
other samples were also tested for genotoxicity (Figure 59b). No increase in DNA 
damage was detected, thus the samples are not genotoxic. 
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Figure 59: a) No cytotoxicity of untreated and ozonated TCEP in HPLC-water (0.1 mg/L), but 
cytotoxic effects after 60 min UV/H2O2 treatment. b) No genotoxic effects of non cytotoxic 
TCEP samples.    cytotoxic effects; n.t.=not tested 
 
 
5.8.3. Triphenyl phosphate (TPP) 
TPP is used as a flame retardant as well as a plasticizer which is, according to its 
safety data sheet, highly toxic to aquatic organisms and can have effects on the 
human health upon exposure.  
TPP was dissolved in HPLC-water with a final concentration of 0.1 mg/L during 
exposure. Samples before and after ozonation (5 mg/L) or UV/H2O2 (Hg-LP 3 W; 
1 mg/L H2O2) treatment were analyzed for cytotoxicity and genotoxicity. The results 
of the cytotoxicity test revealed, that neither sample resulted in a loss in viability 
(Figure 60a). However, the results of the Alkaline Comet Assay showed an increase 
in the OTM for the untreated samples whereas both the ozone and UV/H2O2 treated 
samples after 60 min resulted in no significant changes of the OTM (Figure 60b). 
The UV/H2O2 treated sample was in addition tested for remaining peroxides but none 
were detected. Thus the natural genotoxicity of 0.1 mg/L TPP was removed through 
the application of both oxidation methods. 
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Figure 60: a) No cytotoxicity of 0.1 mg/L TPP in HPLC-water before and after ozonation or 
UV/H2O2 treatment. b) Genotoxicity only before oxidative treatment (0 min) 
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6. Discussion 
Substances of anthropogenic origin are introduced into the water system by a variety 
of pathways. One major source of their introduction into surface waters is the effluent 
of waste water treatment plants. For most of these substances only a small part is 
removed during the common waste water treatment process. Since a large amount 
of those substances is designed to be biologically active they might have an 
influence on the ecosystem and even on the human health. Therefore additional 
treatment steps are needed in order to remove remaining micropollutants and at the 
same time preventing their release into the environment where they might cause 
harm. Despite the variety of possible removal methods, advanced oxidation 
processes are the most promising techniques due to their low costs, ease of 
applicability and efficiency. However one drawback of these processes is the 
formation of oxidation by-products through an incomplete degradation. These by-
products might then differ in their toxicological properties. Due to a lack of 
information on the toxicity of many micropollutants and their by-products a general 
statement on the safe use of Advanced Oxidation Processes is difficult. 
The efficiency of the here used AOP methods (Ozonation and UV/H2O2 oxidation) 
was evaluated based on the formation of oxidation by-products and their toxicity. 
Therefore pure water as well as waste water treatment plant effluent samples were 
spiked with pharmaceuticals, musk fragrances, estrogenic substances, biocides or 
organophosphates and subjected to oxidation. Samples were taken time 
dependently starting before the oxidation. Afterwards their ability to induce cytotoxic 
and genotoxic as well as to some part estrogenic and mutagenic effects was 
examined. 
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 Endocrine disruption 6.1.
Although the focus of this work in regard to endocrine disruption was laid on 
estrogenicity, other effects like androgenicity, glucocorticoid activity or thyroid 
hormone like activity of water samples etc. can not be excluded. Different classes of 
chemicals (phthalates, polychlorinated biphenyls, pesticides etc.), either of natural or 
synthetic origin, detected in water systems have already been identified to be 
endocrine disrupting because of their structural similarity compared to hormones 
[188-192]. In 2000 the BKH Consulting Engineers published a list of priority 
substances based on existing lists resulting in 564 substances which are suspected 
to be endocrine disrupting. Out of this list 146 chemicals were evaluated and 66 
were classified as “Category 1” chemicals indicating that there is certain evidence for 
endocrine disrupting effects in living organisms. Most of these Category 1 chemicals 
were also considered having a high exposure concern [193]. Outcomes of an 
exposure to endocrine disruptors, e.g. the feminization of alligators, birds or fish 
have been linked to the presence of endocrine disruptors [194-198]. Most of the 
endocrine effects detected so far are affecting the estrogenic cycle. It has been 
shown that e.g. obesity or certain kinds of cancer besides other health effects are 
related to an exposure to estrogens [199-204]. This is supported by the US EPA 
stating that endocrine disruption is a mode of action which potentially might lead to 
adverse effects e.g. carcinogenic, developmental or reproductive effects. However 
they also state, that only a limited number of studies are available showing a direct 
correlation between estrogen exposure and adverse effects in humans especially in 
the development of cancer [191].  
It is now questionable whether humans who are exposed to endocrine disrupting 
chemicals in drinking water, food, etc. are susceptible to hormonal disturbances thus 
adverse health effects. Even though there is no direct linkage between endocrine 
disruptors in the environment and human health impacts it can not be neglected. 
Animal data clearly proves a correlation between biological active substances and 
endocrine disruption. Due to the high persistence of these substances long-term 
studies investigating single compounds as well as complex mixtures are needed for 
a risk assessment. Long-term studies covering chronic exposures are also important 
in regard to low-dose effects (concentrations below the physiological level) of single 
substances and complex substance mixtures because this is the most probable 
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scenario of exposure in the environment. The term low-dose effects has been 
defined as those biological effects which occur at the range of a typical human 
exposure or a dose lower than those which are typically used in the US EPA 
standard testing paradigm [205]. Although endocrine disrupting effects are usually 
detected at concentrations higher than those found in the environment, knowledge 
about a chronic exposure to low concentrations is scarce. In a review by Vandenberg 
et al. (2012) it is concluded that results from a high-dose exposure study can not be 
used to predict effects of a low-dose exposure [206]. In addition combination effects 
such as additive or synergistic effects occurring in complex water matrices through 
the presence of a variety of substances with the same mode of action need to be 
considered when discussing low-dose effects (see chapter 6.3 on mixture effects). 
Low-dose effects also might differ from effects detected at higher concentrations. 
Reasons for this might be cytotoxic effects as well as a down-regulation of the 
receptors of high concentrations whereas low-doses might result in an increased 
receptor acitivity thus an up-regulation of specific genes [206]. Therefore measures 
should be taken not only to detect and identify endocrine disrupting micropollutants 
in water samples but also to investigate their possible health effects at high and low 
doses and finally to develop methods to successfully remove them from the 
environment. 
Since the effects of hormones occur at very low concentrations it is necessary to use 
test systems which are able to detect endocrine disruptors at those low 
concentrations. Kase et al. (2009) therefore reviewed available test systems applied 
in the aquatic environment for the detection of endocrine disrupting substances. A 
huge variety of in vitro test systems is available and examples as well as their mode 
of action are displayed in Figure 61. This battery of tests then allows a mode of 
action based risk assessment which can also be modified according to certain 
needs. They conclude that a combination of in vivo and in vitro methods is needed to 
gather information on the different levels, namely the hormone activity and endocrine 
disruption as well as reproductive effects [71].  
Discussion 
139 
 
 
Figure 61: In vitro test methods for the determination of endocrine effects adapted from Kase 
et al. 2009 [71] 
 
Different other publications also show the applicability of in vitro test systems as 
sensitive methods for the determination of endocrine effects. However they also 
conclude that a risk assessment should not only be based on in vitro methods, thus 
a combination of in vitro and in vivo methods is favorable [207-210].  
 
 
 Antibacterial activity during advanced oxidation processes 6.2.
Another concern of antibiotics and their transformation products present in water 
systems is their potential to support the establishment of resistances [3]. The 
isolation and identification of bacterial strains exhibiting certain resistances is 
steadily increasing. Due to the widespread use (human and veterinary) and the high 
amount of antibiotic prescriptions annually they are ubiquitously found in the 
environment, including groundwater, at concentrations up to several µg/L [3, 211]. 
Resistances are distinguished by either being primary (naturally occurring, without 
gene mutation) or secondary (acquired during exposure through e.g. mutations or 
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gene transfer) [212] with the latter one being the interesting one in regard to water 
systems. The importance of this problem, e.g. the ineffectiveness of antibiotic 
therapy especially for the treatment of nosocomial infections, is well understood and 
in 2001 the WHO released a Global Strategy for Containment of Antimicrobial 
Resistance [213]. In addition the German Ministry of Health also published a strategy 
for further actions regarding antimicrobial resistances [212]. One of the most 
prominent cases of antibiotic resistance is the Methicillin-resistent Staphylococcus 
aureus (MRSA) strain, first detected in the early 1960’s against which most of the 
antibiotics are not effective [214, 215]. While Staphylococcus epidermidis is the 
nonpathogenic form found on human skin and mucuous membranes, 
Staphylococcus aureus is the pathogenic form associated with e.g. pneumonia or 
meningitis [216].  
Because of these resistances advanced oxidation processes should also take into 
account the complete removal of antibacterial activity resulting from antibiotics 
present in waste waters. Therefore it is also important that formed oxidation by-
products also do not exhibit antibacterial acitivty. A variety of studies investigating 
the antibacterial activity during oxidation processes were already published. Dodd et 
al. (2009) were able to prove the loss of antibacterial activity due to oxidation for e.g. 
Sulfamethoxazole, Ciprofloxacin and Triclosan whereas the oxidation of Penecillin G 
and Cephalexin led to the formation of by-products with antibacterial activity [217]. 
As a part of the here presented project Claudia vom Eyser (IUTA, Duisburg) 
therefore also looked at the bacterial growth inhibition by water samples (pure water 
and WWTP effluent) spiked with Ciprofloxacin or Ofloxacin in her Master Thesis 
(2011). She found that the antibacterial effect decreased over time of oxidative 
treatment thus the formed oxidation by-products have no antibacterial effects [218]. 
Similar results have been shown by Wammer et al. (2006). They tested three sulfa 
drugs (Sulfathiazole, Sulfamethoxazole, Sulfachloropyridazine) and Triclosan as well 
as their transformation products after photochemical treatment for their potential to 
inhibit bacterial growth. Although a growth inhibition was detected for the parent 
compound none of these tested antibiotics revealed antibacterial acitivities after 
photolysis [17]. 
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 Mixture effects 6.3.
Although the here presented results as well as published data demonstrate that 
adverse toxicological effects of single substances mostly occur at much higher 
concentrations than those usually detected in waste water treatment plant effluents 
and surface waters, mixture effects need to be considered. This becomes even more 
apparent since not each single micropollutant as well as their metabolites and 
transformation products can be determined or investigated regarding its toxicity. 
Organisms are usually not solely exposed to single substances but rather to complex 
mixtures containing a variety of substances with different toxic effetcs. In addition the 
amount of TOC (total organic carbon) does not give any information on the biological 
activity especially the toxicity and therefore whole effluent samples should be 
analyzed. A variety of studies have been performed proving a good accuracy of 
concentration addition models for substances with a similar mode of action [219-
221]. In this context e.g. Chèvre et al. (2006) propose the use of a risk quotient for 
the assessment of herbicides with a similar mode of action based on a concentration 
addition model rather than using a limit value of 0.1 µg/L for each individual pesticide 
as a water qualitiy criteria in Switzerland [222]. In Germany the drinking water 
guideline also sets a limit value of 0.1 µg/L for individual biocides and their 
metabolites as well as a limit value of 0.5 µg/L for the sum of pesticides [85]. Brian et 
al. (2005) investigated the estrogenic effects of Estradiol, Ethinyestradiol, 
Nonylphenol, Octylphenol, and Bisphenol A individually for each substance as well 
as for mixtures. They found that even a concentration below the effect level of each 
single substance will result in effects after mixing with a good correlation to a 
concentration addition model [223]. But it has also to be noted that a concentration 
addition model can only be applied when the constituents of a mixture as well as 
their concentrations are known. In contrast, the effect prediction of mixtures 
containing substances from different classes and different modes of action are not 
that easily estimated by concentration addition or response addition since 
synergistic, antagonistic or additive effects might occur (Table 31) [224-226]. 
Hernando et al. (2003) were able to show that the toxicity of pesticides increased in 
the presence of Methyl-tert-butyl-ether, a fuel oxygenate also commonly found in 
water systems [227]. In another study with different pesticides synergistic, 
antagonistic as well as additive effects of substance mixtures on different organisms 
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were seen. The results also indicated that the mixture effects were not always the 
same in different aquatic organisms [228].  
However, despite these studies, knowledge about mixture effects is still scarce 
especially for water environments and needs to be further investigated for a secure 
risk assessment. 
 
Table 31: Possible mixture effects in regard to biological effects 
Effect Description 
Synergistic Substances acting together resulting in an increased effect, thus 
an effect higher than would have been predicted by the addition 
of the potency of the single compounds 
Antagonistic Inhibition of a substance by another substance resulting in a 
decreased effect 
Additive All substances of a mixture with a common mode of action 
resulting in a jointly action of effect addition, by proportionally 
contributing to the overall effect even at a concentration lower 
than their observed effect level  
 
 
To overcome this gap of knowledge on mixture effects, methods like the QSAR 
approach (Quantitative Structure-Activity Relationship) or the use of –omics 
techniques might be a solution. Modelling the effects of single substances using 
QSAR approaches can then be used for an assessment of mixture toxicity.  
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 Use of toxicological in vitro methods for water quality control 6.4.
Most regulations nowadays still require the use of animals for risk assessments. 
However, the vast amount of compounds (existing and new ones) which need to be 
analyzed by means of toxicity is far too huge to be tested in vivo. Animal testing 
requires a large amount of test animals and in addition it is cost and time consuming. 
Another fact to consider is the extrapolation of results gained from in vivo studies 
e.g. aquatic or rodent studies to a human health risk assessment. Due to inter- or 
intraspecies effects this extrapolation is not always possible and a certain risk 
remains. To overcome this gap uncertainty factors also called safety factors have 
been used to set values for an acceptable daily intake. These take into account the 
intra- as well as the interspecies variation and the quality of the data (e.g. short-term, 
long-term, study size) [229, 230]. Although uncertainty factors can be applied, there 
still might remain a possible risk for humans.  
To fully understand the whole range of possible health effects through emerging 
contaminants, an approach at the cellular level for a screening purpose is promising. 
Cellular test methods can be applied as high-throughput systems with low costs. An 
improvement in this matter are reporter gene assays, e.g. Calux test systems, which 
are more sensitive than e.g. yeast cell based assays [71]. The use of the so called  
“–omics” techniques might be another step towards the application of cellular based 
test systems. These techniques allow an analysis on the whole organism situation 
e.g. changes in DNA expression (genomics) or protein profiles (proteomics) [231]. 
For further or more detailed analyses in vivo methods might then be applied after 
limiting the vast amount of adverse effects through in vitro testing. 
Although the use of toxicological in vitro methods is not a general parameter in most 
guidelines for water quality testing, they have been proven as a relevant 
enhancement in this matter [22, 26, 232, 233]. Chemical methods are limited to a 
qualitative and quantitative detection of micropollutants, but a statement about their 
biological effects (e.g. toxic, bactericidal) is not possible. In this context a combined 
approach of chemical and biological analyses, called effect-directed analysis (EDA) 
combining chemical analyses, biological test systems and fractionation processes for 
a cause-effect relationship is most promising [234, 235] (Figure 62). 
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Figure 62: Schematic overview of the EDA (effect directed analysis) of mixtures published by 
Werner Brack [234]. 
 
An approach called “Adverse Outcome Pathway” published by the US EPA (2010) 
(Figure 63) also suggests the use of cellular and molecular techniques as a basis 
(Anchor 1) followed by tests at the organism- and population-level (Anchor 2) 
combining both test principles to link an effect at the molecular level to an adverse 
outcome at the organism/population level, spanning different biological levels [236].  
 
 
Figure 63: Adverse Outcome Pathway proposed by the US EPA for risk assessment based on 
in vitro and in vivo methods [236]. 
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According to a variety of studies bioassays in general but especially cell culture 
based systems have been established world wide for an assessment of the risk 
resulting from organic micropollutants as well as their by-products (oxidation and 
disinfection) [22, 26, 158, 237]. The variety of in vitro methods covering different 
toxicological endpoints is large and steadily growing and improving. With the use of 
non specific toxicity tests e.g. cell proliferation assays a general statement about the 
overall toxicity of a sample is possible including mixture effects. The additional use of 
more specific in vitro tests investigating reporter gene activities, DNA damaging 
potentials etc. will then help to establish a human health risk assessment. 
A combination of in vitro and in vivo methods allows a screening at the molecular 
level through cell based systems as well as a more targeted analysis using in vivo 
methods. The addition of chemical analyses and aquatic studies will then give a 
complete overview starting with the detection of a substance, the determination of 
the concentration, the detection of molecular and systemic effects of a certain 
substance or mixture effects, e.g. dose-response curves, or effects on whole 
populations. 
 
 
 Applicability of ozonation and UV/H2O2 oxidation during 6.5.
waste water treatment 
Advanced oxidation processes function through the formation of highly reactive 
hydroxyl radicals which then attack the substituents of the organic matrix (e.g. 
through electron transfer, hydrogen abstraction, etc.) and initiate the mineralization 
of these compounds [238]. Despite the advantages of those methods the formation 
of oxidation by-products needs to be considered since a complete degradation might 
not be economical. Therefore the efficiency of the applied methods is dependent on 
the ease of applicability, the cost effectiveness and the potential to remove as much 
DOC (dissolved organic carbon) as possible without generating bioactive, e.g. 
endocrine disrupting, genotoxic or mutagenic by-products [53, 239]. In addition to 
oxidative techniques, sand filtration or activated carbon addition might be applied as 
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the last treatment step to yield a higher degree of micropollutant and especially 
metabolite and oxidation by-product removal [14, 24, 240, 241].  
In regard to the efficiency of the two in this study investigated advanced oxidation 
processes (UV/H2O2 and Ozonation), the results of the toxicological testing 
presented here demonstrate that these methods are applicable for waste water 
treatment plant effluent matrices. Neither cytotoxic nor genotoxic effects were 
detected before and after the oxidative treatment of the two ß-blocker Atenolol and 
Metoprolol, the antibiotics Ciprofloxacin, Ofloxacin and Sulfamethoxazole as well as 
the musk fragrance AHTN and the biocide Irgarol 1051 at the tested concentrations. 
In addition Ciprofloxacin was also found not to be mutagenic in the Ames test using 
the Salmonella typhimurium strains TA98 and TA100.  
The results also indicate that their oxidation by-products, formed as a result of an 
incomplete degradation, are also not toxic and the UV/H2O2 treatment as well as the 
ozonation are sufficient methods for the successful removal of these micropollutants 
from the effluents of waste water treatment plants using the above mentioned 
settings. Although other studies showed toxic effects of these substances the 
concentrations used were to some extent much higher than the concentrations used 
in this study and the concentrations detected in water bodies.  
The oxidation of HHCB, Ciprofloxacin, and Bisphenol A clearly showed that the 
structure of the formed oxidation by-products as well as their toxicity might be 
dependent on the used method as well as the water matrix which is supported by 
other published studies [16, 20, 66, 242]. 
Overall these results clearly demonstrate that the treatment duration, the used 
amount of oxidant as well as the oxidation method are of great importance in regard 
to a complete removal of the substances and the loss of biological (antibacterial, 
toxic, endocrine etc.) activity. It has also been shown, that the here used in vitro 
methods are applicable for the testing of water samples which is supported by other 
previously published studies, proving the usefulness and applicability of a variety of 
in vitro test systems [14, 22, 26, 232, 243]. 
These results are in accordance with other published studies, proving the 
applicability of oxidative methods for water purification. It has been long known that 
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oxidative methods are useful in the removal of organic micropollutants. However, it is 
also known that an incomplete oxidation might result in the formation of oxidation by-
products with different toxicological profiles and therefore should be prevented and 
measures be taken [241, 244-246].  
 
 
 Concentration of water samples 6.6.
The steady improvement of chemical analytical methods is one reason for the 
increase in the amount of detected organic micropollutants over the last years. The 
concentration of water samples and high resolution analytical tools allow the 
detection of substances as low as ng/L concentrations. In addition to the benefit of a 
lower detection limit disturbing substances e.g. phosphate, nitrate or ammonia are 
also removed during concentration. A disadvantage of the concentration step before 
a biological test might be the loss of substances. Therefore the extraction method 
should take into account a yield of as much substance as possible and at the same 
time an exclusion of as many interfering substances as possible. Desbrow et al. 
(1998) were able to show that the concentration of an effluent sample using a C18 
column resulted in a loss of estrogenic activity of 80 % depending on the elution 
method [247]. Erger et al. (2012) investigated the influence of water residuals on the 
SPE performance and subsequent chemical analysis and found far-reaching 
influences on the performance of the GC-MS analysis [248]. Thus extraction 
methods should be thoroughly evaluated (e.g. using an internal control) to e.g. 
prevent the loss of substances.  
Another advantage of extraction methods is that they can also be used to improve 
the sensitivity of biological test systems as well as analytical tools and to identify 
substances with a low concentration in water samples. This is especially important in 
the case of bioactive substances, e.g. those mimicking the hormonal activity, 
because they are usually active at very low concentrations. Since environmental 
samples contain a complex matrix extraction methods should also be capable of 
extracting several pollutants at the same time. 
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A further approach in regard to the monitoring and detection efficiencies is the 
method of passive sampling. The principle behind this method, independent of the 
used system, is the free analyte flow from the tested medium (e.g. waste water 
treatment plant effluent) to the sampler material which due to different chemical 
gradients is a result of varying e.g. concentrations or pressures [249, 250]. An 
advantage of passive sampling is the identification of the average concentration of 
the analytes over a certain period of time, called time-weighted analysis [250]. A few 
studies as well as reviews already showed the use of passive samplers in 
environmental analyses, especially with water systems. They are for example used 
during monitoring processes of micropollutants as a screening tool [249, 251]. Their 
use in research over the past years is increasing and has been shown as a good 
alternative to active sampling [252-255]. Since each method has its advantages and 
its disadvantages there is no single method for all applications. Filtration steps 
before an SPE might result in the loss of substance whereas liquid-liquid extractions 
require organic solvents which are toxic and the whole procedure is time consuming. 
Thus depending on the purpose of the study each method should be evaluated and 
optimised before analyses. 
 
 
 ß-blocker 6.7.
Due to their longterm use and high amount of ß-blocker intake they are commonly 
detected in water systems and might pose a threat to the environment. 
Concentrations of Metoprolol in waste water treatment plant effluents range up to 
almost 4 µg/L [256]. Therefore two of the most prescribed ß-blocker, namely 
Metoprolol and Atenolol, were investigated.  
In the here presented study no cyto- or genotoxicity was detected for Atenolol and 
Metoprolol (chapter 5.3) before and after ozonation or UV/H2O2 oxidation. There 
were also no differences observed between pure water and waste water treatment 
plant effluent spiked with either of the ß-blocker. These results reflect what has 
already been published by others. Using Ceriodaphnia dubia (C. dubia) an EC50 of 
33.4 mg/L for Atenolol and 45.3 mg/L for Metoprolol was determined by Fraysse et 
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al. (2005) [257]. An acute toxicity study using the same organism also revealed that 
the EC50 values range from 1.4 to 163.4 mg/L after two days of exposure depending 
on the tested ß-blocker (Acebutolol, Atenolol, Metoprolol, Nadolol, Oxprenolol, 
Propranolol) [257]. Cheong et al. (2008) used the MTT test to detect cytotoxic effects 
of ß-blockers, including Atenolol and Metoprolol, on human corneal epithelial and 
retinal cells. They also found great differences in IC50 values when comparing eight 
ß-blockers. Atenolol resulted in an IC50 of 6.13 g/L and the IC50 for Metoprolol was 
2.74 g/L [258]. 
Another study showed that no genotoxic effects occurred after a chronic exposure to 
50 mg Atenolol per day [259]. In addition, tests with different cell types 
(haematocytes, gill and digestive gland primary cells) of the zebra mussel did not 
reveal notable toxic effects [260]. Ioannou et al. (2011) were able to show that the 
solar/TiO2 degradation of 10 mg/L Atenolol first resulted in an increased mortality of 
D. magna which then decreased over time thus they concluded that the formation of 
toxic oxidation by-products led to these effects [261].  
Huggett et al. (2002) also tested the toxicity of Metoprolol and found 48 h LC50 
values of 63.9 mg/L in D. magna and 8.8 mg/L in C. dubia whereas the LC50 values 
were above 100 mg/L when using H. azteca and Medaka as test organisms [262] 
and the EC50 in Danio rerio was determined as 31 mg/L [263]. Tests with Daphnia 
magna resulted in an EC50 value of 200 mg/L [264] or an LOEC of 12 mg/L after a 9-
day exposure [265]. Thus great species differences can be seen 
Compared to the concentrations used in this study (Atenolol = 0.2 mg/L; 
Metoprolol = 0.1 and 1.4 mg/L) toxic effects are detected at much higher 
concentrations. The amounts of ß-blockers commonly found in waste water 
treatment plant effluents and surface waters are usually in the µg/L range or even 
lower [2, 8, 266]. Benner et al. (2009) were able to demonstrate the formation of 
oxidation by-products as well as reaction pathways of Metoprolol after ozonation 
[267]. A few of these ONP have been confirmed by our own studies but new ones 
were also found [151]. However, although by-products were found after oxidative 
treatment they did not have an effect on CHO cells in the here used test systems. As 
has been shown by own studies as well as published data by other groups toxic 
effects occur at concentrations much higher than commonly found in water bodies. 
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 Estrogenic substances 6.8.
6.8.1. Ethinylestradiol 
As a main constituent of contraceptive pills Ethinylestradiol is excreted and found in 
waste water treatment plant effluents as well as other water systems at ng/L 
concentrations [4, 268-270] and might therefore have an influence on e.g. the 
reproduction of aquatic organisms. Therefore these substances should be 
completely eliminated during waste water treatment before the effluent reaches 
surface waters. 
Own results show that there was no cytotoxicity detected for Ethinylestradiol but 
estrogenic effects have been detected before and throughout the entire duration of 
oxidative treatment, however slightly diminished because only a minor decrease was 
seen over time. A variety of studies have been published concerning the toxicity, 
including the estrogenicity of Ethinylestradiol. No mutagenic effects were detected 
using the chromosomal aberration test in human lymphocytes and mouse bone 
marrow cells [271] and the Ames test [272]. However, Siddique et al. (2005) were 
able to show genotoxic effects of 5 µM (~ 1.5 mg) Ethinylestradiol. These effects, in 
fact, were only detected after metabolic activation and the addition of NADP [273]. 
Estrogenic effects were, amongst others, detected by Dussault et al. (2008) showing 
an influence on the reproduction starting at 0.36 mg/L Ethinylestradiol [269]. Medaka 
exposed to 0.06 mg/L Ethinylestradiol revealed effects on their fertility [274] and 
Salierno et al. (2009) detected behavioral changes as well as changes of the 
hormonal system and the sex characteristics in fish exposed to 0.04 mg/L 
Ethinylestradiol [275]. Thus comparing the above results to the concentration used in 
this study, a possible impact on the environment might occur after the release of 
Ethinylestradiol into surface waters. This is also supported by a study published by 
Caldwell at al. (2008). They reviewed the available literature on the aquatic toxicity of 
17α-Ethinylestradiol to derive a PNEC (predicted no effect concentration) value and 
concluded that a PNEC of 0.35 ng/L could be recommended as a safe measure for 
water systems, even for chronic exposures. They also concluded, that even a 
concentration of 0.5 ng/L might have no effects on the ecosystem [276]. However 
this value does not take into account e.g. additive effects resulting from the complex 
matrix of a water sample as well as low dose and long term effects (see chapter 6.1). 
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Comparing this PNEC value to the results from this study it can be seen, that the 
here used ozonation and UV oxidation did not lead to a decrease of Ethinyestradiol 
below 0.35 ng/L thus in this case both treatment methods were not sufficient in 
removing the biological activity. 
 
6.8.2. Bisphenol A 
As a basic material during polycarbonate synthesis, Bisphenol A is found in many 
products of the everyday life e.g. reusable water bottles and other food containers. 
Trace amounts of it might then leach into foods and drinks. Because of its health 
impacts the EU enacted a directive (2011/8/EU) which banned Bisphenol A from the 
production of infant feeding bottles made of plastics starting in March 2011 [277].  
Own toxicity tests with Bisphenol A performed in the here presented study indicated 
that toxic effects are linked to the used water matrix (chapter 5.4.2). The oxidation of 
waste water treatment plant effluent containing Bisphenol A did not result in the 
formation of toxic oxidation by-products. In addition, no effects were detected before 
and after ozonation of pure water containing 1.4 mg/L Bisphenol A whereas cytotoxic 
effects were seen after the UV oxidation of 0.1 mg/L Bisphenol A in pure water. 
These effects can be related to formed oxidation by-products since no remaining 
peroxides were detected in the sample. Comparing these results to published data it 
can be seen that differences in toxic effects between pure water and waste water 
treatment plant effluent due to different reaction pathways and competing reactions 
have already been described before [16]. When comparing distilled and surface 
water a better degradation of Clofibric acid and Ibuprofen was observed in distilled 
water [20]. Trovo et al. (2009) were able to demonstrate that the Photo-Fenton 
treatment of distilled water and seawater containing Sulfamethoxazole only resulted 
in an increase in toxicity when oxidatively treating seawater [66]. Differences in 
regard to toxic effects of substances were also seen when dissolved in seawater or 
distilled water, thus again the water matrix (salinity, amount of other sustances) had 
an effect on the structure of the formed by-products and thus the toxicity [242]. 
Apart from the cytotoxicity and genotoxicity testing the estrogenic activity of 
Bisphenol A before and after UV/H2O2 oxidation was also examined as a part of the 
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here presented study. The results displayed in chapter 5.4.2 show that the oxidation 
was sufficient in removing the estrogenic activity of 0.1 mg/L Bisphenol A from 
HPLC-water. While there were estrogenic effects observable before UV/H2O2 
treatment, there were no more estrogenic effects detected after 10 and 60 min of 
treatment.  
Toxic or in general biological effects of Bisphenol A described in the literature are 
mainly based on its estrogenic effects [278]. As already shown for other substances, 
EC50 values vary (10 – 253 µg/L) between organisms, test methods and the duration 
of exposure used [279, 280]. Golub et al. (2010) reviewed the available literature in 
regard to toxic effects of Bisphenol A and found that it mainly affects the offspring 
viability, the sex-differentiation, the immune hyperresponsiveness and the gender-
differentiated morphology, with the specific endpoint being dose related [281]. In 
addition to the already published data, Bisphenol A is one of 90 substances listed in 
the Community Rolling Action Plan (CoRAP) released by the ECHA in February 
2012. The CoRAP includes substances which are suspected to have a risk on 
human health and therefore need to be further evaluated within the next three years. 
Bisphenol A was added to this list because of its potential endocrine disruptive 
activity as well as its widespread use [282, 283]. 
The results for Ethinylestradiol and Bisphenol A from our study demonstrate that 
there are differences in their degradation according to the detection of estrogenic 
effects. UV/H2O2 treatment of Bisphenol A resulted in a complete removal of 
estrogenic effects. In contrast, neither the UV/H2O2 treatment for up to 60 min, nor 
the use of up to 10 mg/L ozone resulted in a complete removal of the estrogenic 
activity of Ethinylestradiol after 60 min of treatment. Schrank et al. (2009) proved that 
the removal efficiency of estrogenic effects is strongly related to treatment 
parameters, especially the pH. Low pH values resulted in an increase in 
estrogenicity while a high pH during treatment resulted in a complete removal of 
estrogenic effects. This might be due to the fact that a decomposition of ozone takes 
place at higher pH values leading to the formation of radicals [284]. Schrank et al. 
(2009) also showed that despite a decrease in acute toxicity towards V. fisheri and 
D. magna, estrogenic effects occur after ozonation even though the untreated 
sample did not exhibit estrogenic effects [244]. A reason for this might be the 
Discussion 
153 
 
elimination of substances which are structurally similar to estrogens and have a 
higher binding affinity thus blocking the estrogen receptor and preventing estrogenic 
substances from binding to it. Once these antagonistic substances are removed from 
the sample through ozonation estrogenic substances are then able to bind to the 
receptor and initiate DNA transcription. Another fact to consider in regard to 
estrogenicity and endocrine disruption in general is the exposure to low doses over 
long periods of time (see chapter 6.1 on low-dose effects). 
 
 
 Antibiotics 6.9.
Antibiotics are pharmaceuticals ubiquitously used for the treatment of a great variety 
of infections. Depending on their mode of action and point of attack they are 
classified into different groups. Antibiotics are biologically active and might therefore 
pose a threat to the environment. Concentrations commonly detected in waste water 
treatment plant effluents are in the µg/L range. In this study one antibiotic from the 
group of sulfonamides (Sulfamethoxazole) and two fluoroquinolones (Ciprofloxacin 
and Ofloxacin) as well as the bactericide Triclosan have been investigated. 
 
6.9.1. Sulfamethoxazole 
Sulfamethoxazole belongs to the group of sulfonamide antibiotics which were 
originally used as bactericides. Nowadays some diuretics are also based on the 
sulfonamide group. The widespread use of sulfonamides has led to their detection in 
water bodies with concentrations up to 2 µg/L [285]. Therefore techniques for a 
complete removal of these substances are needed. Sulfamethoxazole was chosen 
as a representative of this group of antibiotics to investigate the effects of oxidative 
treatment on its toxic properties. 
The above presented results for Sulfamethoxazole (5.5.1) indicate that neither the 
ozonation nor the UV/H2O2 oxidation resulted in toxic effects. Although the formation 
of oxidation by-products has been described [151, 286-288] none of the treated 
samples had an effect. This is in agreement with the results published by Yargeau et 
al. (2008) who tested a mixture of Sulfamethoxazole degradation products on human 
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hepatocellular carcinoma cells (HepG2) and found no toxic effects on cell 
morphology or metabolism [288]. Another study showed that using TiO2, the 
photocatalysis of Sulfamtheoxazole also leads to the formation of by-products which 
show a lesser toxicity on the green alga Chlorella vulgaris than the parent compound 
[289]. In contrast Dirany et al. (2011) detected toxic effects of intermediates formed 
during the electro-Fenton treatment of Sulfamtheoxazol in the V. fischeri 
luminescence test and thus an increase in toxicity compared to the untreated 
solution [245]. Toxic effects were also reported by del Mar Gomez-Ramos et al. 
(2011) after the ozonation of Sulfamethoxazole using Daphnia magna and 
Pseudokirchneriella subcapitata as test organisms proving the formation of toxic 
oxidation by-products [290]. Dantas et al. (2008) used the V. fischeri luminescence 
test and also showed an increase in toxicity within the first 30 minutes of ozonation 
followed by an increase over the next 30 minutes of treatment, thus a degradation 
dependent toxicity was observed [291]. Reported EC50 values range from 1.57 mg/L 
to 210 mg/L depending on the organism used for testing [17, 232, 289, 292]. 
Differences in toxicity can be due to the use of much higher initial conentrations of 
Sulfamethoxazole before treatment than used in this study. All these results indicate 
that different oxidation by-products might be formed depending on the oxidation 
method used. Additionally a great variance in organism susceptibility might be the 
reason for these differing effects.  
 
 
6.9.2. Fluoroquinolone antibiotics 
Fluoroquinolone antibiotics are commonly used as broad spectrum-antibiotcs in 
human as well as veterinary medicine. In human medicine they are an important part 
during the treatment of nosocomial infections. In addition to their widespread use a 
general misuse of antibiotics has led not only to the development of multi-resistant 
bacterial strains but also to their detection in waters of up to 124 µg/L [293]. 
Fluoroquinolones are of great concern due to their widespread and common use. 
Two antibiotics of this group (Ciprofloxacin and Ofloxacin) were therefore chosen for 
comparative analyses regarding their toxicity before and after oxidative treatment. 
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The results of Ciprofloxacin gained in this study (chapter 5.5.2) demonstrate that 
again the toxicity after oxidation is dependent on the water matrix (e.g. pure water, 
waste water). While there were no cytotoxic or genotoxic effects after the treatment 
of WWTP effluent containing Ciprofloxacin, weak cytotoxic effects have been 
detected after the treatment of HPLC water. Cytotoxic effects of Ciprofloxacin were 
shown by Gürbay et al. (2005) with Ciprofloxacin concentrations > 50 mg/L in HeLa 
cells [294]. The V. fischeri test performed by Hernando et al. (2007) revealed no 
toxic effects and the EC50 value (> 5.9 mg/L) was above the water solubility [242]. A 
study with Giardia lambia however showed toxic effects of Ciprofloxacin looking at a 
variety of endpoints [295].  
Another endpoint often investigated is the mutagenic activity of Ciprofloxacin. The 
results presented above (chapter 5.5.2), show that Ciprofloxacin itself as well as the 
samples after UV/H2O2 treatment are not mutagenic in the Ames test using the S. 
typhimurium strains TA98 and TA100. This is in contrast to published data. Clerch et 
al. (1996) tested the effects of Ciprofloxacin on a variety of S. typhimurium strains 
and found it to be mutagenic [296]. Hartmann et al. (1998) tested hospital waste 
waters using the umuC test and identified Ciprofloxacin as a main source for toxic 
effects in this test [293]. 
Like Ciprofloxacin, Ofloxacin is a fluoroquinolone antibiotic. The results of the tests 
with Ofloxacin (chapter 5.5.3) are similar to those with Ciprofloxacin. No initial toxicity 
was detected and the tests after ozonation or UV/H2O2 treatment did also show no 
toxic effects in the here used test systems. A literature research by Ferrari et al. 
(2004) revealed EC50 values of acute toxicity tests between 0.01 mg/L and even 
more than 90 mg/L of Ofloxacin depending on the organism and exposure time used 
(bacterium, protozoan, algae, crustacean, fish) [297]. Since fluoroquinolones are 
also commonly used in medical treatment by eye care professionals e.g. for the 
treatment of bacterial keratitis Bezwada et al. (2008) tested their cytotoxic effects on 
human corneal keratocytes and endothelial cells. While Ciprofloxacin was cytotoxic 
at all tested concentrations (10 µg/L – 1 g/L), Ofloxacin only showed statistically 
significant effects at the highest tested concentration after 15 min of exposure, 
however an exposure time dependent toxicity (decrease in concentration resulting in 
effects) was detected [298]. A similar study was performed by Tsai et al. (2010). 
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They also tested the cytotoxic effects of fluoroquinolone antibiotics on human 
corneal epithelial cells. Toxic effects were also shown to be exposure time 
dependent, however Ciprofloxacin had stronger cytotoxic effects in all three tests 
(MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) assay, TEER (Trans Epithelial Electric Resistance) test, cell 
morphology) than Ofloxacin [299]. In addition the cytotoxicity of Ofloxacin against 
rabbit corneal epithelial cells was tested by Scuderi et al. (2003). Both test systems, 
the MTT and the Neutral Red assay, resulted in a dose (1.5 – 6 g/L) and time 
dependent (8 – 72 h) decrease in cell viability. However the lowest dose (1.5 g/L) 
already resulted in a statistically significant loss of viability after the shortest 
exposure time (8 h) [300]. The phototoxic effects of Oflocaxin on HL60 and K 562 
cells have been studied by Trisciuoglio et al. (2002) since photosensitizing effects on 
the skin are a well known side effect during drug therapy. They report 
photosensitizing effects only in Ofloxacin treated cells (0.05 mM) irradiated with a 
wavelength of 330 nm [301]. Genotoxic effects of fluoroquinolones were investigated 
by Itoh et al. (2006) using human lymphoma cells (WTK-1) in the Alkaline Comet 
Assay. A maximum of 1 g/L of Ofloxacin did not induce DNA damage after up to 20 h 
of exposure. In contrast the same test with Ciprofloxacin resulted in significant 
effects which are again exposure time and concentration dependent. The lowest 
concentration resulting in genotoxic effects was 250 mg/L after 20 hours of 
exposure. Besides these two, they also tested six other quinolone antibiotics 
(Naladixic acid, Pipemidic acid, Oxolinic acid, Piromidic acid, Enoxacin and 
Norfloxacin), however only Norfloxacin also showed an increase in DNA damage 
after exposure [302]. This study indicated that substances from the same class of 
antibiotics do not necessarily result in the same cell damaging effects. Since these 
effects were observed in vitro, McQueen et al. (1991) performed a comparative study 
looking at in vitro and in vivo genotoxic effects of quinolone antibiotics in rat 
hepatocytes. Genotoxic effects (unscheduled DNA synthesis (UDS)) were only 
detected in vitro possibly due to a missing metabolism in isolated hepatocytes. 
However except Naladixic acid, all tested quninolone antibiotics induced UDS, 
including Ciprofloxacin and Ofloxacin with an effective concentration of 400 µg/mL 
[303]. 
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6.9.3. Triclosan and 2.4-Dichlorophenol 
Triclosan is a bactericide and a constituent of disinfection products, preservatives, 
and everyday products e.g. toothpaste or sports clothing. Although it is found in 
many different products it raises concern. As well as Bisphenol A, Triclosan has also 
been added to the CoRAP list because of its persistent, bioaccumulative, and toxic 
properties [282, 304]. Because of this reason it was selected to be investigated in 
this study for a better understanding of its behavior during oxidative treatment and 
the resulting toxicity since it was found in influents of waste water treatment plants 
with the highest detected concentrations around 80 µg/L [305]. 
Triclosan has been described as toxic towards a variety of species. The adverse 
effects of Triclosan include cytotoxic, genotoxic and endocrine properties. These 
effects have been shown by various groups. Jirasripongpun et al. (2008) tested 
Triclosan for its cytotoxic and genotoxic effects towards three animal cell lines (BHK-
21, Vero and KB cells). Reported IC50 values range from 9.8 – 75.28 mg/L 
depending on the cell line indicating a higher susceptibility to Triclosan of the primate 
cell lines (Vero and KB) than the rodent cell line (BHK-21). In terms of genotoxicity 
they report initial effects in the Comet Assay after a three day exposure to 6.66 mg/L 
which increased after five days of exposure [306]. Genotoxic effects of Triclosan 
were also described by Binelli et al. (2009) using the in vitro Alkaline Comet Assay in 
zebra mussel hemocytes after an exposure time of 60 minutes. Significant increases 
in DNA damage were already detected at the lowest tested concentration 
(28.95 µg/L) [307] which is comparable to the concentrations (0-100 µg/L) used here 
in this study (chapter 5.5.4), with the first significant effect detected at 1 µg/L after 
24 h of exposure. Another Comet Assay was performed by Ciniglia et al. (2005) 
describing a significant increase in tail moment, thus DNA damage, after an 
exposure of Closterium ehrengergii to 0.25 mg/L Triclosan. Cytotoxic effects were 
detected at 0.187 mg/L [308]. Zuckerbraun et al. (1998) describe first notable effects 
in different cytotoxicity tests starting at 2.9 mg/L [309]. As has been shown for other 
substances EC50 values vary between test, exposure time and organisms used. An 
exposure to Triclosan resulted in EC50 values in the range of 0.7 µg/L to 350 µg/L 
depending on the organism [305, 310-312]. First effects on algae were seen at 
0.015 µg/L [313]. Besides its cyto- and genotoxic effects, Triclosan was also reported 
being an endocrine-disrupting compound in aquatic organisms however at 
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concentrations much higher than commonly found in water bodies [188, 314]. 
Despite all these reported toxic effects a review on Triclosan and its environmental 
impacts by Dann et al. (2011) summarizes that the use of Triclosan can be 
considered as safe, however further research regarding its impact on the ecosystem 
and the human health needs to be done [171]. A similar statement was published by 
the Scientific Committee on Consumer Products (2009). They conclude that its use 
as a preservative is safe, however its use in e.g. body lotions and mouth washs 
might not be safe because of the high levels of exposure [315]. The US FDA (2008) 
in addition classified Triclosan as a Category III product due to insufficient 
information on the safety and effectiveness, especially on missing data of its possible 
dermal carcinogenicity [316]. 
2,4-Dichlorophenol is a substance originating not only from the ozonation and 
photodegradation of Triclosan, but also from its metabolization [173, 317]. In the 
German surface water guideline, 2,4-Dichlorophenol has been regulated with an 
environmental qualitiy standard of 10 µg/L. Environmental quality standards are 
applied when a substances is belived to have a negative impact for the environment 
or human health [30]. The toxicity of 2,4-Dichlorophenol was amongst others 
investigated by Chen et al. (2004) using L929 (mouse fibroblasts). The EC50 value 
after a 24 h exposure was 135.29 mg/L. Additionally Chen et al. (2004) were able to 
show the properties of 2,4-Dichlorophenol to induce DNA fragmentation and 
apoptosis. Looking at other chlorophenols they also found that the cytotoxicity 
increased with an increasing number of chlorine atoms [318]. This was also reported 
by Jiang et al. (2004) who also investigated the cytotoxicity of chlorophenols on L929 
but also on HepG2 cells. The LC50 values of 127.3 mg/L (L929) and 128.77 mg/L 
(HepG2) for both cells lines are comparable. In regard to the simultaneously 
performed QSAR approach correlating the chemical structure and biological activity 
of 2,4-Dichlorophenol they not only found a relationship of cytotoxicity and the 
number of chlorine atoms, they also found a connection between toxicity and the 
position of the chlorine atoms [319]. An increase in chromosomal aberrations after 
an exposure of CHO cells to 97.8 mg/L (with S9) and 195.6 mg/L (without S9) was 
shown whereas no statistically significant effects were seen in TK6 cells [320]. The 
effects of 2,4-Dichlorophenol were also investigated by Ensley et al. (1994). Using 
the angiosperm Lemna gibba for their experiments they detected an EC50 of 
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1.5 mg/L and a lethal concentration of 6.52 mg/L [321]. Own tests with 2,4-
Dichlorophenol demonstrate that neither cytotoxic nor genotoxic effects have been 
detected at concentrations between 0 and 100 µg/L (chapter 5.5.4). Comparing 
these results to the environmental quality standard (EQS) of 10 µg/L it can be said 
that this value seems to be a safe measure.  
Overall it can be concluded that Triclosan can be removed from water by ozonation 
and that the ozonation leads to the formation of the less genotoxic by-product 2,4-
Dichlorophenol. However an EQS for 2,4-Dichlorophenol has been established and 
its formation should therefore be avoided. 
 
 
 
 Biocides 6.10.
6.10.1. Irgarol 1051 
Irgarol® 1051 is a constituent of paints used e.g. on ship hulls to prevent algal growth 
or on facades reaching waste water treatment plants through leaching and wahs-off 
into the sewage system [322]. Therefore its presence in the water system is likely 
(up to 2.5 µg/L in freshwater [323]) and a reason it was investigated in this project.  
Own results showed that although the ozonation of Irgarol led to the formation of 
different oxidation by-products [151] no cytotoxic or genotoxic effects were detected 
before or after ozonation. In addition no differences in cell viability or Olive Tail 
Moment were observed comparing the use of 56 µg or 400 µg ozone (chapter 5.6.1).  
Published studies showed that the toxicity of Irgarol 1051 has been investigated 
using a variety of aquatic organisms, since they are most affected by its presence in 
water systems. Although Irgarol is produced as a biocide effects in non-target 
organisms should be avoided. EC50 values gained from the V. fischeri luminescence 
test range from 2.42 mg/L to more than 50 mg/L depending on the exposure time 
[227, 228, 324-326]. Irgarol has also been tested for its effects on D. magna resulting 
in EC50 values of 7.3 or 8.3 mg/L [227, 228, 324, 325] and in the microalgae 
Selenastrum capricronotum with EC50 values between 0.01 and 15.5 mg/L [174, 228, 
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324, 327]. Mesocosm studies by Mohr et al. (2009) revealed direct effects on the 
used organisms after only one single application of Irgarol. The most sensitive 
organism from this mesocosm was Myriophyllum verticillatum with an EC50 of 
0.21 µg/L after 150 days of exposure [323]. A study performed by Noguerol et al. 
(2006) investigated the interactions of vertebrate receptors (estrogen and aryl 
hydrocarbon receptors) with a variety of pollutants including Irgarol 1051. Their 
results show that Irgarol 1051 did not lead to a response (inhibition or activation) in 
those yeast based test systems. Since they did also not detect any effects for the 
structurally similar Sea-Nine biocide they concluded that heterocyclic substances are 
not able to interact with estrogen or aryl hydrocarbon receptors [328]. 
 
Other studies also focused on M1 (2-Methylthio-4-tert-butylamino-6-amino-s-triazine) 
a degradation product formed through biological or chemical degradation as well as 
through photodegradation of Irgarol® 1051 [329-331]. Okamura et al. (2003) looked 
at a variety of organisms, to detect differences in their susceptibility to Irgarol and its 
degradation product M1 and found differences in EC50 values [327] which was also 
reported by Fernandez-Alba et al. [228]. The results of both studies are displayed in 
Table 32. Their results also show great differences in organism susceptibility towards 
Irgarol® 1051 or M1 with a huge range of EC50 values (0.0081 mg/L - > 50 mg/L for 
Irgarol® 1051 and 0.0071 mg/L - > 50 mg/L for M1). It can also be seen, that for 
some organisms (e.g. L. sativa or V. fischeri) the EC50 of M1 is lower than the one for 
Irgarol® 1051 thus indicating an increase in toxicity due to the formation of a more 
toxic transformation product. 
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Table 32: Summary of EC50 or LC50 values of Irgarol 1051 and M1 found in the literature 
Author Organism  
(Exposure time) 
Irgarol
®
 1051 
EC50 [mg/L] 
M1 
EC50 [mg/L] 
Reference 
Okamura et al. S. capricornotum (3 d) 1.6 19 [325, 327] 
L. gibba (7 d) 0.11 0.12 
L. minor (7 d) 0.0081 0.0071 
L. sativa (5 d) > 50 4.3 
V. fischeri (30 min) > 50 > 50 
D. magna (48 h) 8.3 (LC50) 11 (LC50) 
D. duplex (24 h) 5.7 (LC50) 27 (LC50) 
T. platyurus (24 h) 12 (LC50) 19 (LC50) 
A. salina (24 h) > 40 > 40 
Fernandez-Alba et al. V. fischeri (15 min) 50.8 6.5 [228] 
S. capricornotum (30 h) 15.5 4.7 
D. magna (48 h) 7.3 18.9 
 
 
 
6.10.2. Terbutryn 
Terbutryn is a biocide and as Irgarol® 1051 it is used in paints for facades or ship 
hulls. It is also used as a control agent for grasses and weeds which might also lead 
to a washing-off into surface waters. Due to rain events Terbutryn might leach 
directly into surface water or the sewer system and after an incomplete removal in a 
waste water treatment plant it might also reach surface waters [322]. Velisek et al. 
(2010) reported a concentration of 5.6 µg/L detected in surface waters.  
For Terbutryn the above presented results of this study show an influence of the 
ozone concentration on the toxicity (chapter 5.6.2). It could be shown that the 
substance itself already has genotoxic effects. Depending on the O3 concentration 
the effects became even stronger indicated by an increase in the Olive Tail Moment 
compared to the untreated samples but genotoxic effects were completely removed 
at the highest O3 concentration (800 µg). This indicates that using 800 µg O3 the 
genotoxic Terbutryn had been degraded without the formation of toxic oxidation by-
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products which have only been formed at the lower ozone concentrations (36 – 
195 µg). However ozone concentrations commonly applied during waste water 
treatment are usually higher than 800 µg. Thus there probably is no risk in applying 
ozone to waters containing Terbutryn since the toxic Terbutryn is removed by ozone 
and the formed genotoxic oxidation by-products only occur at low O3 concentrations. 
The toxicity of Terbutryn itself has been shown by others before, however with 
differing results. Arufe et al. (2004) observed a LC50 value of 1.4 mg/L using Sparus 
aurata larvae (gilt-head bream) while the EC50 value derived from Vibrio fischeri was 
15.94 mg/L [332]. In contrast, Hernando et al. (2007) classified Terbutryn as non-
harmful for Vibrio fischeri according to the toxicity categories of the EU legislation 
[242]. The general toxicity of Terbutryn was also tested using V. fisheri by Gaggi et 
al. (1995) resulting in an EC50 of 13 mg/L, comparable to the published data by Arufe 
et al. In comparison, the EC50 values for two algae were 2.7 mg/L (Selenastrum 
capricornutum) or 3.1 mg/L (Dunaliella tertiolecta) and 22 mg/L for the brine shrimp 
Artemia salina [333]. Genotoxic effects of Terbutryn in human peripheral blood 
leukocytes were detected at a concentration of 5 mg/L using the Alkaline Comet 
Assay [176, 334] whereas no effects were seen in the Sister Chromatid Exchange 
and in the Micronucleus Assay testing concentrations up to 150 mg/L [176]. Toxic 
effects of Terbutryn on aquatic organisms were tested by Velisek et al. (2010) and 
Plhalova et al. (2010) LC50 values for juvenile Poecilia reticulata and Danio rerio (D. 
rerio) were 2.85 mg/L and 5.71 mg/L whereas the LC50 value for embryonic D. rerio 
was determined as 8.04 mg/L, thus showing great differences in susceptibility 
according to age and organism [335]. Velisek at al. investigated various parameters 
(hematology, histology, blood, biochemistry and biometric parameters) in carp 
exposed to Terbutryn and found effects starting at 0.04 mg/L [336] and even lower 
effective concentrations (0.02 µg/L) on the early life stages of carp [337].  
The above described results (chapter 5.6.2) from this PhD study clearly show an 
increase in genotoxic effects after ozonation of Terbutryn which can be related to 
formed oxidation by-products. Brix et al. (2009) also found an increase in toxicity 
after oxidative treatment of Terbutryn. In their study they looked at disinfection by-
products after hypochlorite (HClO) treatment. The toxicity was determined by the 
Vibrio fischeri luminescence test and showed a decrease of the EC50 value of 
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Terbutryn from 24 mg/L in untreated water to 15 mg/L in HClO treated water thus 
they concluded the formation of disinfection by-products which are more toxic than 
Terbutryn itself [338].  
Own results as well as results from other studies demonstrated the formation of toxic 
by-products resulting from the oxidation of Terbutryn. Terbutryn has toxic effects 
even at low concentrations and its presence in water bodies therefore is a risk for the 
environment. However higher amounts of oxidant seem to be effective in removing 
Terbutryn as well as its toxic by-products and lower its risk potential.  
 
 
 Musk fragrances 6.11.
6.11.1. AHTN and HHCB 
Musk fragrances like AHTN and HHCB are aromatic substances ubiquitously used in 
cosmetics, perfumery and detergents. Since they have a low water solubility they 
easily bioaccumulate. This characteristic has led to their detection in the environment 
(up to 45 µg/L [1]) as well as human blood samples. The use of musk fragrances in 
cosmetics etc. has been classified as safe however their behavior and fate in the 
environment needs further investigation [339]. 
Comparing own results of AHTN (chapter 5.7.1) before, during, and after ozonation 
or UV/H2O2 treatment it can be seen, that the ozonation does not result in the 
formation of toxic by-products, whereas after 20 min of UV/H2O2 treatment weak 
cytotoxic effects occur. These effects are related to formed oxidation by-products, 
since no remaining peroxides were detected. Although oxidation by-products were 
also formed during ozonation [186] no cytotoxic or genotoxic effects were observed. 
HHCB-lactone was tested for toxicity at concentrations between 0 µg/L and 50 µg/L 
but neither cytotoxic nor genotoxic effects occurred. Cytotoxic effects however, were 
only detected after 60 min UV/H2O2 oxidation of 0.1 mg/L HHCB. This reflects the 
findings for Bisphenol A (chapter 5.4.2), where only the UV/H2O2 treatment resulted 
in a reduced viability, indicating that different oxidation by-products are formed 
depending on the applied oxidation method. The toxicity of both substances, HHCB 
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and its oxidation by-product HHCB-lactone, has been studied before by others and 
resulted in a classification as not harmful for the environment based on PNEC 
(predicted non effect concentration) values for soil dry weight and for aquatic species 
[340]. The genotoxicity tests performed in this study confirm previously published 
results by Api et al. (1999) who did not find genotoxic or mutagenic effects of AHTN 
and HHCB in different test systems (Ames Test, Chromosome abberations, 
Unscheduled DNA synthesis and Micronucleus test) [341]. Effects of AHTN and 
HHCB on the early life stages of zebrafish have been investigated by Carlsson et al. 
(2004). While AHTN had effects on the heart rate (LOEC = 33 µg/L) no effects were 
seen on the survival time with a maximum concentration of 100 µg/L. HHCB in 
contrast had no effects in both tests up to a concentration of 1 mg/L [342]. However, 
Randelli et al. (2011) reported effects of AHTN on the regulation of 
immunoregulatory genes in gonadal cells of the rainbrow trout, while there were no 
effects on cell viability [343].  
In addition to the cytotoxicity and genotoxicity testing in this study HHCB and HHCB-
lactone were also tested for estrogenicity (chapter 5.7.1 and 5.7.2), but no effects 
were detected supporting other published results. Estrogenic effects of AHTN and 
HHCB have been studied by Seinen et al. (1999) They found effects on the uterus 
weight of mice starting at 50 ppm AHTN and an induction of the ERα transcription 
starting at 50 µM AHTN. However, they concluded that compared to effects resulting 
from a 17ß-estradiol exposure the effects induced by AHTN are not noteworthy. 
Thus, they also state that AHTN does not have a negative effect on the environment 
[344]. Schreurs et al. (2005) investigated the interactions of musk fragrances with 
different hormonal receptors and found AHTN as well as HHCB to be antagonists 
towards the ERß receptor [345] which confirms the above presented findings of our 
own investigations where no estrogenic activity of HHCB was detected. 
Antiestrogenic effects of HHCB were also reported by Simmons et al. (2012) after 
performing the Yes-assay, as well as other in vitro and in vivo test systems [346]. A 
set of different reporter gene assays (estrogen, androgen, progesterone, and 
glucocorticoid) was used to test HHCB and AHTN for their potential endocrine 
effects. Here again it was reported that neither substance had agonistic effects 
whereas antagonistic effects were detected in each assay except the glucocorticoid 
system [347]. Another study by Schreurs et al. (2003) also proves the antiestrogenic 
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effect, this time using a transgenic zebrafish assay [348]. The same findings on the 
antagonistic mode of action by polycyclic musks have been reported in a literature 
review by Witorsch and Thomas (2010) [349]. Although HHCB has been shown to 
act estrogenic, the concentrations inducing these effects were much higher 
(2.58 mg/L) than those used in our study (max. 0.1 mg/L) [350]. Schreurs et al. (2002 
and 2005) were also able to prove, that the endocrine mode of action (agonistic or 
antagonistic) of HHCB is cell line dependent, and HHCB does not always result in 
estrogenic effects [345, 351]. Despite the published data on the toxicity and 
endocrine activity of HHCB and AHTN further analyses especially in regard to the 
formation of oxidation by-products should be performed since both substances are 
frequently detected in water systems [36, 352]. 
 
 
 
 Organophosphates: TCEP, TCPP and TPP 6.12.
Organophosphates are substances commonly used as constituents of biocides and 
thus are designed to be biologically active. Besides this they are also used as flame 
retardants and might therefore reach water systems. Although despite their 
widespread use, toxicological data about the three here used organophosphates is 
scarce.  
TCEP has been added to the candidate list of substances of very high concern 
(SVHC) by the ECHA due to its classification as a reproductive toxicant [180]. The 
SVHC supporting document also indicates neurotoxic effects after an exposure to 
TCEP [353].  
The toxicity of TPP has been investigated by Lin et al. (2009). They report LC50 
values of 0.51 mg/L and 0.09 mg/L for Daphnia magna exposed to TPP for 24 h or 
48 h [221]. Föllmann et al. (2006) tested TCEP and TCPP for their potential to 
induce cytotoxic, genotoxic, mutagenic, and estrogenic effects in vitro. The results 
show, that an exposure of V79 cells (hamster fibroblasts) to both substances did not 
result in genotoxic and mutagenic effects using the Alkaline Comet Assay and the 
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Ames test with and without metabolic activation (S9). In addition no estrogenic or 
anti-estrogenic effects were detected for a maximum concentration of 1 mM (TCEP = 
250 mg/L; TCPP = 327.55 mg/L). However, cytotoxic effects for both substances 
were seen at concentrations above 10 µM for TCEP and 1 mM for TCPP but only in 
the presence of the S9 liver homogenate [354]. Similar results for genotoxic or 
mutagenic effects were also published by others [355-358]. Ren et al. (2009) were 
able to show cytotoxic effects to start at 1 mg/L in the LDH assay using primary rat 
renal cells. At these concentrations TCEP also had an influence on the ion uptake 
and the expression of ion-transporters [359]. Another study of the same group also 
showed possible risks on the ecosystem and the human health [360]. Endocrine 
effects of organophsophates on H295R and MVLN cells have been investigated by 
Liu et al. (2012) demonstrating the potential of endocrine disruption of TCEP, TCPP 
and TPP as well as other organophosphates starting at low µg/L concentrations. At 
the same time they were able to show differences in the mode of action [361]. 
Comparing the published data for TCEP and TCPP to results obtained during this 
study it can be seen, that effects occur at mainly much higher concentrations than 
tested here (chapter 5.8.2 and 5.8.3). 0.1 mg/L of the organophosphates did not 
result in cytotoxic or genotoxic effects. Cytotoxic effects were only seen after 
UV/H2O2 treatment but not after ozonation, indicating the formation of toxic oxidation 
by-products. 
In contrast to the above mentioned data from the literature, Higley et al. (2012) 
performed a study with sediments from the upper Danube river using an effect-
directed analysis looking at endocrine disrupting, mutagenic, and teratogenic effects. 
Although they found toxic effects for some fractions of the extracted sediments, the 
fractions containing organophosphates did not result in any effects [362]. 
The results for TPP however are different. 0.1 mg/L TPP did not result in a decrease 
in cell viability neither before nor after ozonation. Genotoxic effects however were 
detected before oxidative treatment but not after 60 min of treatment. Thus ozonation 
and UV/H2O2 oxidation were useful to remove the toxic TPP from water samples. 
Flaskos et al. (1994) report an IC50 value of 250 mg/L for TPP in PC12 cells (rat 
pheochromocytoma cells) [363]. This IC50 value in fact is a lot higher than the 
concentration tested here. 
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In conclusion it can be said that these results show that substances belonging to the 
same class of chemicals do not necessarily exhibit the same mode of action and 
oxidative treatment might result in different outcomes.  
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 Conclusions and future directions 6.13.
The results of this study also demonstrate that a generalized statement about toxic 
effects of waste water treatment plant effluents is not possible. The water 
composition as well as the waste water treatment plant design and the operating 
conditions might vary between different plants and over time. In addition four in vitro 
tests have been applied in this study and most of the substances and treatment 
conditions resulted in no toxic effects. However, other toxicological test methods as 
well as in vivo methods might give different results, due to a different mode of action 
or in case of in vivo methods, the metabolization of micropollutants. Therefore further 
research (e.g. EDA) regarding the toxicity of micropollutants, their metabolites as 
well as their oxidation by-products is needed especially since up to now the methods 
of waste water treatment have not been applied or modified in regard to 
micropollutant removal.  
Another step towards a better surveillance of water quality by means of toxicity is the 
development or establishment of existing online monitoring systems, for a faster on-
site analysis in combination with other test systems.  
Further technologies that might also be applied for a risk assessment of organic 
micropollutants in water systems are the QSAR-approaches or toxicogenomics as 
well as biosensors which allow a toxicological analysis at the source, e.g. directly at 
the WWTP effluent discharge point or even in front of it. The use of the so called     
“–omics” techniques might be another step towards the application of cellular based 
test systems. These techniques allow an analysis on the whole organism situation 
e.g. changes in DNA expression (genomics) or protein profiles (proteomics) [231]. 
For further or more detailed analyses in vivo methods might then be applied after 
limiting the vast amount of adverse effects through in vitro testing. Concepts like the 
Adverse Outcome Pathways proposed by the US EPA (2010), effect directed 
analysis or procedures as suggested by Kase et al. (2009) are most promising for a 
secure risk assessment [71, 234, 236]. 
.
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8. Annex 
 List of Chemicals 8.1.
Product Company 
CHO Cells ECACC; Salisbury, UK 
T47D Cells BioDetectionSystems (BDS); Amsterdam, NL 
Salmonella typhimurium TA98 Xenometrix; Allschwil, CH 
Salmonella typhimurium TA100 Xenometrix; Allschwil, CH 
17ß-Ethinylestradiol BDS; Amsterdam, NL 
2-Aminoanthracene Xenometrix; Allschwil, CH 
2-Nitrofluorene Xenometrix; Allschwil, CH 
4-Nitroquinolone-N-Oxide Xenometrix; Allschwil, CH 
Acetic acid AppliChem; Darmstadt, D 
Ames MPF Aqua 98/100 Test Kit (J10-210) Xenometrix; Allschwil, CH 
Ames Exposure Medium Solution A (10x) Xenometrix; Allschwil, CH 
Ames Exposure Medium Solution B (10x) Xenometrix; Allschwil, CH 
Ampicillin Xenometrix; Allschwil, CH 
Ampuwa (sterile water) Fresenius Kabi; Bad Homburg, D 
Blood agar plates Oxoid; Wesel, D 
CO2 (N45) Air Liquide; Düsseldorf, D 
Dimethylsulfoxide (DMSO) Sigma-Aldrich; Steinheim, D 
DMEM F12 with Phenolred Gibco; Karlsruhe, D 
DMEM F12 without Phenolred Gibco; Karlsruhe, D 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich; Steinheim, D 
N-ethyl-N-nitrosourea (ENU) Sigma-Aldrich; Steinheim, D 
Fetal Calf Serum (FCS) Gibco; Karsruhe, D 
Gentamycin c.c.pro; Oberdorla, D 
GlowMix BDS; Amsterdam, NL 
Growth Medium (Ames) Xenometrix; Allschwil, CH 
HAM’s F12 c.c.pro; Oberdorla, D 
Hydrochloric acid (HCl) Merck; Darmstadt, D 
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Product Company 
Indicator Medium (Ames) Xenometrix; Allschwil, CH 
LDH I (Reconstitution Solution) Xenometrix; Allschwil, CH 
LDH II (NADH) Xenometrix; Allschwil, CH 
LDH III (Pyruvate) Xenometrix; Allschwil, CH 
L-Glutamine c.c.pro; Oberdorla, D 
Liquid nitrogen Air products; Bochum, D 
Low melting point (L.M.P.) Agarose Invitrogen; Paisley, UK 
Lysis solution ER Calux BDS; Amsterdam, NL 
MTT Sigma-Aldrich; Steinheim, D 
MMAIII (Monomethylarsonous acid) Argus Chemicals; Vernio, I 
Sodiumchloride (NaCl) Merck; Darmstadt, D 
Sodiumhydroxide (NaOH) Sigma-Aldrich; Steinheim, D 
N-Laurylsarcosine Sodium Salt Sigma-Aldrich; Steinheim, D 
Non-essential amino acids (NEAA) c.c.pro; Oberdorla, D 
NR I (Washing solution) Xenometrix; Allschwil, CH 
NR II (Labeling solution) Xenometrix; Allschwil, CH 
NR III (Fixing solution) Xenometrix; Allschwil, CH 
NR IV (Solubilization solution) Xenometrix; Allschwil, CH 
PAN I Cytotoxicity Kit (PAN I 96.1200) Xenometrix; Allschwil, CH 
Phosphate Buffered Saline (PBS) Gibco; Karlsruhe, D 
Reference water BDS; Amsterdam, NL 
S9 Fraction Xenometrix; Allschwil, CH 
S9 Buffer Salts Xenometrix; Allschwil, CH 
S9 G-6-P Xenometrix; Allschwil, CH 
S9 NADP Xenometrix; Allschwil, CH 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich; Steinheim, D 
SRB I (Washing solution) Xenometrix; Allschwil, CH 
SRB II (Fixing solution) Xenometrix; Allschwil, CH 
SRB III (labeling solution) Xenometrix; Allschwil, CH 
SRB IV (Rinsing solution) Xenometrix; Allschwil, CH 
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Product Company 
SRB V (Solubilization solution) Xenometrix; Allschwil, CH 
Stripped FCS (Fetal Calf Serum) BDS; Amsterdam, NL 
SYBR-Green® Sigma-Aldrich, Steinheim, D 
Triton-X Merck; Darmstadt, D 
Trizma Sigma-Aldrich; Steinheim, D 
Trypsin-EDTA c.c.pro; Oberdorla, D 
XTT I (Substrate) Xenometrix; Allschwil, CH 
XTT II (Buffer) Xenometrix; Allschwil, CH 
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 List of Materials 8.2.
Material 
Catalogue 
number 
Company 
Cell culture flask (25 cm
2
) 90025 TPP; Trasadingen, CH 
Cell culture flask (75 cm
2
) 90076 TPP; Trasadingen, CH 
Cell culture flask (150 cm
2
) 90151 TPP; Trasadingen, CH 
Chamber Slides(8 chambers) 354118 BD Falcon; Heidelberg, D 
Cover glasses  24 x 60 mm Engelbrecht; Edermünde, D 
Cuvettes 12.5x12.5x45 mm Brand; Wertheim, D 
Erlenmeyer flask (100 mL) 21216240 Schott; Mainz, D 
Gelbond Film 53734 Lonza; Basel, CH 
Microscope slides 631-1554 VWR; Darmstadt, D 
24-well tissue culture plate 662160 Greiner Bio One; Frickenhausen, D 
96-well microtiter plate (transparent) 167008 
Nalge Nunc International; 
Wiesbaden, D 
96-well microtiter plate (white) 655075 Greiner Bio One; Frickenhausen, D 
96-well microtiter plate (transparent) 353072 BD Falcon; Heidelberg, D 
384-Well microtiter plate 164688 
Nalge Nunc International; 
Wiesbaden, D 
Minisart® Filter (0.2 µm) 16534 
Sartorius Stedim Biotech; 
Göttingen, D 
Microcentrifuge tubes (1.5 mL) 780400 Brand; Wertheim, D 
QUANTOFIX® Peroxide 25 91319 Macherey-Nagel; Düren, D 
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 List of Equipment 8.3.
Equipment Name Company 
8-channel Pipette Finnpipette® 
Thermo Fisher Scientific; Bonn, 
D 
8-channel pipette (electronic) 07 CH81250 Süd-Laborbedarf; Gauting, D 
Autoclave Dampfsterilisator 25-T 120°C 
Thermo Fisher Scientific; Bonn, 
D 
Cold chamber (4 °C) Integra P 2.5 – 230 S Viessmann; Allendorf, D 
Comet Assay Software Comet 4 
Perceptive Instruments; Suffolk, 
UK 
CO2-Incubator Model 3548 S/N Heraeus; Hanau, D 
Electrophoresis Chamber Classic CSSU911 
Thermo Fisher Scientific; Bonn, 
D 
Electrophoresis Powersupply EC 105 
E-C Apparatus Corporation; St. 
Petersburg, US 
Fluorescence microscope Leica DMBL 
Leica DMBL; Leitz GmbH & Co 
KG, Wetzlar, D 
Fridge (4 °C) Premium Liebherr; Ochsenhausen, D 
Fridge (4 °C) - Freezer (-20 °C) Privileg 064.476 5 München, D 
Ice machine  INCO Ziegra; Isernhagen, D 
Laminar Flow work bench II Hera Safe, Typ HS 18 
Thermo Electron Corporation; 
Langenselbond, D 
Laminar Flow work bench I 
Cytostatic safety cabinet  
H-130 
Berner International GmbH; 
Elmshorn, D 
Light microscope Labovert FS 
Leitz GmbH & Co. KG; Wetzlar, 
D 
Magnetic stirrer IKAMAG®RET 
Janke und Kunkel GmbH & Co. 
KG; Staufen i. Br, D 
Microplate reader (Absorbance 
at 340, 480, 540 and 595 nm; 
Luminescence) 
TECAN GENios 
TECAN Trading AG; Männedorf , 
Ch 
Microscope camera Marlin - F046B 
Allied Vision Technologies 
GmbH; Stadtroda, D 
Multipette® Plus 3122 000.035, 3122 000.051 Eppendorf AG; Hamburg, D 
Neubauer chamber Neubauer Improved Brand GmbH; Wertheim, D 
Liquid nitrogen tank MVE xc 34/18 
Cryodepot/nexAir, LLC; 
Memphis, US 
ph Meter pH 521 
Wissenschaftlich-technische 
Werkstätten; Weilheim i. OB, D 
Pipetting aid Pipetus Hirschmann; Eberstadt/Württ, D 
Serological pipettes  1 – 50 mL 
Greiner Bio-One; Frickenhausen, 
D 
Shaker IKA-Vibrax-VXR 
Janke und Kunkel GmbH & Co. 
KG; Staufen i. Br, D 
Storage boxes   
Vortex REAX 2000 
Heidolph Instruments GmbH & 
Co. KG; Schwalbach, D 
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Equipment Name Company 
Weigh LE 225D-0CE Sartorius AG; Göttingen, D 
Water bath (37 °C) GFL Typ 1002 
GFL Gesellschaft für 
Labortechnik GmbH; Burgwedel, 
D 
Water bath (78 °C) GFL Typ 1004 
GFL Gesellschaft für 
Labortechnik GmbH; Burgwedel, 
D 
µL Pipettes with tips 
3120 000.020, 3120 000.046, 
3120 000.054, 3120 000.062 
Eppendorf AG; Hamburg, D 
 
  
Annex 
199 
 
 Curriculum vitae 8.5.
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 Raw data 8.6.
Listed below are the results in numbers for each substance (sorted according to the 
alphabet). Each experiment was performed in triplicate. The results for the 
cytotoxicity testing (MTT and PAN I test) are displayed as the mean viability of three 
individual experiments with the standard deviation (SD). The results of the Alkaline 
Comet Assay are also displayed as the mean Olive Tail Moment (OTM) or relative 
OTM of three individual experiments and the standard error of mean (SEM). In 
addition the degree of cytotoxicity and the p-value (p> 0.05 =not significant: n.s.; 
p=0.01 – 0.05 = significant: *; p=0.001 – 0.01 = very significant: **; p< 0.001 = highly 
significant; ***) as a statistical measure for the significance are listed. The results of 
the ER Calux are displayed as ER Calux EEQ in pM/Well and the results of the 
Ames Test are displayed as number of positive wells. 
 
AHTN: 
AHTN  
[0.1 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] Degree of 
cytotoxicity 
p-value 
UV/H2O2 [UV-Hg; 254 nm] 
neg. control 100.0 (0.00) 0.09 (0.012) 0   
pos. Control 0.0 (0.00) 0.61 (0.074) 3 *** 
Matrix control 105.4 (3.72) 0.06 (0.023) 0 n.s. 
0 min 92.5 (10.86) 0.07 (0.017) 0 n.s. 
5 min 92.4 (8.09) 0.15 (0.028) 0 n.s. 
20 min 74.3 (7.69) 0.05 (0.017) 1 n.s. 
 
AHTN 
[0.1 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] Degree of 
cytotoxicity 
p-value 
Ozonation [10 mg/L] 
neg. control 100.0 (0.00) 0.07 (0.008) 0   
pos. Control 0.0 (0.00) 0.38 (0.015) 3 *** 
Matrix control 92.2 (3.67) 0.10 (0.013) 0 n.s. 
0 min 101.6 (1.61) 0.12 (0.014) 0 n.s. 
10 min 102.0 (0.50) 0.12 (0.013) 0 n.s. 
60 min 102.4 (2.22) 0.08 (0.012) 1 n.s. 
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Atenolol: 
Atenolol 
[0.2 mg/L] 
LDHe 
[rel. LDHe 
activity] 
XTT  
[% Viability 
(SD)] 
NR  
[% Viability 
(SD)] 
SRB  
[% Viability 
(SD)] 
Comet 
[OTM 
(SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 0 100 (0) 100 (0) 100 (0) 0.18 (0.025) 0  
pos. Control 100 0 (0) 0.2 (0.09) 4.6 (0.84) 0.44 (0.04) 3 *** 
untreated 4.4 94.4 (2.80) 94.8 (3.40) 81.7 (1.38) 0.13 (0.018) 0 n.s. 
60 min ozone 0.1 93.8 (1.23) 101.9 (4.23) 83.8 (5.81) 0.15 (0.02) 0 n.s. 
 
 
Bisphenol A: 
Bisphenol A*  
HPLC- water MTT  
[% Viability (SD)] 
Comet  
[rel. OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 1 0   
pos. Control 13.9 (0.45) 2.55 (0.098) 3 *** 
Matrix control 92.5 (7.36) 0.95 (0.137) 0 n.s. 
untreated 104.7 (3.51) 1.32 (0.170) 0 n.s. 
60 min O3 93.3 (3.23) 0.97 (0.126) 0 n.s. 
60 min UV/H2O2 9.5 (3.34) n.t. 3   
 
Bisphenol A* 
WWTP 
MTT 
[% Viability (SD)] 
Comet 
[rel. OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 1 0   
pos. Control 13.9 (0.45) 2.93 (0.084) 3 *** 
Matrix control 96.6 (0.99) 0.94 (0.122) 0 n.s. 
untreated 99.8 (3.57) 1.08 (0.122) 0 n.s. 
60 min O3 95.1 (7.50) 0.54 (0.086) 0 n.s. 
60 min UV/H2O2 96.0 (3.30) 1.20 (0.139) 0 n.s. 
* c(Bisphenol A) ozonation = 1.4 mg/L; c(Bisphenol A) UV/H2O2 = 0.1 mg/L 
 
Bisphenol A [0.1 mg/L]  
HPLC- water 
ER Calux 
EEQ [pM] 
untreated 2.7 
10 min UV/H2O2 0 
60 min UV/H2O2 0 
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Ciprofloxacin: 
Ciprofloxacin 
WWTP effluent 
[1.4 mg/L] 
MTT 
[% Viability 
(SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
Ozonation [5 mg/L] 
neg. control 100.0 (0.00) 0.22 (0.020) 0   
pos. Control 13.9 (0.45) 0.772 (0.037) 3 *** 
Matrix control 82.4 (4.49) 0.21 (0.030) 0 n.s. 
0 min 96.4 (1,79) 0.12 (0.013) 0 n.s. 
60 min 91.9 (2.93) 0.13 (0.037) 0 n.s. 
 
Ciprofloxacin 
HPLC-water 
[0.1 mg/L] 
MTT [% 
Viability (SD)] 
Comet  
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
UV/H2O2 [Hg-LP, 15 W; 1 g/L H2O2] 
neg. control 100.0 (0.00) 0.36 (0.022) 0   
pos. Control 13.9 (0.45) 0.72 (0.037) 3 *** 
Matrix control 96.7 (4.56) 0.43 (0.056) 0 n.s. 
0 min 87.1 (1,41) 0.38 (0.047) 0 n.s. 
10 min - 0.42 (0.052) - n.s. 
30 min - 0.32 (0.059) - n.s. 
60 min 69.4 (11.10) n.t. 2   
 
Ciprofloxacin 
WWTP effluent 
[1.4 mg/L] 
LDHe 
[rel. LDHe activity] 
XTT 
[% Viability 
(SD)] 
NR 
[% Viability 
(SD)] 
SRB 
[% Viability 
(SD)] 
Degree of 
cytotoxicity 
Comet 
[OTM (SEM)] 
p-value 
Ozonation [5 mg/L] 
neg. control 0 100.0 (0.00) 100.0 (0.00) 100.0 (0.00) 0 0.18 (0.014)   
pos. Control 100 0.0 (0.00) 0.2 (0.00) 4.8 (0.20) 3 0.48 (0.026) *** 
Matrix control 0 95.0 (0.00) 87.0 (0.00) 86.0 (0.00) 0 0.17 (0.022) n.s. 
0 min 0 100.3 (3.58) 99.7 (6.30) 106.2 (5.45) 0 0.20 (0.024) n.s. 
60 min 0 93.3 (5.09) 103.3 (4.26) 97.0 (7.48) 0 0.21 (0.025) n.s. 
 
Ciprofloxacin 
HPLC-water 
[0.1 mg/L] 
LDHe 
[rel. LDHe 
activity] 
XTT [% 
Viability (SD)] 
NR [% 
Viability (SD)] 
SRB [% 
Viability 
(SD)] 
Degree of 
cytotoxicity 
Comet [OTM 
(SEM)] 
p-value 
UV/H2O2 [Hg-LP, 15 W; 1 g/L H2O2] 
neg. control 0 100.0 (0.00) 100.0 (0.00) 100.0 (0.00) 0 0.18 (0.014)   
pos. Control 100 1.3 (0.32) 2.5 (0.87) 7.3 (1.29) 3 0.48 (0.026) *** 
Matrix control 0 98.2 (0.61) 89.4 (0.90) 88.0 (5.54) 0 0.14 (0.018) n.s. 
0 min 0 87.9 (3.36) 100.0 (0.00) 87.1 (3.52) 0 0.14 (0.021) n.s. 
10 min 0 86.5 (1.54) 100.0 (0.00) 98.7 (0.98) 0 0.14 (0.018) n.s. 
60 min 0 76.0 (5.27) 100.0 (0.00) 89.6 (1.36) 0 0.16 (0.021) n.s. 
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Ethinylestradiol: 
UV/H2O2 
MTT 
[Viability % (SD)] 
ER Calux  
[pM ER Calux EEQ] Degree of 
cytotoxicity 
Ethinylestradiol 
[0.015 g/L] 
UV/H2O2 [UV-Hg; 254 nm; 0.33 g/L H2O2] 
neg. control 100.0 (0.14) - 0 
pos. control 0,3 (0.03) - 3 
untreated 94.9 (3.34) 1.8 0 
10 min 96.0 (0.33) 1.4 0 
60 min 91.4 (2.70) 0.9 0 
 
O3 
MTT 
[Viability % (SD)] 
ER Calux  
[pM ER Calux EEQ] Degree of 
cytotoxicity 
Ethinylestradiol 
[0.015 g/L] 
Ozonation [5 mg/L] 
neg. control 100.0 (0.14) - 0 
pos. control 0,3 (0.03) - 3 
untreated 94.9 (3.34) 1.6 0 
1 mg/L O3 88.7 (6.63) 1.6 0 
5 mg/L O3 90.6 (7.08) 1.3 0 
10mg/L O3 94.2 (8.30) 1.1 0 
 
 
 
HHCB: 
HHCB [µg/L] 
Ozonation 
ER Calux 
[RLU (%SD)] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 391 (36.1) 100.0 (0.00) 0.2 (0.02) 0   
pos. Control n.t. 0.2 (0.13) 0.7 (0.04) 3 *** 
0.05 n.t. 97.4 (3.96) 0.208 (0.04) 0 n.s. 
0.1 n.t. 99.9 (2.25) 0.259 (0.04) 0 n.s. 
0.5 126 (17.5) 101.1 (1.50) 0.214 (0.02) 0 n.s. 
1 152 (46.7) 109.1 (2.91) 0.198 (0.04) 0 n.s. 
5 104 (23.9) 100.9 (6.51) 0.235 (0.5) 0 n.s. 
10 60 (7.8) 90.2 (8.60) 0.229 (0.05) 0 n.s. 
50 100 (14.2) 101.6 (7.18) 0.230 (0.09) 0 n.s. 
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HHCB 
[0.1 mg/L] UV/H2O2 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. Control 100.0 (0.00) 0.103 (0.01) 0   
pos. Control 0.0 (0.00) 0.620 (0.08) 3 *** 
Matrix control 91.7 (6.78) 0.202 (0.05) 0   
0 min 89.3 (3.93) 0.189 (0.09) 0   
30 min 92.8 (4.69) 0.086 (0.01) 0   
60 min 45.8 (0.73) n.t. 3 n.t. 
 
 
HHCB-Lacton: 
HHCB Lacton  
[µg/L] 
ER Calux 
[RLU (%SD)] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. Control 391 (36.1) 100.0 (0.00) 0.2 (0.02) 0   
pos. Control n.t. 0.2 (0.13) 0.7 (0.04) 3 *** 
0.05 n.t. 100.8 (3.87) 0.106 (0.02) 0 n.s. 
0.1 n.t. 96.5 (4.30) 0.093 (0.03) 0 n.s. 
0.5   99.6 (1.83) 0.103 (0.02) 0 n.s. 
1   98.1 (5.60) 0.117 (0.02) 0 n.s. 
5   101.1 (1.38) 0.123 (0.02) 0 n.s. 
10   100.3 (0.99) 0.169 (0.02) 0 n.s. 
50   107.7 (2.34) 0.224 (0.04) 0 n.s. 
 
 
 
Irgarol 1051: 
Irgarol 1051      
[0.75 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. Control 100.0 (0.00) 0.11 (0.007) 0   
pos. Control 0.2 (0.13) 0.67 (0.023) 3 *** 
Matrix 
control 106.5 (5.35) 0.09 (0.041) 0 n.s. 
56 µg/L O3 103.1 (5.58) 0.13 (0.014) 0 n.s. 
400 µg/L O3 96.5 (4.30) 0.10 (0.011) 0 n.s. 
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Matrix controls: 
WWTP 
effluent  
MTT 
[Viability % (SD)] 
Comet  
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100 (0.0) 0.1 (0.01) 0 - 
pos. control 18.4 (4.80) 0.6 (0.05) 3 *** 
untreated 86.2 (8.35) 0.1 (0.02) 0 n.s. 
Ozone 82.6 (4.65) 0.1 0.03) 0 n.s. 
UV/H2O2 93.6 (1.08) 0.1 (0.02) 0 n.s. 
 
HPLC-water 
LDHe  
[rel. LDHe 
activity] 
XTT 
[% Viability 
(SD)] 
NR  
[% Viability 
(SD)] 
SRB  
[% Viability 
(SD)] 
Degree of 
cytotoxicity 
Comet 
[OTM 
(SEM)] 
p-value 
neg. control 0.1 100.0 (0.00) 100.0 (0.00) 100.0 (0.00) 0 0.2 (0.03) - 
pos. Control 100 0.2 (0.09) 0.4 (0.09) 4.6 (0.84) 3 0.4 (0.04) ***  
untreated 0.1 90.3 (2.29) 90.3 (3.94) 87.9 (7.29) 0 0.2 (0.02) n.s. 
Ozone 0.1 95.4 (2.78) 100.1 (9.29) 89.1 (3.18) 0 0.2 (0.02) n.s. 
UV/H2O2 5.8 100.0 (0.00) 96.0 (5.60) 97.2 (1.40) 0 0.2 (0.02) n.s. 
 
 
 
Metoprolol: 
Metoprolol* 
 HPLC water 
MTT [% 
Viability (SD)] 
Comet 
[rel. OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 1 0   
pos. Control 27.0 (2.8) 2.66 (0.141) 3 *** 
Matrix control 90.0 (1.8) 0.99 (0.176) 0 n.s. 
untreated 70.0 (9.4) 0.39 (0.070) 0 n.s. 
60 min O3 92.0 (3.8) 1.06 (0.159) 0 n.s. 
60 min UV/H2O2 78.0 (7.3) 1.18 (0.122) 0 n.s. 
 
Metoprolol* 
WWTP effluent 
MTT [% 
Viability (SD)] 
Comet  
[rel. OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 1 0   
pos. Control 27.0 (2.8) 3.31 (0.249) 3  *** 
Matrix control 90.0 (1.8) 0.70 (0.085) 0 n.s. 
untreated 70.0 (9.4) 0.95 (0.114) 0 n.s. 
60 min O3 92.0 (3.8) 1.27 (0.185) 0 n.s. 
60 min UV/H2O2 78.0 (7.3) 1.05 (0.135) 0 n.s. 
* c(Metoprolol) ozonation = 1.4 mg/L; c(Metoprolol) UV/H2O2 = 0.1 mg/L 
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Ofloxacin: 
Ofloxacin 
[0.1 mg/L] 
HPLC water 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] Degree of 
cytotoxicity 
p-value 
Ozonation [10 mg/L] 
neg. control 100.0 (0.00) 0.11 (0.057) 0   
pos. Control 0.4 (0.50) 0.79 (0.057) 3 *** 
Matrix control 94.0 (8.63) 0.20 (0.046) 0 n.s. 
0 min 97.7 (10.47) 0.14 (0.025) 0 n.s. 
10 min 87.7 (3.46) 0.15 (0.034) 0 n.s. 
30 min 87.1 (6.43) 0.12 (0.019) 0 n.s. 
60 min 87.6 (0.28) 0.13 (0.022) 0 n.s. 
 
 
Ofloxacin 
[0.1 mg/L] 
WWTP effluent 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] Degree of 
cytotoxicity 
p-value 
UV/H2O2 [UV-Hg; 254 nm] 
neg. control 100.0 (0.00) 1.00 (0.000) 0   
pos. Control 1.7 (1.41) 6.30 (0.446) 3 *** 
Matrix control 103.3 (8.31) 1.14 (0.370) 0 n.s. 
O3 110.5 (1.27) 0.78 (0.237) 0 n.s. 
UV/H2O2 90.7 (1.84) 0.99 (0.070) 0 n.s. 
 
 
 
Sulfamethoxazole: 
Sulfamethoxazole 
[1.4 mg/L] 
HPLC 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] Degree of 
cytotoxicity 
p-value 
5 mg/L O3 
neg. control 100.0 (0.00) 0.18 (0.010) 0   
pos. Control 14.0 (0.08) 0.48 (0.015) 3 *** 
Matrix control 92.5 (7.36) 0.21 (0.031) 0 n.s. 
0 min 103.2 (4.37) 0.22 (0.024) 0 n.s. 
60 min 100.5 (7.63) 0.19 (0.035) 0 n.s. 
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Sulfamethoxazole 
[0.1 mg/L]  
WWTP effluent 
MTT  
[% Viability (SD)] 
Comet  
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
UV/H2O2 [Hg-LP, 15 W; 1 g/L H2O2] 
neg. control 100.0 (0.00) 0.13 (0.008) 0   
pos. Control 14.0 (0.08) 0.36 (0.013) 3 *** 
Matrix control 98.2 (2.15) 0.14 (0.018) 0 n.s. 
0 min 96.1 (3.97) 0.10 (0.014) 0 n.s. 
60 min 102.0 (3.95) 0.12 (0.025) 0 n.s. 
 
 
Sulfamethoxazole 
[0.1 mg/L] 
 HPLC 
LDHe 
[rel. LDHe 
activity] 
XTT  
[% Viability 
(SD)] 
NR  
[% Viability 
(SD)] 
SRB [% 
Viability 
(SD)] 
Degree of 
cytotoxicity 
Comet 
 [OTM 
(SEM)] 
p-value 
UV/H2O2 [Hg-LP, 15 W; 1 g/L H2O2] 
neg. control 0 100.0 (0.00) 100.0 (0.00) 
100.0 
(0.00) 0 
0.18 
(0.010)   
pos. Control 100 1.1 (0.55) 0.3 (0.18) 6.8 (1.34) 3 
0.48 
(0.015) *** 
Matrix control 0 93.9 (0.02) 83.4 (0.07) 98.2 (0.04) 0 
0.14 
(0.018) n.s. 
0 min 0 96.6 (2.50) 94.2 (8.18) 98.6 (1.67) 0 
0.13 
(0.020) n.s. 
10 min 0 96.5 (3.22) 97.6 (3.41) 95.4 (2.08) 0 
0.19 
(0.022) n.s. 
60 min 0 98.0 (1.17) 96.3 (5.17) 
100.0 
(0.01) 0 
0.14 
(0.018) n.s. 
 
Sulfamethoxazole 
[1.4 mg/l] 
 WWTP effluent 
LDHe 
[rel. LDHe 
activity] 
XTT [% 
Viability 
(SD)] 
NR [% 
Viability 
(SD)] 
SRB [% 
Viability 
(SD)] 
Degree of 
cytotoxicity 
Comet  
[OTM (SEM)] 
p-value 
Ozonation [5 mg/L]  
neg. control 0 
100.0 
(0.00) 
100.0 
(0.00) 100.0 (0.00) 0 0.13 (0.007)   
pos. Control 100 1.29 (0.32) 0.2 (0.00) 4.8 (0.00) 3 0.36 (0.013) *** 
Matrix control 0 95.0 (0.10) 87.0 (0.08) 86.0 (0.06) 0 0.17 (0.022) n.s. 
0 min 0 89.1 (2.88) 91.9 (0.98) 86.8 (3.68) 0 0.20 (0.024) n.s. 
60 min 0 95.7 (2.95) 
102.9 
(3.97) 89.2 (3.17) 0 0.21 (0.034) n.s. 
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TCEP: 
TCEP 
[0.1 mg/L] 
HPLC water 
MTT  
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
Ozonation [5 mg/L] 
neg. control 100.0 (0.00) 0.18 (0.097) 0   
pos. Control 0.0 (0.00) 0.59 (0.090) 3 *** 
Matrix control 98.8 (8.52) 0.08 (0.036) 0 n.s. 
0 min 94.5 (1.77) 0.07 (0.020) 0 n.s. 
60 min 103.7 (4.99) 0.14 (0.089) 0 n.s. 
 
 
TCEP 
[0.1 mg/L] 
HPLC water 
MTT  
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
UV/H2O2 [UV-Hg; 254 nm] 
neg. control 100.0 (0.00) 0.15 (0.038) 0   
pos. Control 0.0 (0.00) 0.58  (0.134) 3 *** 
Matrix control 100.7 (4.12) 0.13 (0.029) 0 n.s. 
0 min 98.4 (5.90) 0.07 (0.019) 0 n.s. 
60 min 39.3 (3.15) n.t. 3 n.s. 
 
 
TCPP: 
TCPP               
[0.1 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. Control 100.0 (8.71) 0.10 (0.022) 0   
pos. Control 0.0 (0.00) 0.63 (0.102) 3 *** 
Matrix control 102.7 (7.27) 0.21 (0.092) 0 n.s. 
0 min O3 100.1 (4.39) 0.10 (0.024) 0 n.s. 
60 min O3 99.9 (3.61) 0.09 (0.013) 0 n.s. 
0 min UV 100.8 (3.87) 0.14 (0.030) 0 n.s. 
60 min UV 67.9 (5.35) n.t. 2 n.t. 
O3 = 5 mg/L; UV = UV-Hg, 254 nm 
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Terbutryn: 
Terbutryn  
[0.2 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 1.00 0   
pos. control 0.3 (0.24) 5.88 (0.200) 3 *** 
0 µg/L O3 91.8 (6.56) 1.46 (0.172) 0 ** 
36 µg/L O3 101.1 (3.40) 2.47 (0.263) 0 *** 
100 µg/L O3 90.9 (4.72) 2.36 (0.296) 0 *** 
195 µg/L O3 91.9 (2.77) 2.47 (0.341) 0 *** 
800 µg/L O3 86.8 (6.52) 0.55 (0.083) 0 n.s. 
 
 
TPP: 
TPP               
[0.1 mg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (8.71) 0.19 (0.039) 0   
pos. control 14.0 (0.84) 0.59 (0.071) 3 *** 
Matrix control 100.5 (4.53) 0.24 (0.065) 0 n.s. 
0 min O3 102.3 (4.14) 0.60 (0.090) 0 *** 
60 min O3 96.6 (10.05) 0.12 (0.020) 0 n.s. 
0 min UV 99.1 (3.88) 0.34 (0.052) 0 *** 
60 min UV 96.7 (2.42) 0.14 (0.011) 0 n.s. 
O3 = 5 mg/L; UV = UV-Hg, 254 nm 
 
 
Triclosan: 
Triclosan [µg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. control 100.0 (0.00) 0.21 (0.015) 0   
pos. control 32.2 (7.36) 0.64 (0.033) 3 *** 
0.5 104.7 (7.93) 0.23 (0.019) 0 n.s. 
1 108.0 (3.74) 0.36 (0.043) 0 * 
5 107.7 (2.36) 0.40 (0.040) 0 n.s. 
10 102.0 (2.16) 0.45 (0.049) 0 ** 
50 99.3 (2.49) 0.65 (0.069) 0 ** 
100 97.0 (2.45) 0.57 (0.047) 0 * 
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2.4-Dichlorophenol: 
2,4-
Dichlorophenol 
[µg/L] 
MTT 
[% Viability (SD)] 
Comet 
[OTM (SEM)] 
Degree of 
cytotoxicity 
p-value 
neg. Control 100.0 (0.00) 0.21 (0.015) 0   
pos. Control 32.2 (7.36) 0.64 (0.033) 3 *** 
0.5 104.0 (2.83) 0.12 (0.010) 0 n.s. 
1 99.3 (4.50) 0.39 (0.055) 0 * 
5 103.3 (7.72) 0.28 (0.035) 0 n.s. 
10 98.7 (1.70) 0.43 (0.046) 0 n.s. 
50 100.0 (3.27) 0.32 (0.040) 0 n.s. 
100 91.0 (6.16) 0.36 (0.038) 0 n.s. 
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 Erklärung 8.7.
 
Hiermit versichere ich, dass ich die vorliegende Arbeit mit dem Titel 
 
„Toxicological in vitro evaluation of organic micropollutants before and after oxidative 
waste water treatment” 
 
selbst verfasst und keine außer den angegebenen Hilfsmitteln und Quellen benutzt 
habe, und dass die Arbeit in dieser oder ähnlicher Form noch bei keiner anderen 
Universität eingereicht wurde. 
 
 
Wuppertal, im Januar 2013 
 
 
 
 
 
 
